GeneIndex	SideEffectIndex	Target	UMLS_CUI	SE_name	EF	Pvalue	Qvalue	ChiSquare	FunctionalAnnotation
20	3753	ABCB1	C0038362	Stomatitis	3.44	7.5e-08	0.00062	28.9	Binding
20	149	ABCB1	C0002170	Alopecia	2.91	2.6e-06	0.012	22.1	Antagonist
20	1919	ABCB1	C0020473	Hyperlipidaemia	6.09	8.8e-11	7.7e-07	42.1	Binding
20	2824	ABCB1	C0028949	Oligomenorrhoea	4.74	7.4e-08	0.00061	28.9	Binding
20	203	ABCB1	C0002994	Angioedema	3.3	2.9e-06	0.022	21.9	Binding
20	149	ABCB1	C0002170	Alopecia	2.93	4.3e-10	3.7e-06	39	Binding
20	2571	ABCB1	C0333355	Mucosal inflammation	5.22	6.8e-09	5.7e-05	33.6	Binding
20	389	ABCB1	C0004509	Azoospermia	5.73	5.4e-10	4.6e-06	38.5	Binding
38	3866	ABCC8	C0040034	Thrombocytopenia	4.87	3.9e-08	0.00032	30.2	Binding
38	2309	ABCC8	C0023530	Leukopenia	5.75	6.3e-11	5.5e-07	42.7	Binding
38	1934	ABCC8	C0020517	Hypersensitivity	5.04	4.7e-23	4.5e-19	97.8	Binding
38	3364	ABCC8	C0015230	Rash	3.71	1e-05	0.046	19.5	Antagonist
38	3364	ABCC8	C0015230	Rash	3.01	1.2e-07	0.00097	28	Binding
38	1934	ABCC8	C0020517	Hypersensitivity	5.37	1.1e-11	5.4e-08	46.2	Antagonist
39	1934	ABCC9	C0020517	Hypersensitivity	5.37	1.8e-16	1.7e-12	67.8	Binding
49	167	ABCG2	C0002871	Anaemia	3.76	3.1e-06	0.024	21.8	Binding
49	3866	ABCG2	C0040034	Thrombocytopenia	3.45	4.2e-07	0.0034	25.6	Binding
1724	203	ACE	C0002994	Angioedema	16.06	4e-54	3.9e-50	240	Binding
1724	1005	ACE	C0010200	Cough	10.57	2.8e-45	2.8e-41	199.4	Binding
1724	2928	ACE	C0030252	Palpitations	3.51	2.8e-07	0.0023	26.4	Binding
1724	2938	ACE	C0030305	Pancreatitis	8.8	4e-15	3.7e-11	61.7	Binding
1724	1005	ACE	C0010200	Cough	10.28	6.7e-20	3.4e-16	83.4	Antagonist
1724	1216	ACE	C0013378	Dysgeusia	4.59	1.5e-07	0.0013	27.5	Binding
76	3525	ACHE	C0037036	Salivary hypersecretion	7.27	7.9e-29	7.6e-25	124.1	Binding
76	1143	ACHE	C0011991	Diarrhoea	1.99	1e-06	0.0082	23.9	Binding
76	2679	ACHE	C0027497	Nausea	1.71	1.8e-06	0.014	22.8	Binding
76	3525	ACHE	C0037036	Salivary hypersecretion	7.53	3.7e-15	1.8e-11	61.9	Antagonist
171	2928	ADORA2A	C0030252	Palpitations	4.34	1.8e-10	1.6e-06	40.6	Binding
171	200	ADORA2A	C0002962	Angina pectoris	7.15	6.7e-12	5.9e-08	47.1	Binding
171	1524	ADORA2A	C0016382	Flushing	4.06	5.3e-09	4.5e-05	34.1	Binding
172	2928	ADORA2B	C0030252	Palpitations	5.91	2.7e-11	2.4e-07	44.4	Binding
179	2662	ADRA1A	C0027424	Nasal congestion	2.52	1.1e-07	0.00052	28.2	Antagonist
179	2662	ADRA1A	C0027424	Nasal congestion	2.64	7.5e-17	7e-13	69.5	Binding
179	2662	ADRA1A	C0027424	Nasal congestion	4.84	1.8e-07	0.00014	27.2	Agonist
179	1655	ADRA1A	C0340274	Gestational hypertension	5.87	4.6e-13	4.1e-09	52.4	Binding
179	1268	ADRA1A	C0235969	Ejaculation disorder	3.57	6.6e-08	0.00032	29.2	Antagonist
179	2928	ADRA1A	C0030252	Palpitations	1.99	2.8e-11	2.5e-07	44.3	Binding
179	1483	ADRA1A	C0015726	Fear	8.83	2.3e-38	2.2e-34	167.8	Binding
179	595	ADRA1A	C0428977	Bradycardia	2.76	4.1e-06	0.0031	21.2	Agonist
179	244	ADRA1A	C0003467	Anxiety	3.03	1.5e-05	0.011	18.7	Agonist
179	4135	ADRA1A	C0085612	Ventricular arrhythmia	4.16	2.3e-09	1.9e-05	35.7	Binding
179	2161	ADRA1A	C0917801	Insomnia	1.59	4.7e-07	0.0038	25.4	Binding
179	3779	ADRA1A	C0011071	Sudden death	9.22	1e-17	9.6e-14	73.5	Binding
179	1240	ADRA1A	C0013428	Dysuria	1.9	5.1e-07	0.0041	25.2	Binding
179	3293	ADRA1A	C0033975	Psychotic disorder	3.01	1.7e-05	0.012	18.5	Agonist
179	1219	ADRA1A	C0013384	Dyskinesia	2.91	6.7e-11	5.8e-07	42.6	Binding
179	2875	ADRA1A	C0020651	Orthostatic hypotension	2.09	2.1e-12	1.9e-08	49.4	Binding
179	3293	ADRA1A	C0033975	Psychotic disorder	1.8	2.1e-06	0.017	22.5	Binding
179	2665	ADRA1A	C0231919	Nasal dryness	8.36	2.7e-27	2.6e-23	117.1	Binding
179	1938	ADRA1A	C0020538	Hypertension	2.56	6.7e-05	0.045	15.9	Agonist
179	1483	ADRA1A	C0015726	Fear	8.34	2.8e-17	2.5e-14	71.5	Agonist
179	3312	ADRA1A	C0034063	Pulmonary oedema	3.71	6e-08	5e-04	29.3	Binding
179	4118	ADRA1A	C1456863	Vasoconstriction	7.86	1.1e-22	1e-18	96.2	Binding
179	2875	ADRA1A	C0020651	Orthostatic hypotension	2.48	3e-10	1.5e-06	39.7	Antagonist
179	2211	ADRA1A	C0022107	Irritability	3.55	6e-05	0.041	16.1	Agonist
179	3666	ADRA1A	C0851578	Sleep disorder	1.82	1.9e-07	0.0016	27.1	Binding
179	2663	ADRA1A	C0858259	Nasal discomfort	5.67	6.3e-10	5.5e-06	38.2	Binding
179	1573	ADRA1A	C0017086	Gangrene	3.76	1.5e-08	0.00013	32.1	Binding
179	2712	ADRA1A	C0027765	Nervous system disorder	4.81	4.6e-08	0.00038	29.9	Binding
179	2928	ADRA1A	C0030252	Palpitations	2.69	2.5e-06	0.0019	22.1	Agonist
179	3821	ADRA1A	C0039231	Tachycardia	1.78	5.5e-11	4.8e-07	43	Binding
179	1240	ADRA1A	C0013428	Dysuria	3.11	1.9e-05	0.014	18.3	Agonist
179	1913	ADRA1A	C0020458	Hyperhidrosis	1.85	3.7e-08	3e-04	30.3	Binding
179	1268	ADRA1A	C0235969	Ejaculation disorder	2.82	6.3e-09	5.3e-05	33.7	Binding
179	3680	ADRA1A	C0037383	Sneezing	5.61	1.2e-10	1.1e-06	41.4	Binding
179	2924	ADRA1A	C0030232	Pallor	3.88	2e-10	1.7e-06	40.5	Binding
179	778	ADRA1A	C2937358	Cerebral haemorrhage	5.71	4.5e-16	4.2e-12	66	Binding
180	4118	ADRA1B	C1456863	Vasoconstriction	7.98	2.2e-20	2.1e-16	85.6	Binding
180	2662	ADRA1B	C0027424	Nasal congestion	2.66	3e-08	0.00014	30.7	Antagonist
180	2924	ADRA1B	C0030232	Pallor	4.69	2.7e-14	2.4e-10	58	Binding
180	2875	ADRA1B	C0020651	Orthostatic hypotension	2.13	1.3e-11	1.2e-07	45.8	Binding
180	1219	ADRA1B	C0013384	Dyskinesia	3.45	1e-06	0.0047	23.9	Antagonist
180	2928	ADRA1B	C0030252	Palpitations	1.99	7.6e-10	6.5e-06	37.9	Binding
180	2665	ADRA1B	C0231919	Nasal dryness	9.61	3.4e-32	3.3e-28	139.5	Binding
180	1483	ADRA1B	C0015726	Fear	9.35	1e-37	9.7e-34	164.8	Binding
180	1094	ADRA1B	C0549249	Depressed level of consciousness	2.82	1.5e-06	0.012	23.2	Binding
180	1268	ADRA1B	C0235969	Ejaculation disorder	2.59	2.6e-06	0.02	22.1	Binding
180	1219	ADRA1B	C0013384	Dyskinesia	3.26	7.3e-13	6.5e-09	51.5	Binding
180	1268	ADRA1B	C0235969	Ejaculation disorder	3.42	1.2e-06	0.0056	23.6	Antagonist
180	2662	ADRA1B	C0027424	Nasal congestion	2.68	1.6e-15	1.5e-11	63.5	Binding
180	2712	ADRA1B	C0027765	Nervous system disorder	5.54	1.3e-09	1.1e-05	36.9	Binding
180	778	ADRA1B	C2937358	Cerebral haemorrhage	5.47	9.6e-13	8.5e-09	50.9	Binding
180	1913	ADRA1B	C0020458	Hyperhidrosis	1.86	2.6e-07	0.0021	26.5	Binding
180	3821	ADRA1B	C0039231	Tachycardia	1.74	8.5e-09	7.2e-05	33.2	Binding
180	1655	ADRA1B	C0340274	Gestational hypertension	7.23	4.2e-18	3.9e-14	75.2	Binding
180	3312	ADRA1B	C0034063	Pulmonary oedema	3.47	5.6e-06	0.043	20.6	Binding
180	595	ADRA1B	C0428977	Bradycardia	2.88	1e-05	0.0078	19.4	Agonist
180	2663	ADRA1B	C0858259	Nasal discomfort	6.52	9e-12	7.9e-08	46.5	Binding
180	595	ADRA1B	C0428977	Bradycardia	1.8	5.1e-06	0.04	20.8	Binding
180	1573	ADRA1B	C0017086	Gangrene	3.81	8.6e-08	7e-04	28.7	Binding
180	244	ADRA1B	C0003467	Anxiety	3.22	2.2e-05	0.016	18	Agonist
180	3680	ADRA1B	C0037383	Sneezing	6.45	1.2e-12	1.1e-08	50.5	Binding
180	3438	ADRA1B	C1260922	Respiration abnormal	3.25	1.6e-06	0.013	23	Binding
180	2875	ADRA1B	C0020651	Orthostatic hypotension	2.4	1.1e-08	5.4e-05	32.6	Antagonist
181	1219	ADRA1D	C0013384	Dyskinesia	3.02	9.1e-10	7.8e-06	37.5	Binding
181	2662	ADRA1D	C0027424	Nasal congestion	2.53	3.8e-12	3.4e-08	48.2	Binding
181	595	ADRA1D	C0428977	Bradycardia	2.97	1.1e-05	0.0084	19.3	Agonist
181	3821	ADRA1D	C0039231	Tachycardia	1.75	2.4e-08	2e-04	31.1	Binding
181	2875	ADRA1D	C0020651	Orthostatic hypotension	2.17	2.4e-11	2.1e-07	44.6	Binding
181	2733	ADRA1D	C0027932	Neurosis	2.21	3.3e-06	0.025	21.7	Binding
181	778	ADRA1D	C2937358	Cerebral haemorrhage	4.76	1.4e-08	0.00011	32.2	Binding
181	1655	ADRA1D	C0340274	Gestational hypertension	6.29	3e-12	2.7e-08	48.7	Binding
181	1913	ADRA1D	C0020458	Hyperhidrosis	1.81	3.2e-06	0.025	21.7	Binding
181	2928	ADRA1D	C0030252	Palpitations	1.99	3e-09	2.6e-05	35.2	Binding
181	4118	ADRA1D	C1456863	Vasoconstriction	6.36	2.1e-11	1.8e-07	44.9	Binding
181	2665	ADRA1D	C0231919	Nasal dryness	8.8	2.2e-24	2.1e-20	103.9	Binding
181	2875	ADRA1D	C0020651	Orthostatic hypotension	2.48	1.2e-08	5.8e-05	32.5	Antagonist
181	1483	ADRA1D	C0015726	Fear	8.39	2.3e-27	2.2e-23	117.5	Binding
181	2924	ADRA1D	C0030232	Pallor	4.13	8.8e-10	7.6e-06	37.6	Binding
181	244	ADRA1D	C0003467	Anxiety	3.25	4.2e-05	0.029	16.8	Agonist
182	1655	ADRA2A	C0340274	Gestational hypertension	8.64	2.2e-22	2.1e-18	94.7	Binding
182	1483	ADRA2A	C0015726	Fear	10.2	4.2e-38	4.1e-34	166.5	Binding
182	2662	ADRA2A	C0027424	Nasal congestion	5.13	8.7e-09	7.2e-06	33.1	Agonist
182	1766	ADRA2A	C0018524	Hallucination	2.15	2.9e-06	0.023	21.9	Binding
182	2712	ADRA2A	C0027765	Nervous system disorder	6.02	1e-09	8.8e-06	37.3	Binding
182	2665	ADRA2A	C0231919	Nasal dryness	12.7	5.1e-49	5e-45	216.6	Binding
182	2928	ADRA2A	C0030252	Palpitations	1.92	1.9e-07	0.0015	27.2	Binding
182	3693	ADRA2A	C2830004	Somnolence	1.54	2.1e-06	0.016	22.5	Binding
182	2875	ADRA2A	C0020651	Orthostatic hypotension	2.68	6.9e-09	3.4e-05	33.5	Antagonist
182	1219	ADRA2A	C0013384	Dyskinesia	4.69	3.6e-27	3.5e-23	116.5	Binding
182	4027	ADRA2A	C0042024	Urinary incontinence	3.39	6.2e-07	0.005	24.9	Binding
182	1483	ADRA2A	C0015726	Fear	6.69	4.1e-11	3.5e-08	43.6	Agonist
182	4118	ADRA2A	C1456863	Vasoconstriction	7.63	1.9e-15	1.7e-11	63.2	Binding
182	2663	ADRA2A	C0858259	Nasal discomfort	7.09	8e-12	7.1e-08	46.8	Binding
182	3438	ADRA2A	C1260922	Respiration abnormal	3.4	3.4e-06	0.027	21.6	Binding
182	2733	ADRA2A	C0027932	Neurosis	2.43	1.5e-07	0.0012	27.6	Binding
182	595	ADRA2A	C0428977	Bradycardia	2.04	5.2e-08	0.00043	29.7	Binding
182	1268	ADRA2A	C0235969	Ejaculation disorder	2.71	4.2e-06	0.033	21.2	Binding
182	3221	ADRA2A	C0033117	Priapism	3.42	8.4e-08	0.00069	28.7	Binding
182	1573	ADRA2A	C0017086	Gangrene	3.65	5.5e-06	0.043	20.6	Binding
182	1219	ADRA2A	C0013384	Dyskinesia	4.28	4.2e-08	3.4e-05	30	Agonist
182	1219	ADRA2A	C0013384	Dyskinesia	4.46	4.2e-09	2.1e-05	34.5	Antagonist
182	2662	ADRA2A	C0027424	Nasal congestion	2.73	7.1e-14	6.4e-10	56.1	Binding
182	778	ADRA2A	C2937358	Cerebral haemorrhage	5.23	1e-09	8.9e-06	37.2	Binding
182	2924	ADRA2A	C0030232	Pallor	5.07	1.9e-14	1.7e-10	58.6	Binding
182	3680	ADRA2A	C0037383	Sneezing	8.35	1.3e-18	1.2e-14	77.6	Binding
182	2875	ADRA2A	C0020651	Orthostatic hypotension	2.02	3e-08	0.00025	30.7	Binding
182	595	ADRA2A	C0428977	Bradycardia	2.79	1.7e-06	0.0013	22.9	Agonist
182	1094	ADRA2A	C0549249	Depressed level of consciousness	3.21	9.1e-08	0.00075	28.6	Binding
183	2733	ADRA2B	C0027932	Neurosis	2.57	2.1e-08	0.00018	31.4	Binding
183	1483	ADRA2B	C0015726	Fear	10.25	1.7e-36	1.6e-32	159.2	Binding
183	1219	ADRA2B	C0013384	Dyskinesia	4.71	4.9e-26	4.7e-22	111.4	Binding
183	4027	ADRA2B	C0042024	Urinary incontinence	3.58	1.6e-07	0.0013	27.5	Binding
183	3438	ADRA2B	C1260922	Respiration abnormal	3.59	1.1e-06	0.0084	23.8	Binding
183	2662	ADRA2B	C0027424	Nasal congestion	2.66	2.9e-12	2.6e-08	48.8	Binding
183	1766	ADRA2B	C0018524	Hallucination	2.33	1.3e-07	0.0011	27.9	Binding
183	595	ADRA2B	C0428977	Bradycardia	2.67	1.6e-05	0.012	18.6	Agonist
183	2662	ADRA2B	C0027424	Nasal congestion	4.93	1.2e-07	9.9e-05	28	Agonist
183	2665	ADRA2B	C0231919	Nasal dryness	12.77	6.3e-47	6.2e-43	207	Binding
183	1655	ADRA2B	C0340274	Gestational hypertension	9.13	7.5e-24	7.1e-20	101.4	Binding
183	1219	ADRA2B	C0013384	Dyskinesia	3.83	5.6e-06	0.0042	20.6	Agonist
183	4118	ADRA2B	C1456863	Vasoconstriction	7.38	1.2e-13	1.1e-09	54.9	Binding
183	595	ADRA2B	C0428977	Bradycardia	1.93	2.5e-06	0.019	22.2	Binding
183	2875	ADRA2B	C0020651	Orthostatic hypotension	2.5	5.8e-07	0.0027	25	Antagonist
183	3680	ADRA2B	C0037383	Sneezing	8.14	1.1e-16	1e-12	68.7	Binding
183	778	ADRA2B	C2937358	Cerebral haemorrhage	5.06	1.4e-08	0.00012	32.2	Binding
183	1094	ADRA2B	C0549249	Depressed level of consciousness	3.22	1.9e-07	0.0015	27.2	Binding
183	1219	ADRA2B	C0013384	Dyskinesia	4.06	6e-07	0.0028	24.9	Antagonist
183	2875	ADRA2B	C0020651	Orthostatic hypotension	1.89	2.9e-06	0.023	21.9	Binding
183	2924	ADRA2B	C0030232	Pallor	5.07	1e-13	9.2e-10	55.3	Binding
184	595	ADRA2C	C0428977	Bradycardia	2.7	7.1e-05	0.048	15.8	Agonist
184	2733	ADRA2C	C0027932	Neurosis	2.69	6.8e-09	5.7e-05	33.6	Binding
184	1483	ADRA2C	C0015726	Fear	10.49	1.4e-35	1.4e-31	155	Binding
184	3438	ADRA2C	C1260922	Respiration abnormal	3.87	1.9e-07	0.0015	27.2	Binding
184	3680	ADRA2C	C0037383	Sneezing	8.77	3.6e-18	3.3e-14	75.5	Binding
184	778	ADRA2C	C2937358	Cerebral haemorrhage	4.96	1.2e-07	0.001	28	Binding
184	2665	ADRA2C	C0231919	Nasal dryness	13.06	1.1e-45	1.1e-41	201.3	Binding
184	1219	ADRA2C	C0013384	Dyskinesia	4.94	3.4e-27	3.3e-23	116.7	Binding
184	2924	ADRA2C	C0030232	Pallor	5.46	3.9e-15	3.6e-11	61.8	Binding
184	3693	ADRA2C	C2830004	Somnolence	1.54	6.3e-06	0.049	20.4	Binding
184	1655	ADRA2C	C0340274	Gestational hypertension	9.83	5.5e-26	5.3e-22	111.2	Binding
184	2875	ADRA2C	C0020651	Orthostatic hypotension	2.54	6.1e-07	0.0029	24.9	Antagonist
184	2875	ADRA2C	C0020651	Orthostatic hypotension	2.03	1.5e-07	0.0012	27.6	Binding
184	4118	ADRA2C	C1456863	Vasoconstriction	7.23	4.3e-12	3.8e-08	48	Binding
184	2662	ADRA2C	C0027424	Nasal congestion	2.69	8.9e-12	7.8e-08	46.6	Binding
184	1219	ADRA2C	C0013384	Dyskinesia	4.62	6.7e-09	3.2e-05	33.6	Antagonist
184	595	ADRA2C	C0428977	Bradycardia	1.96	3.1e-06	0.025	21.7	Binding
184	4027	ADRA2C	C0042024	Urinary incontinence	3.86	2.2e-08	0.00018	31.3	Binding
184	3221	ADRA2C	C0033117	Priapism	3.46	3.9e-07	0.0031	25.8	Binding
184	1766	ADRA2C	C0018524	Hallucination	2.31	5.7e-07	0.0045	25	Binding
184	1094	ADRA2C	C0549249	Depressed level of consciousness	3.29	2.5e-07	0.002	26.6	Binding
185	244	ADRB1	C0003467	Anxiety	4.02	2.2e-07	0.00017	26.9	Agonist
185	313	ADRB1	C0003811	Arrhythmia	1.8	1e-10	8.8e-07	41.8	Binding
185	2734	ADRB1	C0235032	Neurotoxicity	5.78	7e-12	6.2e-08	47	Binding
185	364	ADRB1	C0004245	Atrioventricular block	5.01	4.7e-17	4.4e-13	70.4	Binding
185	2384	ADRB1	C0024115	Lung disorder	2.53	1.8e-06	0.014	22.8	Binding
185	595	ADRB1	C0428977	Bradycardia	3.23	5.5e-11	2.7e-07	43	Antagonist
185	708	ADRB1	C0018801	Cardiac failure	10.06	2e-37	1.9e-33	163.5	Binding
185	1483	ADRB1	C0015726	Fear	9.87	4.3e-26	4.2e-22	111.6	Binding
185	656	ADRB1	C0006266	Bronchospasm	4.22	1.3e-22	1.2e-18	95.8	Binding
185	1766	ADRB1	C0018524	Hallucination	2.44	5.2e-07	0.0042	25.2	Binding
185	3039	ADRB1	C0277925	Peripheral coldness	21.98	1.2e-80	6.4e-77	361.6	Antagonist
185	656	ADRB1	C0006266	Bronchospasm	4.67	1.5e-13	7.7e-10	54.5	Antagonist
185	200	ADRB1	C0002962	Angina pectoris	2.66	2.2e-06	0.017	22.4	Binding
185	710	ADRB1	C0018802	Cardiac failure congestive	10.45	5.3e-41	5.2e-37	179.8	Binding
185	595	ADRB1	C0428977	Bradycardia	3.16	2.3e-22	2.2e-18	94.7	Binding
185	349	ADRB1	C0004093	Asthenia	1.62	2e-06	0.016	22.6	Binding
185	710	ADRB1	C0018802	Cardiac failure congestive	11.6	5.9e-25	3e-21	106.4	Antagonist
185	1198	ADRB1	C0314719	Dry eye	13.47	1.5e-72	1.5e-68	324.5	Binding
185	364	ADRB1	C0004245	Atrioventricular block	4.98	4.2e-09	2.1e-05	34.5	Antagonist
185	3666	ADRB1	C0851578	Sleep disorder	2.48	8.3e-12	7.3e-08	46.7	Binding
185	708	ADRB1	C0018801	Cardiac failure	11.44	2.3e-20	1.1e-16	85.6	Antagonist
185	3375	ADRB1	C0034735	Raynaud's phenomenon	16.44	9.4e-56	9.3e-52	247.4	Binding
185	3039	ADRB1	C0277925	Peripheral coldness	18.95	2.6e-143	2.6e-139	649.7	Binding
185	2928	ADRB1	C0030252	Palpitations	3.74	6.6e-10	5.5e-07	38.1	Agonist
185	313	ADRB1	C0003811	Arrhythmia	2.44	1.6e-06	0.0012	23.1	Agonist
185	3666	ADRB1	C0851578	Sleep disorder	2.66	7.1e-07	0.0033	24.6	Antagonist
185	3293	ADRB1	C0033975	Psychotic disorder	2.15	7.5e-07	0.006	24.5	Binding
185	1198	ADRB1	C0314719	Dry eye	14.41	3.3e-37	1.7e-33	162.5	Antagonist
185	2502	ADRB1	C0025517	Metabolic disorder	15.92	2.9e-29	2.8e-25	126.1	Binding
185	1061	ADRB1	C0151588	Deafness transitory	8.71	5.4e-15	4.9e-11	61.1	Binding
185	2928	ADRB1	C0030252	Palpitations	2.06	2.4e-07	0.002	26.7	Binding
186	703	ADRB2	C0018790	Cardiac arrest	2.71	4.3e-06	0.034	21.1	Binding
186	3666	ADRB2	C0851578	Sleep disorder	2.12	2.9e-07	0.0023	26.3	Binding
186	4135	ADRB2	C0085612	Ventricular arrhythmia	5.83	4e-11	3.5e-07	43.6	Binding
186	2734	ADRB2	C0235032	Neurotoxicity	4.9	3.2e-08	0.00026	30.6	Binding
186	656	ADRB2	C0006266	Bronchospasm	4.12	2.5e-21	2.4e-17	89.9	Binding
186	3956	ADRB2	C0040822	Tremor	3.29	4.1e-08	3.4e-05	30.1	Agonist
186	2928	ADRB2	C0030252	Palpitations	2.57	2.2e-14	2e-10	58.4	Binding
186	708	ADRB2	C0018801	Cardiac failure	10.57	1.5e-41	1.5e-37	182.3	Binding
186	1483	ADRB2	C0015726	Fear	10.56	4.3e-30	4.2e-26	129.9	Binding
186	710	ADRB2	C0018802	Cardiac failure congestive	9.05	7e-30	6.8e-26	128.9	Binding
186	364	ADRB2	C0004245	Atrioventricular block	4.3	6.4e-07	0.003	24.8	Antagonist
186	1198	ADRB2	C0314719	Dry eye	13.57	8.2e-35	4.2e-31	151.5	Antagonist
186	200	ADRB2	C0002962	Angina pectoris	3.02	7.6e-09	6.4e-05	33.4	Binding
186	3039	ADRB2	C0277925	Peripheral coldness	20.69	1.4e-75	7.1e-72	338.5	Antagonist
186	2928	ADRB2	C0030252	Palpitations	4.8	7.1e-17	6.2e-14	69.7	Agonist
186	656	ADRB2	C0006266	Bronchospasm	4.4	1.9e-12	9.6e-09	49.6	Antagonist
186	4119	ADRB2	C0595862	Vasodilatation	2.86	3.1e-07	0.0025	26.2	Binding
186	3039	ADRB2	C0277925	Peripheral coldness	17.54	2.3e-121	2.3e-117	548.8	Binding
186	2631	ADRB2	C0027051	Myocardial infarction	3	1e-06	0.00081	23.9	Agonist
186	313	ADRB2	C0003811	Arrhythmia	2.8	6.2e-09	5.1e-06	33.8	Agonist
186	3843	ADRB2	C0233494	Tension	17.46	2.6e-32	2.5e-28	140	Binding
186	710	ADRB2	C0018802	Cardiac failure congestive	10.01	2.4e-19	1.2e-15	80.9	Antagonist
186	244	ADRB2	C0003467	Anxiety	3.64	1.5e-05	0.011	18.7	Agonist
186	313	ADRB2	C0003811	Arrhythmia	1.97	3.5e-15	3.2e-11	61.9	Binding
186	2631	ADRB2	C0027051	Myocardial infarction	2.23	2.4e-12	2.1e-08	49.1	Binding
186	3956	ADRB2	C0040822	Tremor	1.9	1.3e-07	0.0011	27.9	Binding
186	595	ADRB2	C0428977	Bradycardia	3.21	1.9e-23	1.8e-19	99.5	Binding
186	3375	ADRB2	C0034735	Raynaud's phenomenon	12.83	1e-32	9.8e-29	141.9	Binding
186	595	ADRB2	C0428977	Bradycardia	3.67	4.2e-16	2.1e-12	66.2	Antagonist
186	200	ADRB2	C0002962	Angina pectoris	5.74	4.5e-10	3.8e-07	38.9	Agonist
186	3821	ADRB2	C0039231	Tachycardia	3.74	2.3e-10	1.9e-07	40.2	Agonist
186	364	ADRB2	C0004245	Atrioventricular block	4.37	2.5e-12	2.2e-08	49	Binding
186	708	ADRB2	C0018801	Cardiac failure	11.84	2.3e-23	1.2e-19	99.2	Antagonist
186	1198	ADRB2	C0314719	Dry eye	12.11	1.6e-57	1.5e-53	255.6	Binding
187	2928	ADRB3	C0030252	Palpitations	2.46	4.2e-08	0.00035	30	Binding
187	595	ADRB3	C0428977	Bradycardia	3.86	1.8e-23	1.7e-19	99.7	Binding
187	708	ADRB3	C0018801	Cardiac failure	13.48	4e-42	3.9e-38	185	Binding
187	1766	ADRB3	C0018524	Hallucination	3.13	9.7e-09	8.2e-05	32.9	Binding
187	595	ADRB3	C0428977	Bradycardia	3.83	4.6e-12	2.3e-08	47.8	Antagonist
187	364	ADRB3	C0004245	Atrioventricular block	6.14	1.4e-16	1.3e-12	68.4	Binding
187	3293	ADRB3	C0033975	Psychotic disorder	2.44	2.1e-06	0.017	22.5	Binding
187	313	ADRB3	C0003811	Arrhythmia	1.82	3.3e-07	0.0027	26.1	Binding
187	710	ADRB3	C0018802	Cardiac failure congestive	11.01	1.7e-27	1.6e-23	118.1	Binding
187	2928	ADRB3	C0030252	Palpitations	4.36	1.3e-10	1.1e-07	41.3	Agonist
187	3039	ADRB3	C0277925	Peripheral coldness	26.49	3.3e-82	1.7e-78	368.9	Antagonist
187	1198	ADRB3	C0314719	Dry eye	15.38	1.5e-57	1.4e-53	255.7	Binding
187	3039	ADRB3	C0277925	Peripheral coldness	23.34	1.4e-132	1.4e-128	600.3	Binding
187	3666	ADRB3	C0851578	Sleep disorder	3.04	3e-13	2.7e-09	53.2	Binding
187	708	ADRB3	C0018801	Cardiac failure	16.37	4.3e-30	2.2e-26	129.9	Antagonist
187	656	ADRB3	C0006266	Bronchospasm	5.69	4.6e-15	2.3e-11	61.4	Antagonist
187	3375	ADRB3	C0034735	Raynaud's phenomenon	16.64	7.8e-34	7.6e-30	147	Binding
187	656	ADRB3	C0006266	Bronchospasm	5.41	3.1e-25	3e-21	107.7	Binding
187	313	ADRB3	C0003811	Arrhythmia	2.51	2.1e-05	0.016	18.1	Agonist
187	200	ADRB3	C0002962	Angina pectoris	3.07	6.3e-06	0.049	20.4	Binding
187	1198	ADRB3	C0314719	Dry eye	16.21	6.8e-33	3.5e-29	142.7	Antagonist
187	3666	ADRB3	C0851578	Sleep disorder	2.9	2.8e-06	0.013	22	Antagonist
210	1171	AGTR1	C0012833	Dizziness	4.19	2.2e-08	0.00019	31.3	Binding
244	1600	AKR1B1	C0017178	Gastrointestinal disorder	2.75	4.9e-06	0.022	20.9	Antagonist
259	3866	ALB	C0040034	Thrombocytopenia	2.13	4.7e-08	0.00039	29.8	Binding
259	2002	ALB	C3203356	Hypoprothrombinaemia	4.05	6e-08	0.00049	29.4	Binding
259	3278	ALB	C1257843	Pseudomembranous colitis	9.97	1.6e-17	1.5e-13	72.5	Binding
259	3039	ALB	C0277925	Peripheral coldness	4.46	2.8e-07	0.0022	26.4	Binding
259	3594	ALB	C0036830	Serum sickness	11.64	8.4e-21	7.9e-17	87.5	Binding
259	4114	ALB	C0042384	Vasculitis	3.64	7.7e-07	0.0062	24.4	Binding
259	1379	ALB	C0014742	Erythema multiforme	2.92	1.7e-07	0.0014	27.4	Binding
259	2221	ALB	C0022354	Jaundice cholestatic	3.28	1.4e-06	0.011	23.3	Binding
259	708	ALB	C0018801	Cardiac failure	4.4	3.8e-07	0.003	25.8	Binding
259	3749	ALB	C0038325	Stevens-Johnson syndrome	4.59	6.3e-07	0.005	24.8	Binding
259	1346	ALB	C0014457	Eosinophilia	4.16	1.3e-13	1.1e-09	54.9	Binding
259	3930	ALB	C0014518	Toxic epidermal necrolysis	3.95	3.5e-08	0.00029	30.4	Binding
259	267	ALB	C0002874	Aplastic anaemia	3.63	4e-08	0.00033	30.1	Binding
259	1603	ALB	C0017181	Gastrointestinal haemorrhage	2.75	3.1e-06	0.024	21.8	Binding
413	1719	AR	C0018418	Gynaecomastia	3.62	2.7e-15	2.5e-11	62.4	Binding
413	2314	AR	C0011124	Libido decreased	5.02	1e-07	0.00082	28.4	Binding
413	46	AR	C0702166	Acne	20	6.6e-128	6.6e-124	578.9	Binding
413	4219	AR	C0043094	Weight increased	3.49	1.9e-06	0.0089	22.7	Antagonist
413	2488	AR	C0025345	Menstrual disorder	5.3	1.2e-10	6.1e-07	41.4	Antagonist
413	2518	AR	C0025874	Metrorrhagia	20.95	3e-43	3e-39	190.1	Binding
413	1865	AR	C0019572	Hirsutism	12.71	1.1e-34	1.1e-30	150.9	Binding
413	2488	AR	C0025345	Menstrual disorder	5.85	5.1e-36	4.9e-32	157	Binding
413	46	AR	C0702166	Acne	20.47	1.3e-54	1.2e-51	242.1	Agonist
413	1297	AR	C0342579	Electrolyte imbalance	3.38	2.9e-07	0.0024	26.3	Binding
413	4219	AR	C0043094	Weight increased	3.09	4.3e-12	3.8e-08	48	Binding
413	1022	AR	C0332601	Cushingoid	14.4	2.3e-34	2.2e-30	149.4	Binding
413	4219	AR	C0043094	Weight increased	5.88	1.8e-09	1.5e-06	36.2	Agonist
413	2221	AR	C0022354	Jaundice cholestatic	5.09	7.2e-08	0.00059	29	Binding
413	389	AR	C0004509	Azoospermia	9.9	7.8e-21	7.3e-17	87.7	Binding
413	159	AR	C0002453	Amenorrhoea	3.1	1.2e-06	0.0092	23.7	Binding
413	2793	AR	C0013604	Oedema	6.29	3.1e-18	2.8e-15	75.8	Agonist
413	1719	AR	C0018418	Gynaecomastia	4.49	2.3e-10	1.1e-06	40.2	Antagonist
413	1901	AR	C0020437	Hypercalcaemia	11.2	3.2e-38	3.1e-34	167.1	Binding
413	2085	AR	C0021359	Infertility	20.51	3.2e-38	3.1e-34	167.1	Binding
413	3221	AR	C0033117	Priapism	5.34	2.3e-08	0.00019	31.2	Binding
413	2793	AR	C0013604	Oedema	4.06	2.1e-25	2.1e-21	108.5	Binding
413	1814	AR	C0086565	Hepatic function abnormal	4.12	1.4e-07	0.0011	27.8	Binding
413	1365	AR	C0151628	Epiphyses premature fusion	24.39	1.9e-65	1.9e-61	291.9	Binding
413	633	AR	C0024902	Breast pain	26.34	1.3e-97	1.3e-93	439.7	Binding
413	1096	AR	C0011570	Depression	3.32	4e-16	3.7e-12	66.2	Binding
413	1317	AR	C0014130	Endocrine disorder	3	1.9e-08	0.00015	31.6	Binding
413	582	AR	C0005940	Bone disorder	18.13	2.6e-58	2.6e-54	259.2	Binding
413	4165	AR	C0042755	Virilism	64.19	5.5e-192	5.5e-188	873.6	Binding
413	2488	AR	C0025345	Menstrual disorder	12.16	1.2e-28	1.1e-25	123.3	Agonist
413	2891	AR	C0029456	Osteoporosis	17.27	1.3e-48	1.3e-44	214.7	Binding
515	3333	ATP1A1	C0268104	Purine metabolism disorder	16.86	5.3e-31	5.2e-27	134.1	Binding
637	3525	BCHE	C0037036	Salivary hypersecretion	8.64	3.1e-25	3e-21	107.7	Binding
637	3525	BCHE	C0037036	Salivary hypersecretion	11.79	3.3e-23	1.7e-19	98.5	Antagonist
637	595	BCHE	C0428977	Bradycardia	3.26	2.7e-08	0.00022	30.9	Binding
871	2938	CA1	C0030305	Pancreatitis	5.41	4.2e-18	3.9e-14	75.2	Binding
871	3866	CA1	C0040034	Thrombocytopenia	2.6	1.1e-05	0.05	19.3	Antagonist
871	3333	CA1	C0268104	Purine metabolism disorder	12.31	5e-38	4.9e-34	166.2	Binding
871	4243	CA1	C0221185	Xanthopsia	17.07	8.7e-35	8.4e-31	151.4	Binding
871	1744	CA1	C0002878	Haemolytic anaemia	3.35	3.7e-07	0.003	25.8	Binding
871	1696	CA1	C0018099	Gout	6.09	8e-10	3.9e-06	37.8	Antagonist
871	3866	CA1	C0040034	Thrombocytopenia	2.82	4.7e-11	4.1e-07	43.3	Binding
871	1743	CA1	C0019054	Haemolysis	8.1	3.7e-15	3.4e-11	61.9	Binding
871	3333	CA1	C0268104	Purine metabolism disorder	11.79	4.6e-21	2.4e-17	88.7	Antagonist
871	1696	CA1	C0018099	Gout	6.56	4.1e-19	3.9e-15	79.8	Binding
871	1986	CA1	C0020621	Hypokalaemia	6.22	5.7e-15	2.9e-11	61	Antagonist
871	1992	CA1	C0020625	Hyponatraemia	3.9	4.6e-06	0.036	21	Binding
871	267	CA1	C0002874	Aplastic anaemia	6.08	1.8e-15	1.6e-11	63.3	Binding
871	1986	CA1	C0020621	Hypokalaemia	5.75	8.2e-25	7.9e-21	105.8	Binding
871	2931	CA1	C0030286	Pancreatic disorder	5.6	1e-09	9e-06	37.2	Binding
871	1297	CA1	C0342579	Electrolyte imbalance	2.99	3.4e-07	0.0027	26	Binding
871	2938	CA1	C0030305	Pancreatitis	5.32	6.6e-10	3.3e-06	38.1	Antagonist
871	1952	CA1	C0740394	Hyperuricaemia	6.02	3.3e-16	3.1e-12	66.6	Binding
871	1065	CA1	C0232462	Decreased appetite	2.08	1.3e-06	0.01	23.5	Binding
871	1297	CA1	C0342579	Electrolyte imbalance	4.23	2.5e-07	0.0012	26.6	Antagonist
871	1690	CA1	C0017979	Glycosuria	15.01	5.1e-36	5e-32	157	Binding
872	2956	CA10	C0030554	Paraesthesia	3.95	3.6e-09	3e-05	34.9	Binding
873	2956	CA11	C0030554	Paraesthesia	3.95	3.6e-09	3e-05	34.9	Binding
874	2938	CA12	C0030305	Pancreatitis	8.02	4.3e-23	4.1e-19	97.9	Binding
874	3089	CA12	C0162830	Photosensitivity reaction	3.02	2.2e-06	0.017	22.4	Binding
874	1297	CA12	C0342579	Electrolyte imbalance	3.82	2.6e-07	0.0021	26.5	Binding
874	1744	CA12	C0002878	Haemolytic anaemia	4.53	5e-08	0.00042	29.7	Binding
874	1986	CA12	C0020621	Hypokalaemia	9.45	1.2e-39	1.1e-35	173.7	Binding
874	1696	CA12	C0018099	Gout	9.79	5.1e-24	4.9e-20	102.2	Binding
874	1986	CA12	C0020621	Hypokalaemia	10.87	3.7e-23	1.9e-19	98.2	Antagonist
874	3333	CA12	C0268104	Purine metabolism disorder	16.66	4.8e-37	4.7e-33	161.7	Binding
874	1952	CA12	C0740394	Hyperuricaemia	9.51	3.1e-23	3e-19	98.6	Binding
874	1690	CA12	C0017979	Glycosuria	22.14	2e-41	2e-37	181.7	Binding
874	3866	CA12	C0040034	Thrombocytopenia	2.85	2.3e-06	0.018	22.3	Binding
874	267	CA12	C0002874	Aplastic anaemia	7.29	3.6e-12	3.2e-08	48.3	Binding
8783	2956	CA13	C0030554	Paraesthesia	2.91	2.5e-06	0.02	22.1	Binding
8783	1297	CA13	C0342579	Electrolyte imbalance	4.07	2e-06	0.016	22.6	Binding
8783	1986	CA13	C0020621	Hypokalaemia	5.34	2.4e-08	2e-04	31.2	Binding
875	3089	CA14	C0162830	Photosensitivity reaction	3.04	1.8e-06	0.014	22.8	Binding
875	1986	CA14	C0020621	Hypokalaemia	9.93	8.4e-44	8.3e-40	192.6	Binding
875	3333	CA14	C0268104	Purine metabolism disorder	16.8	2.2e-37	2.1e-33	163.3	Binding
875	1696	CA14	C0018099	Gout	9.87	3e-24	2.9e-20	103.2	Binding
875	1744	CA14	C0002878	Haemolytic anaemia	4.57	4.1e-08	0.00034	30.1	Binding
875	1986	CA14	C0020621	Hypokalaemia	11.1	1.1e-23	5.4e-20	100.7	Antagonist
875	2938	CA14	C0030305	Pancreatitis	8.09	2.5e-23	2.4e-19	99	Binding
875	267	CA14	C0002874	Aplastic anaemia	7.35	2.7e-12	2.4e-08	48.9	Binding
875	1690	CA14	C0017979	Glycosuria	22.33	8.6e-42	8.4e-38	183.4	Binding
875	1297	CA14	C0342579	Electrolyte imbalance	4.13	1.1e-08	9.2e-05	32.7	Binding
875	1952	CA14	C0740394	Hyperuricaemia	9.59	1.9e-23	1.8e-19	99.6	Binding
876	3312	CA2	C0034063	Pulmonary oedema	6.88	1.7e-12	1.5e-08	49.8	Binding
876	1952	CA2	C0740394	Hyperuricaemia	6.21	7.8e-18	7.2e-14	74	Binding
876	3335	CA2	C0034150	Purpura	4.76	3e-07	0.0025	26.2	Binding
876	1690	CA2	C0017979	Glycosuria	15.76	5.2e-41	5.1e-37	179.9	Binding
876	1065	CA2	C0232462	Decreased appetite	2.03	3.1e-06	0.024	21.8	Binding
876	3333	CA2	C0268104	Purine metabolism disorder	13.41	6.6e-47	6.5e-43	206.9	Binding
876	1297	CA2	C0342579	Electrolyte imbalance	3.05	9.1e-08	0.00075	28.5	Binding
876	1297	CA2	C0342579	Electrolyte imbalance	4.21	2.8e-07	0.0013	26.4	Antagonist
876	1743	CA2	C0019054	Haemolysis	7.9	1e-14	9.4e-11	59.8	Binding
876	1744	CA2	C0002878	Haemolytic anaemia	3.84	3.4e-10	2.9e-06	39.4	Binding
876	3866	CA2	C0040034	Thrombocytopenia	2.9	3.8e-12	3.4e-08	48.2	Binding
876	3089	CA2	C0162830	Photosensitivity reaction	2.47	9.1e-07	0.0072	24.1	Binding
876	2938	CA2	C0030305	Pancreatitis	5.74	9.2e-12	4.6e-08	46.5	Antagonist
876	2938	CA2	C0030305	Pancreatitis	5.76	2.2e-21	2.1e-17	90.1	Binding
876	1696	CA2	C0018099	Gout	6.75	6.9e-21	6.5e-17	87.9	Binding
876	1696	CA2	C0018099	Gout	6.06	9.1e-10	4.5e-06	37.5	Antagonist
876	4243	CA2	C0221185	Xanthopsia	18.15	1e-40	1e-36	178.5	Binding
876	2931	CA2	C0030286	Pancreatic disorder	5.95	2.2e-11	1.9e-07	44.8	Binding
876	1986	CA2	C0020621	Hypokalaemia	6.2	7e-15	3.5e-11	60.6	Antagonist
876	1986	CA2	C0020621	Hypokalaemia	5.81	5.2e-26	5e-22	111.3	Binding
876	3333	CA2	C0268104	Purine metabolism disorder	11.74	6e-21	3e-17	88.2	Antagonist
876	267	CA2	C0002874	Aplastic anaemia	6.3	3.6e-17	3.4e-13	71	Binding
877	2938	CA3	C0030305	Pancreatitis	6.7	5.2e-11	4.5e-07	43.1	Binding
877	1952	CA3	C0740394	Hyperuricaemia	9.65	8.5e-17	7.9e-13	69.3	Binding
877	1986	CA3	C0020621	Hypokalaemia	6.71	3.4e-13	3.1e-09	52.9	Binding
877	1744	CA3	C0002878	Haemolytic anaemia	5.36	2.1e-08	0.00018	31.4	Binding
877	2956	CA3	C0030554	Paraesthesia	3.21	9.4e-08	0.00077	28.5	Binding
878	2938	CA4	C0030305	Pancreatitis	7.94	8.3e-15	4.2e-11	60.3	Antagonist
878	267	CA4	C0002874	Aplastic anaemia	7.04	5.7e-14	5.1e-10	56.5	Binding
878	3333	CA4	C0268104	Purine metabolism disorder	18.98	2.8e-61	2.8e-57	272.8	Binding
878	1744	CA4	C0002878	Haemolytic anaemia	4.25	1.7e-08	0.00014	31.8	Binding
878	1690	CA4	C0017979	Glycosuria	21.38	2e-48	2e-44	213.8	Binding
878	3866	CA4	C0040034	Thrombocytopenia	2.75	5.2e-07	0.0042	25.2	Binding
878	1986	CA4	C0020621	Hypokalaemia	10.14	7.7e-27	3.9e-23	115	Antagonist
878	4243	CA4	C0221185	Xanthopsia	23.94	5.6e-45	5.5e-41	198	Binding
878	1696	CA4	C0018099	Gout	10.12	3.4e-32	3.3e-28	139.5	Binding
878	1297	CA4	C0342579	Electrolyte imbalance	5.74	3.9e-09	1.9e-05	34.7	Antagonist
878	1952	CA4	C0740394	Hyperuricaemia	9.29	1.7e-27	1.7e-23	118	Binding
878	3861	CA4	C0039971	Thirst	4.2	3.7e-06	0.029	21.4	Binding
878	2931	CA4	C0030286	Pancreatic disorder	7.85	2.9e-13	2.6e-09	53.3	Binding
878	2938	CA4	C0030305	Pancreatitis	7.59	2.2e-25	2.1e-21	108.4	Binding
878	1986	CA4	C0020621	Hypokalaemia	9.19	2.3e-46	2.3e-42	204.4	Binding
878	1297	CA4	C0342579	Electrolyte imbalance	4.39	2.2e-12	1.9e-08	49.3	Binding
878	1696	CA4	C0018099	Gout	9.91	2.5e-17	1.3e-13	71.7	Antagonist
878	3089	CA4	C0162830	Photosensitivity reaction	2.83	1.4e-06	0.011	23.2	Binding
879	1690	CA5A	C0017979	Glycosuria	17.72	1e-32	1e-28	141.9	Binding
879	1986	CA5A	C0020621	Hypokalaemia	7.56	2.8e-30	2.7e-26	130.7	Binding
879	1696	CA5A	C0018099	Gout	8.39	1.7e-21	1.6e-17	90.7	Binding
879	267	CA5A	C0002874	Aplastic anaemia	5.83	2.6e-09	2.2e-05	35.5	Binding
879	2938	CA5A	C0030305	Pancreatitis	6.42	1.5e-17	1.4e-13	72.7	Binding
879	1297	CA5A	C0342579	Electrolyte imbalance	3.71	2.3e-08	0.00019	31.2	Binding
879	3333	CA5A	C0268104	Purine metabolism disorder	14.44	1.8e-34	1.8e-30	149.9	Binding
879	1952	CA5A	C0740394	Hyperuricaemia	7.61	7.3e-18	6.8e-14	74.1	Binding
879	1986	CA5A	C0020621	Hypokalaemia	7.39	8.2e-15	4.1e-11	60.3	Antagonist
879	1297	CA5A	C0342579	Electrolyte imbalance	5.23	3.9e-08	0.00019	30.2	Antagonist
880	1690	CA5B	C0017979	Glycosuria	19.71	1.2e-36	1.2e-32	159.8	Binding
880	267	CA5B	C0002874	Aplastic anaemia	6.49	1.3e-10	1.2e-06	41.2	Binding
880	1696	CA5B	C0018099	Gout	8.71	5.6e-21	5.3e-17	88.3	Binding
880	2938	CA5B	C0030305	Pancreatitis	7.14	4.9e-20	4.6e-16	84	Binding
880	3333	CA5B	C0268104	Purine metabolism disorder	14.82	1.2e-32	1.2e-28	141.6	Binding
880	1986	CA5B	C0020621	Hypokalaemia	8.76	9.6e-38	9.3e-34	164.9	Binding
880	1297	CA5B	C0342579	Electrolyte imbalance	3.89	1.9e-08	0.00015	31.6	Binding
880	1952	CA5B	C0740394	Hyperuricaemia	8.46	2.8e-20	2.7e-16	85.1	Binding
880	1986	CA5B	C0020621	Hypokalaemia	9.15	1.2e-20	6.1e-17	86.8	Antagonist
881	1986	CA6	C0020621	Hypokalaemia	8.72	5.3e-36	5.2e-32	156.9	Binding
881	1952	CA6	C0740394	Hyperuricaemia	8.77	3.9e-21	3.7e-17	89	Binding
881	1690	CA6	C0017979	Glycosuria	20.42	5e-38	4.9e-34	166.2	Binding
881	3333	CA6	C0268104	Purine metabolism disorder	15.36	6.2e-34	6e-30	147.5	Binding
881	1986	CA6	C0020621	Hypokalaemia	9.16	4.7e-19	2.4e-15	79.5	Antagonist
881	3866	CA6	C0040034	Thrombocytopenia	2.76	2.8e-06	0.022	22	Binding
881	1297	CA6	C0342579	Electrolyte imbalance	3.78	1.2e-07	0.00098	28	Binding
881	267	CA6	C0002874	Aplastic anaemia	6.72	4.7e-11	4.1e-07	43.3	Binding
881	1696	CA6	C0018099	Gout	9.03	7.3e-22	6.9e-18	92.3	Binding
881	2938	CA6	C0030305	Pancreatitis	7.4	6.3e-21	5.9e-17	88.1	Binding
882	1690	CA7	C0017979	Glycosuria	18.65	1.5e-34	1.4e-30	150.3	Binding
882	2938	CA7	C0030305	Pancreatitis	7.15	2.9e-21	2.8e-17	89.6	Binding
882	1986	CA7	C0020621	Hypokalaemia	9.57	1e-21	5.1e-18	91.7	Antagonist
882	3333	CA7	C0268104	Purine metabolism disorder	14.03	9.6e-31	9.3e-27	132.9	Binding
882	1744	CA7	C0002878	Haemolytic anaemia	3.82	2.3e-06	0.018	22.3	Binding
882	1297	CA7	C0342579	Electrolyte imbalance	3.45	1.1e-06	0.0084	23.8	Binding
882	3866	CA7	C0040034	Thrombocytopenia	2.76	8.5e-07	0.0068	24.2	Binding
882	267	CA7	C0002874	Aplastic anaemia	6.14	6.4e-10	5.5e-06	38.2	Binding
882	1986	CA7	C0020621	Hypokalaemia	8.29	2.6e-35	2.5e-31	153.8	Binding
882	1952	CA7	C0740394	Hyperuricaemia	8.01	5.3e-19	5e-15	79.3	Binding
882	1696	CA7	C0018099	Gout	8.24	1.2e-19	1.1e-15	82.3	Binding
883	2956	CA8	C0030554	Paraesthesia	3.38	2.9e-07	0.0024	26.3	Binding
884	1986	CA9	C0020621	Hypokalaemia	8.17	4.4e-18	2.2e-14	75.1	Antagonist
884	1986	CA9	C0020621	Hypokalaemia	8.37	1e-35	9.8e-32	155.7	Binding
884	2938	CA9	C0030305	Pancreatitis	6.82	6.1e-19	5.7e-15	79	Binding
884	1696	CA9	C0018099	Gout	9.51	1.4e-26	1.3e-22	113.9	Binding
884	1690	CA9	C0017979	Glycosuria	18.83	6.6e-35	6.5e-31	151.9	Binding
884	267	CA9	C0002874	Aplastic anaemia	6.82	2.4e-12	2.1e-08	49.1	Binding
884	3333	CA9	C0268104	Purine metabolism disorder	16.53	4e-43	3.9e-39	189.5	Binding
884	3866	CA9	C0040034	Thrombocytopenia	2.79	6.5e-07	0.0052	24.8	Binding
884	1297	CA9	C0342579	Electrolyte imbalance	3.95	3.9e-09	3.3e-05	34.7	Binding
884	1952	CA9	C0740394	Hyperuricaemia	8.09	3.3e-19	3.1e-15	80.3	Binding
888	2798	CACNA1A	C0085649	Oedema peripheral	5.46	5e-11	4.4e-07	43.2	Binding
888	1524	CACNA1A	C0016382	Flushing	2.88	3.2e-06	0.025	21.7	Binding
889	1524	CACNA1B	C0016382	Flushing	3.28	1.2e-07	0.00095	28.1	Binding
889	2798	CACNA1B	C0085649	Oedema peripheral	5.25	5.9e-09	5e-05	33.9	Binding
890	1524	CACNA1C	C0016382	Flushing	3.5	4.6e-12	4.1e-08	47.9	Binding
890	313	CACNA1C	C0003811	Arrhythmia	2.13	2e-07	0.0016	27.1	Binding
890	1662	CACNA1C	C0017566	Gingival hyperplasia	10.2	6.8e-18	6.3e-14	74.3	Binding
890	2798	CACNA1C	C0085649	Oedema peripheral	4.49	1.5e-08	0.00013	32	Binding
891	1153	CACNA1D	C0012569	Diplopia	4.59	6.7e-07	0.0054	24.7	Binding
891	2798	CACNA1D	C0085649	Oedema peripheral	5.18	4.6e-11	4e-07	43.4	Binding
891	313	CACNA1D	C0003811	Arrhythmia	2.04	4.6e-06	0.036	21	Binding
891	1524	CACNA1D	C0016382	Flushing	3.08	3.4e-08	0.00028	30.5	Binding
892	1524	CACNA1E	C0016382	Flushing	3.29	2.5e-07	0.002	26.6	Binding
895	1411	CACNA1H	C0015371	Extrapyramidal disorder	3.12	4.5e-06	0.035	21	Binding
897	2798	CACNA1S	C0085649	Oedema peripheral	5.08	1.4e-08	0.00012	32.2	Binding
897	1524	CACNA1S	C0016382	Flushing	4.17	3.2e-14	2.9e-10	57.6	Binding
897	313	CACNA1S	C0003811	Arrhythmia	2.29	3.2e-07	0.0026	26.1	Binding
897	1524	CACNA1S	C0016382	Flushing	3.73	4.5e-07	0.0022	25.4	Antagonist
898	2798	CACNA2D1	C0085649	Oedema peripheral	5.92	3.2e-12	2.9e-08	48.6	Binding
898	313	CACNA2D1	C0003811	Arrhythmia	2.32	1.4e-07	0.0011	27.8	Binding
898	1524	CACNA2D1	C0016382	Flushing	4.04	6e-09	2.9e-05	33.8	Antagonist
898	1524	CACNA2D1	C0016382	Flushing	4.45	8.9e-17	8.2e-13	69.2	Binding
898	1782	CACNA2D1	C0018681	Headache	2.12	2.3e-06	0.018	22.3	Binding
900	1524	CACNB1	C0016382	Flushing	3.6	7.4e-09	6.3e-05	33.4	Binding
900	313	CACNB1	C0003811	Arrhythmia	2.25	3.7e-06	0.029	21.4	Binding
901	1524	CACNB2	C0016382	Flushing	8.3	3.3e-14	1.7e-10	57.5	Antagonist
901	1524	CACNB2	C0016382	Flushing	7.39	1.3e-13	1.1e-09	54.9	Binding
903	1524	CACNB4	C0016382	Flushing	4.02	2.2e-09	1.9e-05	35.8	Binding
904	313	CACNG1	C0003811	Arrhythmia	2.23	4.9e-06	0.038	20.9	Binding
904	1524	CACNG1	C0016382	Flushing	3.75	7.1e-10	6.1e-06	38	Binding
1249	1954	CHRM1	C0020578	Hyperventilation	3.89	1.5e-06	0.012	23.2	Binding
1249	1932	CHRM1	C0392676	Hyperpyrexia	10.24	1.8e-25	1.8e-21	108.7	Binding
1249	3794	CHRM1	C0269993	Suppressed lactation	16.63	8.9e-31	8.6e-27	133	Binding
1249	966	CHRM1	C0009806	Constipation	1.73	9.4e-07	0.0044	24.1	Antagonist
1249	4166	CHRM1	C0344232	Vision blurred	1.88	4.7e-11	4.2e-07	43.3	Binding
1249	4166	CHRM1	C0344232	Vision blurred	1.79	5.1e-06	0.023	20.8	Antagonist
1249	1200	CHRM1	C0151908	Dry skin	4.02	2e-10	1.7e-06	40.5	Binding
1249	1240	CHRM1	C0013428	Dysuria	2.08	2.2e-08	0.00018	31.3	Binding
1249	1411	CHRM1	C0015371	Extrapyramidal disorder	2.15	9.2e-09	7.7e-05	33	Binding
1249	2620	CHRM1	C0026961	Mydriasis	3.5	4.5e-18	4.2e-14	75.1	Binding
1249	4028	CHRM1	C0080274	Urinary retention	2.78	6.6e-14	3.3e-10	56.2	Antagonist
1249	235	CHRM1	C0151500	Anticholinergic syndrome	3.5	6.9e-19	6.5e-15	78.8	Binding
1249	3821	CHRM1	C0039231	Tachycardia	1.97	2.4e-08	0.00012	31.1	Antagonist
1249	1029	CHRM1	C0235238	Cycloplegia	4.15	6.9e-18	3.5e-14	74.2	Antagonist
1249	1199	CHRM1	C0043352	Dry mouth	2.46	7e-33	6.8e-29	142.7	Binding
1249	1029	CHRM1	C0235238	Cycloplegia	4.83	4.1e-41	4.1e-37	180.3	Binding
1249	2620	CHRM1	C0026961	Mydriasis	3.42	4e-10	2e-06	39.1	Antagonist
1249	4028	CHRM1	C0080274	Urinary retention	2.61	5.3e-21	5e-17	88.4	Binding
1249	2199	CHRM1	C0234708	Intraocular pressure increased	4.21	1.3e-10	1.1e-06	41.3	Binding
1249	235	CHRM1	C0151500	Anticholinergic syndrome	3.02	1.4e-08	6.9e-05	32.2	Antagonist
1249	1200	CHRM1	C0151908	Dry skin	4.06	6.5e-06	0.029	20.3	Antagonist
1249	1226	CHRM1	C0011168	Dysphagia	3.09	2.9e-08	0.00024	30.8	Binding
1249	1985	CHRM1	C0020620	Hypohidrosis	19.25	3.4e-51	3.3e-47	226.6	Binding
1249	1199	CHRM1	C0043352	Dry mouth	2.43	1.8e-18	9.2e-15	76.9	Antagonist
1249	2724	CHRM1	C0027849	Neuroleptic malignant syndrome	2.68	5.4e-06	0.042	20.7	Binding
1249	3821	CHRM1	C0039231	Tachycardia	1.95	1.1e-13	9.8e-10	55.2	Binding
1249	966	CHRM1	C0009806	Constipation	1.73	5.2e-11	4.6e-07	43.1	Binding
1249	3087	CHRM1	C0085636	Photophobia	2.61	2.2e-06	0.017	22.4	Binding
1250	4028	CHRM2	C0080274	Urinary retention	2.34	1e-12	8.9e-09	50.8	Binding
1250	1029	CHRM2	C0235238	Cycloplegia	4.4	1.2e-27	1.1e-23	118.8	Binding
1250	235	CHRM2	C0151500	Anticholinergic syndrome	2.85	1.1e-06	0.0051	23.7	Antagonist
1250	1411	CHRM2	C0015371	Extrapyramidal disorder	2.04	1.9e-06	0.015	22.7	Binding
1250	2199	CHRM2	C0234708	Intraocular pressure increased	3.9	1.5e-07	0.0012	27.5	Binding
1250	1932	CHRM2	C0392676	Hyperpyrexia	8.7	5.1e-15	4.7e-11	61.2	Binding
1250	1200	CHRM2	C0151908	Dry skin	5.03	1.6e-08	7.8e-05	31.9	Antagonist
1250	235	CHRM2	C0151500	Anticholinergic syndrome	3.33	4.3e-14	3.9e-10	57	Binding
1250	1200	CHRM2	C0151908	Dry skin	4.27	2.8e-10	2.4e-06	39.8	Binding
1250	1199	CHRM2	C0043352	Dry mouth	2.42	1.5e-26	1.5e-22	113.7	Binding
1250	3821	CHRM2	C0039231	Tachycardia	2.08	4.4e-09	2.1e-05	34.5	Antagonist
1250	966	CHRM2	C0009806	Constipation	1.63	2.1e-07	0.0017	26.9	Binding
1250	4027	CHRM2	C0042024	Urinary incontinence	3.37	7e-07	0.0056	24.6	Binding
1250	1029	CHRM2	C0235238	Cycloplegia	3.5	1.6e-10	7.9e-07	40.9	Antagonist
1250	4028	CHRM2	C0080274	Urinary retention	2.51	3e-09	1.5e-05	35.2	Antagonist
1250	2620	CHRM2	C0026961	Mydriasis	3.1	3.6e-11	3.2e-07	43.8	Binding
1250	3821	CHRM2	C0039231	Tachycardia	2.05	6.5e-14	5.9e-10	56.2	Binding
1250	4166	CHRM2	C0344232	Vision blurred	1.79	6.1e-08	5e-04	29.3	Binding
1250	2620	CHRM2	C0026961	Mydriasis	3.36	9.6e-09	4.6e-05	32.9	Antagonist
1250	1199	CHRM2	C0043352	Dry mouth	2.41	5.4e-16	2.7e-12	65.7	Antagonist
1250	3525	CHRM2	C0037036	Salivary hypersecretion	2.92	4.6e-08	0.00038	29.9	Binding
1251	3821	CHRM3	C0039231	Tachycardia	1.92	1.3e-10	1.1e-06	41.3	Binding
1251	3525	CHRM3	C0037036	Salivary hypersecretion	2.69	2.9e-06	0.022	21.9	Binding
1251	1029	CHRM3	C0235238	Cycloplegia	4.92	1.4e-34	1.3e-30	150.5	Binding
1251	235	CHRM3	C0151500	Anticholinergic syndrome	3.69	1.7e-17	1.6e-13	72.4	Binding
1251	4166	CHRM3	C0344232	Vision blurred	1.83	2.5e-08	0.00021	31.1	Binding
1251	4028	CHRM3	C0080274	Urinary retention	2.45	4.2e-14	3.8e-10	57.1	Binding
1251	1029	CHRM3	C0235238	Cycloplegia	3.76	3.4e-12	1.7e-08	48.5	Antagonist
1251	1932	CHRM3	C0392676	Hyperpyrexia	9.12	7.7e-16	7.1e-12	65	Binding
1251	3821	CHRM3	C0039231	Tachycardia	1.84	9.2e-06	0.041	19.7	Antagonist
1251	1200	CHRM3	C0151908	Dry skin	4.22	1.6e-09	1.4e-05	36.4	Binding
1251	1411	CHRM3	C0015371	Extrapyramidal disorder	2.09	1.1e-06	0.0087	23.8	Binding
1251	966	CHRM3	C0009806	Constipation	1.66	9.9e-08	0.00081	28.4	Binding
1251	1199	CHRM3	C0043352	Dry mouth	2.33	5.8e-14	2.9e-10	56.5	Antagonist
1251	2620	CHRM3	C0026961	Mydriasis	3.14	3.7e-07	0.0017	25.9	Antagonist
1251	235	CHRM3	C0151500	Anticholinergic syndrome	3.08	6.5e-08	0.00031	29.2	Antagonist
1251	2620	CHRM3	C0026961	Mydriasis	3.45	3.8e-14	3.5e-10	57.3	Binding
1251	1199	CHRM3	C0043352	Dry mouth	2.45	3.8e-26	3.7e-22	111.9	Binding
1251	4028	CHRM3	C0080274	Urinary retention	2.45	1.8e-08	8.6e-05	31.7	Antagonist
1251	2199	CHRM3	C0234708	Intraocular pressure increased	4.08	4.7e-08	0.00039	29.8	Binding
1251	1226	CHRM3	C0011168	Dysphagia	3.18	2.6e-07	0.0021	26.5	Binding
1252	1199	CHRM4	C0043352	Dry mouth	2.31	9.2e-19	8.6e-15	78.2	Binding
1252	3864	CHRM4	C0700184	Throat irritation	3.11	1.1e-06	0.0084	23.8	Binding
1252	1029	CHRM4	C0235238	Cycloplegia	4.69	1.6e-26	1.5e-22	113.6	Binding
1252	2620	CHRM4	C0026961	Mydriasis	3.14	7.9e-06	0.036	20	Antagonist
1252	4028	CHRM4	C0080274	Urinary retention	2.46	6.6e-07	0.0031	24.7	Antagonist
1252	1411	CHRM4	C0015371	Extrapyramidal disorder	2.22	5.1e-07	0.0041	25.2	Binding
1252	1199	CHRM4	C0043352	Dry mouth	2.24	5.3e-10	2.6e-06	38.6	Antagonist
1252	966	CHRM4	C0009806	Constipation	1.64	2.2e-06	0.017	22.4	Binding
1252	3821	CHRM4	C0039231	Tachycardia	2.02	1.6e-06	0.0075	23	Antagonist
1252	1029	CHRM4	C0235238	Cycloplegia	4	2.2e-11	1.1e-07	44.8	Antagonist
1252	3821	CHRM4	C0039231	Tachycardia	2.01	8.1e-11	7.1e-07	42.2	Binding
1252	235	CHRM4	C0151500	Anticholinergic syndrome	3.52	2.2e-13	2e-09	53.8	Binding
1252	235	CHRM4	C0151500	Anticholinergic syndrome	3.02	4.2e-06	0.019	21.2	Antagonist
1252	4166	CHRM4	C0344232	Vision blurred	1.91	1.8e-08	0.00015	31.7	Binding
1252	3525	CHRM4	C0037036	Salivary hypersecretion	3.15	3.6e-08	3e-04	30.4	Binding
1252	4028	CHRM4	C0080274	Urinary retention	2.31	3.3e-10	2.9e-06	39.5	Binding
1252	4027	CHRM4	C0042024	Urinary incontinence	4.14	2.9e-09	2.5e-05	35.2	Binding
1252	1226	CHRM4	C0011168	Dysphagia	3.53	3.6e-08	3e-04	30.3	Binding
1252	2620	CHRM4	C0026961	Mydriasis	2.73	1.1e-06	0.0089	23.7	Binding
1253	1199	CHRM5	C0043352	Dry mouth	2.25	2.3e-10	1.1e-06	40.2	Antagonist
1253	4027	CHRM5	C0042024	Urinary incontinence	3.74	4.1e-07	0.0033	25.6	Binding
1253	1029	CHRM5	C0235238	Cycloplegia	3.69	1.2e-09	5.9e-06	37	Antagonist
1253	2875	CHRM5	C0020651	Orthostatic hypotension	1.96	3.7e-06	0.028	21.4	Binding
1253	1199	CHRM5	C0043352	Dry mouth	2.35	4.9e-19	4.6e-15	79.5	Binding
1253	235	CHRM5	C0151500	Anticholinergic syndrome	2.92	8.5e-06	0.038	19.8	Antagonist
1253	4028	CHRM5	C0080274	Urinary retention	2.44	1.4e-11	1.2e-07	45.7	Binding
1253	1411	CHRM5	C0015371	Extrapyramidal disorder	2.41	9.6e-09	8.1e-05	32.9	Binding
1253	3821	CHRM5	C0039231	Tachycardia	1.93	4.3e-09	3.6e-05	34.5	Binding
1253	966	CHRM5	C0009806	Constipation	1.68	8.4e-07	0.0067	24.3	Binding
1253	2620	CHRM5	C0026961	Mydriasis	2.94	6.7e-08	0.00055	29.2	Binding
1253	235	CHRM5	C0151500	Anticholinergic syndrome	3.64	4e-14	3.7e-10	57.2	Binding
1253	4028	CHRM5	C0080274	Urinary retention	2.54	8.9e-08	0.00043	28.6	Antagonist
1253	1029	CHRM5	C0235238	Cycloplegia	4.61	1.4e-24	1.3e-20	104.8	Binding
1253	1200	CHRM5	C0151908	Dry skin	4.14	1.1e-07	0.00092	28.2	Binding
1254	268	CHRNA1	C0003578	Apnoea	4.68	2.2e-08	0.00011	31.3	Antagonist
1254	3447	CHRNA1	C1145670	Respiratory failure	4.69	2.3e-10	2e-06	40.2	Binding
1254	656	CHRNA1	C0006266	Bronchospasm	4.55	1.3e-13	1.2e-09	54.9	Binding
1254	703	CHRNA1	C0018790	Cardiac arrest	4.23	1.6e-09	1.4e-05	36.4	Binding
1254	595	CHRNA1	C0428977	Bradycardia	3.19	1e-11	8.8e-08	46.3	Binding
1254	3525	CHRNA1	C0037036	Salivary hypersecretion	5.22	1.1e-12	9.7e-09	50.7	Binding
1254	3447	CHRNA1	C1145670	Respiratory failure	4.24	3.1e-06	0.014	21.8	Antagonist
1254	1063	CHRNA1	C1306577	Death	3.32	2.6e-06	0.02	22.1	Binding
1254	2384	CHRNA1	C0024115	Lung disorder	3.2	2.5e-06	0.019	22.2	Binding
1254	2007	CHRNA1	C0020649	Hypotension	2	3e-06	0.023	21.8	Binding
1254	3220	CHRNA1	C0700200	Presyncope	4.51	9.8e-07	0.0078	24	Binding
1254	268	CHRNA1	C0003578	Apnoea	5.21	1.1e-15	1e-11	64.2	Binding
8126	3525	CHRNA10	C0037036	Salivary hypersecretion	6.22	6.6e-16	6.1e-12	65.2	Binding
8126	268	CHRNA10	C0003578	Apnoea	4.76	3.2e-07	0.0015	26.2	Antagonist
8126	703	CHRNA10	C0018790	Cardiac arrest	4.4	6.6e-09	5.5e-05	33.7	Binding
8126	2384	CHRNA10	C0024115	Lung disorder	3.81	3.2e-08	0.00026	30.6	Binding
8126	3444	CHRNA10	C0035204	Respiratory disorder	3.1	2.3e-06	0.018	22.3	Binding
8126	2007	CHRNA10	C0020649	Hypotension	2.17	5.5e-07	0.0044	25.1	Binding
8126	3444	CHRNA10	C0035204	Respiratory disorder	3.74	3.4e-06	0.016	21.6	Antagonist
8126	656	CHRNA10	C0006266	Bronchospasm	5.42	2.6e-17	2.5e-13	71.6	Binding
8126	268	CHRNA10	C0003578	Apnoea	5.28	1.2e-13	1.1e-09	54.9	Binding
8126	595	CHRNA10	C0428977	Bradycardia	3.42	8.7e-08	0.00042	28.6	Antagonist
8126	595	CHRNA10	C0428977	Bradycardia	3.68	2.2e-14	2e-10	58.4	Binding
8126	656	CHRNA10	C0006266	Bronchospasm	4.38	4.4e-07	0.0021	25.5	Antagonist
8126	2604	CHRNA10	C0231530	Muscle twitching	3.86	5.7e-06	0.044	20.6	Binding
8126	1063	CHRNA10	C1306577	Death	3.69	6e-07	0.0048	24.9	Binding
8126	3447	CHRNA10	C1145670	Respiratory failure	5.22	3.6e-11	3.2e-07	43.8	Binding
1255	3447	CHRNA2	C1145670	Respiratory failure	4.94	4.4e-11	3.8e-07	43.4	Binding
1255	595	CHRNA2	C0428977	Bradycardia	2.86	7e-06	0.032	20.2	Antagonist
1255	268	CHRNA2	C0003578	Apnoea	4.39	4.2e-07	0.002	25.6	Antagonist
1255	3447	CHRNA2	C1145670	Respiratory failure	4.34	2e-06	0.0093	22.6	Antagonist
1255	2384	CHRNA2	C0024115	Lung disorder	3.37	7.7e-07	0.0061	24.4	Binding
1255	656	CHRNA2	C0006266	Bronchospasm	4	8.5e-07	0.004	24.2	Antagonist
1255	2007	CHRNA2	C0020649	Hypotension	2.2	4.5e-08	0.00038	29.9	Binding
1255	595	CHRNA2	C0428977	Bradycardia	3.36	9.2e-13	8.2e-09	51	Binding
1255	268	CHRNA2	C0003578	Apnoea	4.93	3.7e-13	3.3e-09	52.8	Binding
1255	703	CHRNA2	C0018790	Cardiac arrest	3.61	2.6e-06	0.02	22.1	Binding
1255	656	CHRNA2	C0006266	Bronchospasm	5.46	6.2e-20	5.8e-16	83.6	Binding
1255	3525	CHRNA2	C0037036	Salivary hypersecretion	5.49	1.5e-13	1.3e-09	54.6	Binding
1256	703	CHRNA3	C0018790	Cardiac arrest	3.67	6.5e-07	0.0052	24.7	Binding
1256	595	CHRNA3	C0428977	Bradycardia	3.13	1.9e-07	0.00088	27.2	Antagonist
1256	268	CHRNA3	C0003578	Apnoea	4.32	5.9e-07	0.0028	24.9	Antagonist
1256	268	CHRNA3	C0003578	Apnoea	4.4	1.2e-10	1e-06	41.5	Binding
1256	595	CHRNA3	C0428977	Bradycardia	3.37	1.4e-13	1.3e-09	54.7	Binding
1256	656	CHRNA3	C0006266	Bronchospasm	4.52	1.7e-13	1.5e-09	54.3	Binding
1256	2384	CHRNA3	C0024115	Lung disorder	3.18	2.9e-06	0.022	21.9	Binding
1256	3447	CHRNA3	C1145670	Respiratory failure	4.35	9.1e-09	7.7e-05	33	Binding
1256	3525	CHRNA3	C0037036	Salivary hypersecretion	5.84	1.9e-16	1.8e-12	67.7	Binding
1256	2007	CHRNA3	C0020649	Hypotension	2.03	1.3e-06	0.01	23.4	Binding
1257	2384	CHRNA4	C0024115	Lung disorder	3.23	8.7e-07	0.0069	24.2	Binding
1257	2007	CHRNA4	C0020649	Hypotension	2.11	8.7e-08	0.00071	28.7	Binding
1257	3601	CHRNA4	C0036974	Shock	4.93	4.7e-11	4.1e-07	43.3	Binding
1257	656	CHRNA4	C0006266	Bronchospasm	4.53	3.7e-14	3.3e-10	57.3	Binding
1257	1063	CHRNA4	C1306577	Death	3.36	7.8e-07	0.0063	24.4	Binding
1257	3525	CHRNA4	C0037036	Salivary hypersecretion	5.9	1.4e-17	1.3e-13	72.8	Binding
1257	115	CHRNA4	C0085631	Agitation	2.81	4.9e-07	0.0023	25.3	Antagonist
1257	2287	CHRNA4	C0023066	Laryngospasm	12.68	6.6e-30	3.4e-26	129.1	Antagonist
1257	2769	CHRNA4	C0028738	Nystagmus	6.07	8.8e-10	4.3e-06	37.6	Antagonist
1257	3442	CHRNA4	C0235063	Respiratory depression	6.75	6.7e-21	3.4e-17	88	Antagonist
1257	3444	CHRNA4	C0035204	Respiratory disorder	4.57	4.2e-13	2.1e-09	52.5	Antagonist
1257	2287	CHRNA4	C0023066	Laryngospasm	8.49	8.2e-22	7.8e-18	92.1	Binding
1257	595	CHRNA4	C0428977	Bradycardia	2.94	6.8e-10	5.9e-06	38.1	Binding
1257	268	CHRNA4	C0003578	Apnoea	6.96	7.6e-23	3.9e-19	96.8	Antagonist
1257	3442	CHRNA4	C0235063	Respiratory depression	4.35	8.7e-13	7.8e-09	51.1	Binding
1257	3444	CHRNA4	C0035204	Respiratory disorder	3.5	1.9e-10	1.6e-06	40.6	Binding
1257	268	CHRNA4	C0003578	Apnoea	6.44	9.1e-27	8.8e-23	114.7	Binding
1257	2211	CHRNA4	C0022107	Irritability	6.02	1.3e-10	6.3e-07	41.4	Antagonist
1257	3601	CHRNA4	C0036974	Shock	6.03	1.4e-11	7.1e-08	45.6	Antagonist
1257	3447	CHRNA4	C1145670	Respiratory failure	4.46	1.1e-09	9.6e-06	37.1	Binding
1258	2384	CHRNA5	C0024115	Lung disorder	3.72	4.9e-07	0.004	25.3	Binding
1258	703	CHRNA5	C0018790	Cardiac arrest	3.86	5.7e-06	0.044	20.6	Binding
1258	595	CHRNA5	C0428977	Bradycardia	3.13	8.4e-06	0.038	19.9	Antagonist
1258	595	CHRNA5	C0428977	Bradycardia	3.44	5.6e-11	4.9e-07	42.9	Binding
1258	656	CHRNA5	C0006266	Bronchospasm	5.46	7e-16	6.5e-12	65.1	Binding
1258	268	CHRNA5	C0003578	Apnoea	4.84	4.1e-10	3.5e-06	39.1	Binding
1258	656	CHRNA5	C0006266	Bronchospasm	4.38	1.7e-06	0.0079	22.9	Antagonist
1258	2007	CHRNA5	C0020649	Hypotension	2.24	5e-07	0.004	25.3	Binding
1258	3447	CHRNA5	C1145670	Respiratory failure	4.99	4.3e-09	3.7e-05	34.5	Binding
1258	3525	CHRNA5	C0037036	Salivary hypersecretion	6.5	9e-16	8.3e-12	64.6	Binding
9348	3447	CHRNA6	C1145670	Respiratory failure	4.95	5.2e-09	4.4e-05	34.1	Binding
9348	656	CHRNA6	C0006266	Bronchospasm	4.34	2e-06	0.0091	22.6	Antagonist
9348	2007	CHRNA6	C0020649	Hypotension	2.23	6.4e-07	0.0052	24.8	Binding
9348	268	CHRNA6	C0003578	Apnoea	4.81	5.1e-10	4.4e-06	38.6	Binding
9348	3525	CHRNA6	C0037036	Salivary hypersecretion	6.45	1.3e-15	1.2e-11	64	Binding
9348	2384	CHRNA6	C0024115	Lung disorder	3.69	5.9e-07	0.0047	25	Binding
9348	595	CHRNA6	C0428977	Bradycardia	3.11	9.7e-06	0.044	19.6	Antagonist
9348	656	CHRNA6	C0006266	Bronchospasm	5.42	1e-15	9.2e-12	64.4	Binding
9348	595	CHRNA6	C0428977	Bradycardia	3.42	7.6e-11	6.6e-07	42.4	Binding
1259	2211	CHRNA7	C0022107	Irritability	6.68	4e-13	2e-09	52.7	Antagonist
1259	656	CHRNA7	C0006266	Bronchospasm	3.89	2.2e-10	1.9e-06	40.3	Binding
1259	2287	CHRNA7	C0023066	Laryngospasm	12.9	1.8e-30	9.1e-27	131.7	Antagonist
1259	268	CHRNA7	C0003578	Apnoea	5.38	9.7e-19	9.1e-15	78.1	Binding
1259	2287	CHRNA7	C0023066	Laryngospasm	8.02	2.2e-20	2.1e-16	85.6	Binding
1259	115	CHRNA7	C0085631	Agitation	2.61	1e-05	0.045	19.5	Antagonist
1259	3601	CHRNA7	C0036974	Shock	6.13	8.1e-12	4e-08	46.7	Antagonist
1259	595	CHRNA7	C0428977	Bradycardia	2.6	1.9e-07	0.0015	27.1	Binding
1259	2211	CHRNA7	C0022107	Irritability	3.82	7.8e-07	0.0062	24.4	Binding
1259	268	CHRNA7	C0003578	Apnoea	6.37	2e-18	1e-14	76.7	Antagonist
1259	3601	CHRNA7	C0036974	Shock	4.65	3.1e-10	2.7e-06	39.6	Binding
1259	3444	CHRNA7	C0035204	Respiratory disorder	3.16	1.4e-08	0.00012	32.1	Binding
1259	3442	CHRNA7	C0235063	Respiratory depression	4.3	3.7e-13	3.3e-09	52.8	Binding
1259	2769	CHRNA7	C0028738	Nystagmus	6.17	5.5e-10	2.7e-06	38.5	Antagonist
1259	3442	CHRNA7	C0235063	Respiratory depression	6.87	2.4e-21	1.2e-17	90	Antagonist
1259	3444	CHRNA7	C0035204	Respiratory disorder	4.41	6.8e-12	3.4e-08	47.1	Antagonist
1259	3525	CHRNA7	C0037036	Salivary hypersecretion	5.28	2.1e-14	1.9e-10	58.5	Binding
8275	2384	CHRNA9	C0024115	Lung disorder	3.7	5.5e-07	0.0044	25.1	Binding
8275	268	CHRNA9	C0003578	Apnoea	4.82	4.7e-10	4.1e-06	38.8	Binding
8275	2007	CHRNA9	C0020649	Hypotension	2.23	5.9e-07	0.0047	25	Binding
8275	703	CHRNA9	C0018790	Cardiac arrest	3.84	6.2e-06	0.048	20.4	Binding
8275	595	CHRNA9	C0428977	Bradycardia	3.43	6.8e-11	6e-07	42.6	Binding
8275	656	CHRNA9	C0006266	Bronchospasm	5.43	8.8e-16	8.1e-12	64.7	Binding
8275	3525	CHRNA9	C0037036	Salivary hypersecretion	6.47	1.1e-15	1e-11	64.2	Binding
8275	656	CHRNA9	C0006266	Bronchospasm	4.31	2.3e-06	0.01	22.4	Antagonist
8275	3447	CHRNA9	C1145670	Respiratory failure	4.96	4.9e-09	4.1e-05	34.2	Binding
1260	3447	CHRNB1	C1145670	Respiratory failure	5.42	1.6e-12	1.4e-08	49.9	Binding
1260	595	CHRNB1	C0428977	Bradycardia	3.23	8.9e-07	0.0042	24.2	Antagonist
1260	268	CHRNB1	C0003578	Apnoea	5.23	6.4e-09	3.1e-05	33.7	Antagonist
1260	2007	CHRNB1	C0020649	Hypotension	2.16	5.1e-07	0.0041	25.2	Binding
1260	3447	CHRNB1	C1145670	Respiratory failure	5.18	4.8e-08	0.00023	29.8	Antagonist
1260	3525	CHRNB1	C0037036	Salivary hypersecretion	5.65	3.2e-13	2.9e-09	53.1	Binding
1260	656	CHRNB1	C0006266	Bronchospasm	3.98	9.9e-06	0.044	19.5	Antagonist
1260	268	CHRNB1	C0003578	Apnoea	5.41	6.6e-15	6.1e-11	60.7	Binding
1260	595	CHRNB1	C0428977	Bradycardia	3.57	1.1e-13	9.8e-10	55.2	Binding
1260	1063	CHRNB1	C1306577	Death	3.57	1.2e-06	0.0097	23.5	Binding
1260	656	CHRNB1	C0006266	Bronchospasm	5	8e-15	7.3e-11	60.3	Binding
1260	703	CHRNB1	C0018790	Cardiac arrest	4.27	1.5e-08	0.00013	32	Binding
1260	2384	CHRNB1	C0024115	Lung disorder	3.46	9.5e-07	0.0076	24	Binding
1261	3525	CHRNB2	C0037036	Salivary hypersecretion	6.97	5.6e-24	5.3e-20	102	Binding
1261	2287	CHRNB2	C0023066	Laryngospasm	6.05	9.5e-10	8.2e-06	37.4	Binding
1261	595	CHRNB2	C0428977	Bradycardia	3.35	4.5e-13	4e-09	52.4	Binding
1261	703	CHRNB2	C0018790	Cardiac arrest	3.76	3.8e-07	0.003	25.8	Binding
1261	656	CHRNB2	C0006266	Bronchospasm	4.61	1.7e-09	8.3e-06	36.3	Antagonist
1261	595	CHRNB2	C0428977	Bradycardia	3.15	1.7e-07	0.00079	27.4	Antagonist
1261	656	CHRNB2	C0006266	Bronchospasm	5.51	5.9e-21	5.6e-17	88.2	Binding
1261	3447	CHRNB2	C1145670	Respiratory failure	4.29	2.5e-06	0.012	22.2	Antagonist
1261	268	CHRNB2	C0003578	Apnoea	5.91	5.2e-14	2.6e-10	56.7	Antagonist
1261	3447	CHRNB2	C1145670	Respiratory failure	4.78	1.3e-10	1.2e-06	41.3	Binding
1261	2384	CHRNB2	C0024115	Lung disorder	3.87	7.9e-10	6.8e-06	37.8	Binding
1261	268	CHRNB2	C0003578	Apnoea	5.57	6.1e-18	5.7e-14	74.5	Binding
1261	3525	CHRNB2	C0037036	Salivary hypersecretion	7.21	3.3e-13	1.7e-09	53	Antagonist
1261	2007	CHRNB2	C0020649	Hypotension	2.13	1.8e-07	0.0014	27.3	Binding
1262	268	CHRNB3	C0003578	Apnoea	4.83	4.3e-10	3.8e-06	39	Binding
1262	595	CHRNB3	C0428977	Bradycardia	3.11	9.7e-06	0.044	19.6	Antagonist
1262	595	CHRNB3	C0428977	Bradycardia	3.43	6.1e-11	5.4e-07	42.8	Binding
1262	703	CHRNB3	C0018790	Cardiac arrest	3.85	5.9e-06	0.046	20.5	Binding
1262	2384	CHRNB3	C0024115	Lung disorder	3.71	5.2e-07	0.0042	25.2	Binding
1262	656	CHRNB3	C0006266	Bronchospasm	5.45	7.8e-16	7.2e-12	64.9	Binding
1262	656	CHRNB3	C0006266	Bronchospasm	4.34	2e-06	0.0091	22.6	Antagonist
1262	3447	CHRNB3	C1145670	Respiratory failure	4.98	4.5e-09	3.9e-05	34.4	Binding
1262	2007	CHRNB3	C0020649	Hypotension	2.24	5.4e-07	0.0043	25.1	Binding
1262	3525	CHRNB3	C0037036	Salivary hypersecretion	6.49	9.9e-16	9.1e-12	64.5	Binding
1263	3447	CHRNB4	C1145670	Respiratory failure	4	8.4e-08	0.00069	28.7	Binding
1263	656	CHRNB4	C0006266	Bronchospasm	4.15	5.8e-12	5.2e-08	47.4	Binding
1263	595	CHRNB4	C0428977	Bradycardia	3.1	9e-12	7.9e-08	46.5	Binding
1263	3525	CHRNB4	C0037036	Salivary hypersecretion	5.36	1e-14	9.1e-11	59.9	Binding
1263	703	CHRNB4	C0018790	Cardiac arrest	3.38	4.1e-06	0.032	21.2	Binding
1263	268	CHRNB4	C0003578	Apnoea	3.98	3e-06	0.014	21.8	Antagonist
1263	595	CHRNB4	C0428977	Bradycardia	2.89	1.5e-06	0.0072	23.1	Antagonist
1263	268	CHRNB4	C0003578	Apnoea	4.04	1.8e-09	1.6e-05	36.1	Binding
1264	595	CHRND	C0428977	Bradycardia	3.57	1.1e-13	9.8e-10	55.2	Binding
1264	1063	CHRND	C1306577	Death	3.57	1.2e-06	0.0097	23.5	Binding
1264	703	CHRND	C0018790	Cardiac arrest	4.27	1.5e-08	0.00013	32	Binding
1264	3447	CHRND	C1145670	Respiratory failure	5.42	1.6e-12	1.4e-08	49.9	Binding
1264	656	CHRND	C0006266	Bronchospasm	3.98	9.9e-06	0.044	19.5	Antagonist
1264	2384	CHRND	C0024115	Lung disorder	3.46	9.5e-07	0.0076	24	Binding
1264	268	CHRND	C0003578	Apnoea	5.23	6.4e-09	3.1e-05	33.7	Antagonist
1264	3447	CHRND	C1145670	Respiratory failure	5.18	4.8e-08	0.00023	29.8	Antagonist
1264	268	CHRND	C0003578	Apnoea	5.41	6.6e-15	6.1e-11	60.7	Binding
1264	595	CHRND	C0428977	Bradycardia	3.23	8.9e-07	0.0042	24.2	Antagonist
1264	656	CHRND	C0006266	Bronchospasm	5	8e-15	7.3e-11	60.3	Binding
1264	3525	CHRND	C0037036	Salivary hypersecretion	5.65	3.2e-13	2.9e-09	53.1	Binding
1264	2007	CHRND	C0020649	Hypotension	2.16	5.1e-07	0.0041	25.2	Binding
1265	595	CHRNE	C0428977	Bradycardia	3.43	6.3e-11	5.5e-07	42.7	Binding
1265	2007	CHRNE	C0020649	Hypotension	2.24	5.5e-07	0.0044	25.1	Binding
1265	703	CHRNE	C0018790	Cardiac arrest	3.85	6e-06	0.046	20.5	Binding
1265	656	CHRNE	C0006266	Bronchospasm	5.45	8e-16	7.4e-12	64.9	Binding
1265	3447	CHRNE	C1145670	Respiratory failure	4.97	4.6e-09	3.9e-05	34.3	Binding
1265	3525	CHRNE	C0037036	Salivary hypersecretion	6.48	1e-15	9.4e-12	64.4	Binding
1265	2384	CHRNE	C0024115	Lung disorder	3.71	5.3e-07	0.0042	25.2	Binding
1265	595	CHRNE	C0428977	Bradycardia	3.13	8.4e-06	0.038	19.9	Antagonist
1265	268	CHRNE	C0003578	Apnoea	4.83	4.4e-10	3.8e-06	38.9	Binding
1265	656	CHRNE	C0006266	Bronchospasm	4.38	1.7e-06	0.0079	22.9	Antagonist
1266	268	CHRNG	C0003578	Apnoea	5.41	6.6e-15	6.1e-11	60.7	Binding
1266	703	CHRNG	C0018790	Cardiac arrest	4.27	1.5e-08	0.00013	32	Binding
1266	2007	CHRNG	C0020649	Hypotension	2.16	5.1e-07	0.0041	25.2	Binding
1266	595	CHRNG	C0428977	Bradycardia	3.23	8.9e-07	0.0042	24.2	Antagonist
1266	2384	CHRNG	C0024115	Lung disorder	3.46	9.5e-07	0.0076	24	Binding
1266	595	CHRNG	C0428977	Bradycardia	3.57	1.1e-13	9.8e-10	55.2	Binding
1266	1063	CHRNG	C1306577	Death	3.57	1.2e-06	0.0097	23.5	Binding
1266	3447	CHRNG	C1145670	Respiratory failure	5.18	4.8e-08	0.00023	29.8	Antagonist
1266	268	CHRNG	C0003578	Apnoea	5.23	6.4e-09	3.1e-05	33.7	Antagonist
1266	3525	CHRNG	C0037036	Salivary hypersecretion	5.65	3.2e-13	2.9e-09	53.1	Binding
1266	656	CHRNG	C0006266	Bronchospasm	3.98	9.9e-06	0.044	19.5	Antagonist
1266	3447	CHRNG	C1145670	Respiratory failure	5.42	1.6e-12	1.4e-08	49.9	Binding
1266	656	CHRNG	C0006266	Bronchospasm	5	8e-15	7.3e-11	60.3	Binding
1657	2917	CYP19A1	C0030193	Pain	4.32	6e-07	0.0048	24.9	Binding
1671	149	CYP2C19	C0002170	Alopecia	2.82	3e-06	0.024	21.8	Binding
1671	1823	CYP2C19	C0019158	Hepatitis	3.34	5.1e-06	0.039	20.8	Binding
1673	267	CYP2C9	C0002874	Aplastic anaemia	4.76	3e-07	0.0014	26.3	Antagonist
1673	3364	CYP2C9	C0015230	Rash	1.81	4e-07	0.0032	25.7	Binding
1673	1143	CYP2C9	C0011991	Diarrhoea	1.89	1.5e-06	0.012	23.1	Binding
1673	1732	CYP2C9	C0018965	Haematuria	3.86	5.4e-06	0.024	20.7	Antagonist
1673	3930	CYP2C9	C0014518	Toxic epidermal necrolysis	5.63	8.9e-10	7.6e-06	37.6	Binding
1673	2705	CYP2C9	C0022658	Nephropathy	3.09	2.8e-07	0.0023	26.4	Binding
1673	3866	CYP2C9	C0040034	Thrombocytopenia	2.43	8.9e-07	0.0071	24.2	Binding
1673	1823	CYP2C9	C0019158	Hepatitis	3.59	4.1e-07	0.002	25.6	Antagonist
1673	2705	CYP2C9	C0022658	Nephropathy	3.15	3.5e-06	0.016	21.5	Antagonist
1673	1823	CYP2C9	C0019158	Hepatitis	4.04	1.7e-11	1.5e-07	45.3	Binding
1673	267	CYP2C9	C0002874	Aplastic anaemia	4.99	4.2e-09	3.6e-05	34.5	Binding
1673	1732	CYP2C9	C0018965	Haematuria	4.08	5.1e-08	0.00042	29.7	Binding
1678	2344	CYP3A4	C0877192	Lipodystrophy acquired	7.19	5e-12	4.5e-08	47.7	Binding
1678	13	CYP3A4	C0232492	Abdominal pain upper	1.85	2.2e-08	0.00018	31.3	Binding
1678	1129	CYP3A4	C0011849	Diabetes mellitus	6.11	6.8e-10	5.8e-06	38.1	Binding
1678	1919	CYP3A4	C0020473	Hyperlipidaemia	5.25	4.8e-12	4.3e-08	47.8	Binding
1678	1782	CYP3A4	C0018681	Headache	1.51	1.4e-06	0.011	23.2	Binding
1678	2798	CYP3A4	C0085649	Oedema peripheral	2.44	5e-06	0.039	20.8	Binding
1679	13	CYP3A5	C0232492	Abdominal pain upper	3.85	6.2e-07	0.0049	24.9	Binding
1679	1143	CYP3A5	C0011991	Diarrhoea	3.57	1.6e-07	0.0013	27.4	Binding
1795	3866	DHFR	C0040034	Thrombocytopenia	3.66	5.3e-06	0.041	20.7	Binding
1795	2705	DHFR	C0022658	Nephropathy	5.8	3e-09	2.5e-05	35.2	Binding
1909	2339	DRD1	C0154251	Lipid metabolism disorder	4.95	4.4e-16	4.1e-12	66	Binding
1909	1268	DRD1	C0235969	Ejaculation disorder	4.2	3.8e-18	3.6e-14	75.4	Binding
1909	1268	DRD1	C0235969	Ejaculation disorder	5.34	2.9e-16	1.5e-12	66.9	Antagonist
1909	2724	DRD1	C0027849	Neuroleptic malignant syndrome	4.5	2.7e-18	2.5e-14	76.1	Binding
1909	1907	DRD1	C0020443	Hypercholesterolaemia	7.45	3.3e-21	1.7e-17	89.4	Antagonist
1909	2161	DRD1	C0917801	Insomnia	1.67	2e-06	0.016	22.6	Binding
1909	2008	DRD1	C0413252	Hypothermia	3.98	3e-14	1.5e-10	57.8	Antagonist
1909	1930	DRD1	C0020514	Hyperprolactinaemia	4.35	1.1e-11	5.6e-08	46.1	Antagonist
1909	1719	DRD1	C0018418	Gynaecomastia	2.45	7.2e-08	0.00034	29	Antagonist
1909	830	DRD1	C0008370	Cholestasis	3.62	2.3e-09	2e-05	35.7	Binding
1909	1108	DRD1	C0011606	Dermatitis exfoliative	4.11	1.2e-08	5.7e-05	32.5	Antagonist
1909	2724	DRD1	C0027849	Neuroleptic malignant syndrome	5.39	7.2e-15	3.6e-11	60.5	Antagonist
1909	1317	DRD1	C0014130	Endocrine disorder	2.31	6e-06	0.027	20.5	Antagonist
1909	1930	DRD1	C0020514	Hyperprolactinaemia	3.74	7.2e-14	6.5e-10	56	Binding
1909	2339	DRD1	C0154251	Lipid metabolism disorder	6.16	7.1e-13	3.5e-09	51.5	Antagonist
1909	122	DRD1	C0392156	Akathisia	4.17	7.3e-16	3.7e-12	65	Antagonist
1909	2488	DRD1	C0025345	Menstrual disorder	3.06	2.7e-10	1.3e-06	39.9	Antagonist
1909	159	DRD1	C0002453	Amenorrhoea	3.58	8.6e-14	4.3e-10	55.7	Antagonist
1909	119	DRD1	C0001824	Agranulocytosis	2	5.4e-06	0.042	20.7	Binding
1909	2297	DRD1	C1510497	Lenticular opacities	7.55	3e-15	1.5e-11	62.3	Antagonist
1909	1568	DRD1	C0235660	Galactorrhoea	2.88	1.3e-15	1.2e-11	64	Binding
1909	2662	DRD1	C0027424	Nasal congestion	3.1	2e-19	1.9e-15	81.2	Binding
1909	1199	DRD1	C0043352	Dry mouth	1.65	1.7e-06	0.014	22.9	Binding
1909	743	DRD1	C0086543	Cataract	4.43	8.1e-08	0.00039	28.8	Antagonist
1909	159	DRD1	C0002453	Amenorrhoea	2.99	3.2e-15	2.9e-11	62.2	Binding
1909	2736	DRD1	C0027947	Neutropenia	2.75	9.4e-06	0.042	19.6	Antagonist
1909	1505	DRD1	C0016034	Fibrocystic breast disease	3.69	2.6e-08	0.00013	31	Antagonist
1909	2536	DRD1	C0026205	Miosis	5.35	2.3e-12	1.1e-08	49.2	Antagonist
1909	3827	DRD1	C0686347	Tardive dyskinesia	4.29	5.7e-16	2.9e-12	65.5	Antagonist
1909	122	DRD1	C0392156	Akathisia	3.77	1.2e-22	1.1e-18	95.9	Binding
1909	2974	DRD1	C0242422	Parkinsonism	4.38	2.8e-15	1.4e-11	62.4	Antagonist
1909	1907	DRD1	C0020443	Hypercholesterolaemia	6.11	5.2e-26	5e-22	111.3	Binding
1909	993	DRD1	C0010038	Corneal opacity	5.45	3.1e-10	1.5e-06	39.6	Antagonist
1909	1108	DRD1	C0011606	Dermatitis exfoliative	3.08	3.2e-08	0.00026	30.6	Binding
1909	1568	DRD1	C0235660	Galactorrhoea	3.25	1.6e-12	8.2e-09	49.9	Antagonist
1909	995	DRD1	C0423226	Corneal pigmentation	6.58	2.8e-20	2.7e-16	85.1	Binding
1909	743	DRD1	C0086543	Cataract	3.84	3e-10	2.6e-06	39.6	Binding
1909	3821	DRD1	C0039231	Tachycardia	1.79	2.2e-08	0.00018	31.3	Binding
1909	2974	DRD1	C0242422	Parkinsonism	3.98	3.4e-21	3.2e-17	89.3	Binding
1909	2536	DRD1	C0026205	Miosis	4.19	8.8e-14	7.9e-10	55.6	Binding
1909	1238	DRD1	C0393593	Dystonia	3.52	4.6e-19	4.3e-15	79.6	Binding
1909	1719	DRD1	C0018418	Gynaecomastia	2.12	1.7e-08	0.00014	31.8	Binding
1909	995	DRD1	C0423226	Corneal pigmentation	7.31	1.1e-14	5.5e-11	59.7	Antagonist
1909	1274	DRD1	C0855329	Electrocardiogram change	3.71	1.3e-14	6.6e-11	59.4	Antagonist
1909	2875	DRD1	C0020651	Orthostatic hypotension	2.29	3.2e-12	2.9e-08	48.5	Binding
1909	2008	DRD1	C0413252	Hypothermia	3.51	1.4e-18	1.3e-14	77.4	Binding
1909	2662	DRD1	C0027424	Nasal congestion	3.31	7.2e-13	3.6e-09	51.5	Antagonist
1909	3827	DRD1	C0686347	Tardive dyskinesia	3.79	5.1e-21	4.8e-17	88.5	Binding
1909	2620	DRD1	C0026961	Mydriasis	3.47	5.6e-08	0.00027	29.5	Antagonist
1909	2620	DRD1	C0026961	Mydriasis	3.16	1.4e-11	1.3e-07	45.6	Binding
1909	1238	DRD1	C0393593	Dystonia	3.97	3.1e-14	1.6e-10	57.7	Antagonist
1909	2488	DRD1	C0025345	Menstrual disorder	2.49	1.8e-10	1.5e-06	40.7	Binding
1909	1434	DRD1	C1142111	Eyelash discolouration	5.13	1e-11	5.1e-08	46.3	Antagonist
1909	1411	DRD1	C0015371	Extrapyramidal disorder	3.04	1.5e-20	1.4e-16	86.4	Binding
1909	1411	DRD1	C0015371	Extrapyramidal disorder	3.41	8.9e-16	4.5e-12	64.7	Antagonist
1909	1434	DRD1	C1142111	Eyelash discolouration	4.27	3.7e-14	3.4e-10	57.3	Binding
1909	3089	DRD1	C0162830	Photosensitivity reaction	1.98	4e-06	0.031	21.3	Binding
1909	993	DRD1	C0010038	Corneal opacity	4.37	3.5e-11	3.1e-07	43.9	Binding
1909	4219	DRD1	C0043094	Weight increased	1.95	1.4e-07	0.0012	27.7	Binding
1909	2875	DRD1	C0020651	Orthostatic hypotension	2.47	3.5e-08	0.00017	30.4	Antagonist
1909	1505	DRD1	C0016034	Fibrocystic breast disease	2.99	1e-08	8.7e-05	32.8	Binding
1909	1274	DRD1	C0855329	Electrocardiogram change	3.45	4.1e-21	3.9e-17	88.9	Binding
1909	1219	DRD1	C0013384	Dyskinesia	3.37	9.3e-12	8.2e-08	46.5	Binding
1909	830	DRD1	C0008370	Cholestasis	4.41	9.2e-08	0.00044	28.5	Antagonist
1909	2297	DRD1	C1510497	Lenticular opacities	6.27	4.4e-18	4.1e-14	75.1	Binding
1909	4219	DRD1	C0043094	Weight increased	2.31	2.7e-07	0.0013	26.4	Antagonist
1910	4028	DRD2	C0080274	Urinary retention	1.76	2.8e-06	0.022	22	Binding
1910	3597	DRD2	C0549622	Sexual dysfunction	1.67	2.7e-06	0.021	22	Binding
1910	2662	DRD2	C0027424	Nasal congestion	3.02	1.2e-24	1.2e-20	105	Binding
1910	3821	DRD2	C0039231	Tachycardia	1.83	3.8e-06	0.017	21.4	Antagonist
1910	1274	DRD2	C0855329	Electrocardiogram change	3.32	5.7e-26	5.5e-22	111.1	Binding
1910	2339	DRD2	C0154251	Lipid metabolism disorder	4.08	8.1e-14	7.3e-10	55.8	Binding
1910	1907	DRD2	C0020443	Hypercholesterolaemia	5.81	1.4e-15	7.3e-12	63.7	Antagonist
1910	1434	DRD2	C1142111	Eyelash discolouration	4.27	1e-09	5e-06	37.3	Antagonist
1910	2297	DRD2	C1510497	Lenticular opacities	5.89	2.7e-11	1.3e-07	44.4	Antagonist
1910	1274	DRD2	C0855329	Electrocardiogram change	3.36	2.4e-14	1.2e-10	58.2	Antagonist
1910	995	DRD2	C0423226	Corneal pigmentation	5.71	7.4e-11	3.7e-07	42.4	Antagonist
1910	1199	DRD2	C0043352	Dry mouth	1.81	1.9e-06	0.0086	22.7	Antagonist
1910	1719	DRD2	C0018418	Gynaecomastia	2.4	5.3e-17	4.9e-13	70.2	Binding
1910	2339	DRD2	C0154251	Lipid metabolism disorder	4.8	2.2e-09	1.1e-05	35.8	Antagonist
1910	2724	DRD2	C0027849	Neuroleptic malignant syndrome	4.39	1.6e-23	1.5e-19	99.9	Binding
1910	1411	DRD2	C0015371	Extrapyramidal disorder	3.34	6.1e-19	3.1e-15	79	Antagonist
1910	2297	DRD2	C1510497	Lenticular opacities	5.05	4e-15	3.6e-11	61.7	Binding
1910	1907	DRD2	C0020443	Hypercholesterolaemia	4.92	1.4e-21	1.4e-17	91	Binding
1910	2536	DRD2	C0026205	Miosis	5.01	1.6e-13	8.2e-10	54.4	Antagonist
1910	1568	DRD2	C0235660	Galactorrhoea	3.08	1.4e-13	6.8e-10	54.8	Antagonist
1910	1238	DRD2	C0393593	Dystonia	3.35	1e-22	9.6e-19	96.3	Binding
1910	2488	DRD2	C0025345	Menstrual disorder	2.7	2.9e-09	1.4e-05	35.2	Antagonist
1910	1268	DRD2	C0235969	Ejaculation disorder	3.99	6.8e-22	6.5e-18	92.5	Binding
1910	2620	DRD2	C0026961	Mydriasis	2.94	8.2e-13	7.4e-09	51.2	Binding
1910	1568	DRD2	C0235660	Galactorrhoea	3.23	2.8e-29	2.7e-25	126.2	Binding
1910	2875	DRD2	C0020651	Orthostatic hypotension	2.44	3.3e-20	3.1e-16	84.8	Binding
1910	1238	DRD2	C0393593	Dystonia	3.56	1.1e-13	5.7e-10	55.1	Antagonist
1910	2974	DRD2	C0242422	Parkinsonism	3.73	1.5e-24	1.5e-20	104.5	Binding
1910	159	DRD2	C0002453	Amenorrhoea	2.93	1.3e-19	1.2e-15	82.1	Binding
1910	2974	DRD2	C0242422	Parkinsonism	3.83	6.2e-14	3.1e-10	56.3	Antagonist
1910	830	DRD2	C0008370	Cholestasis	2.89	4.1e-07	0.0033	25.7	Binding
1910	4219	DRD2	C0043094	Weight increased	2.19	1e-07	0.00049	28.3	Antagonist
1910	2488	DRD2	C0025345	Menstrual disorder	2.57	1.5e-15	1.4e-11	63.7	Binding
1910	993	DRD2	C0010038	Corneal opacity	3.52	5.3e-09	4.5e-05	34.1	Binding
1910	995	DRD2	C0423226	Corneal pigmentation	5.27	8.3e-17	7.7e-13	69.3	Binding
1910	122	DRD2	C0392156	Akathisia	3.72	4e-15	2e-11	61.7	Antagonist
1910	1411	DRD2	C0015371	Extrapyramidal disorder	3.34	2e-36	1.9e-32	158.9	Binding
1910	1219	DRD2	C0013384	Dyskinesia	2.95	3.6e-11	3.2e-07	43.8	Binding
1910	2008	DRD2	C0413252	Hypothermia	3.33	1.5e-11	7.4e-08	45.6	Antagonist
1910	1505	DRD2	C0016034	Fibrocystic breast disease	3.73	1.1e-10	5.4e-07	41.7	Antagonist
1910	1505	DRD2	C0016034	Fibrocystic breast disease	3.5	9.6e-18	9e-14	73.6	Binding
1910	1434	DRD2	C1142111	Eyelash discolouration	3.48	1.3e-11	1.1e-07	45.9	Binding
1910	2008	DRD2	C0413252	Hypothermia	3.24	2e-20	1.9e-16	85.8	Binding
1910	1370	DRD2	C0242350	Erectile dysfunction	1.8	1.5e-06	0.012	23.2	Binding
1910	1719	DRD2	C0018418	Gynaecomastia	2.35	1.2e-08	5.8e-05	32.5	Antagonist
1910	1317	DRD2	C0014130	Endocrine disorder	2.24	1.1e-06	0.0052	23.7	Antagonist
1910	1930	DRD2	C0020514	Hyperprolactinaemia	4.02	1.2e-22	1.2e-18	95.9	Binding
1910	2161	DRD2	C0917801	Insomnia	1.81	5.6e-06	0.025	20.6	Antagonist
1910	3827	DRD2	C0686347	Tardive dyskinesia	3.81	4.2e-29	4e-25	125.4	Binding
1910	1930	DRD2	C0020514	Hyperprolactinaemia	4.11	7e-13	3.5e-09	51.5	Antagonist
1910	2875	DRD2	C0020651	Orthostatic hypotension	2.52	8.9e-11	4.4e-07	42	Antagonist
1910	1108	DRD2	C0011606	Dermatitis exfoliative	2.53	1.8e-06	0.014	22.8	Binding
1910	4219	DRD2	C0043094	Weight increased	2.04	9.2e-12	8.2e-08	46.5	Binding
1910	966	DRD2	C0009806	Constipation	1.48	4.3e-06	0.033	21.1	Binding
1910	1268	DRD2	C0235969	Ejaculation disorder	4.79	4.6e-16	2.3e-12	66	Antagonist
1910	1199	DRD2	C0043352	Dry mouth	1.82	8.4e-13	7.5e-09	51.2	Binding
1910	3827	DRD2	C0686347	Tardive dyskinesia	3.72	3.1e-14	1.6e-10	57.7	Antagonist
1910	993	DRD2	C0010038	Corneal opacity	4.26	2e-07	0.00097	27	Antagonist
1910	122	DRD2	C0392156	Akathisia	3.53	4.5e-26	4.4e-22	111.5	Binding
1910	743	DRD2	C0086543	Cataract	3.07	7.3e-08	6e-04	29	Binding
1910	2536	DRD2	C0026205	Miosis	3.93	5.8e-16	5.4e-12	65.5	Binding
1910	1108	DRD2	C0011606	Dermatitis exfoliative	3.21	5e-06	0.023	20.8	Antagonist
1910	4166	DRD2	C0344232	Vision blurred	1.62	6.6e-07	0.0053	24.7	Binding
1910	1317	DRD2	C0014130	Endocrine disorder	2.3	3.1e-13	2.8e-09	53.2	Binding
1910	2724	DRD2	C0027849	Neuroleptic malignant syndrome	4.67	1.4e-13	7.1e-10	54.7	Antagonist
1910	3821	DRD2	C0039231	Tachycardia	1.89	9.7e-14	8.8e-10	55.4	Binding
1910	972	DRD2	C0036572	Convulsion	1.6	5.2e-07	0.0042	25.2	Binding
1910	159	DRD2	C0002453	Amenorrhoea	3.15	1.6e-12	7.8e-09	50	Antagonist
1910	2662	DRD2	C0027424	Nasal congestion	2.9	2.4e-11	1.2e-07	44.6	Antagonist
1910	2161	DRD2	C0917801	Insomnia	1.9	3.4e-14	3.1e-10	57.5	Binding
1910	2620	DRD2	C0026961	Mydriasis	3.16	6.6e-08	0.00032	29.2	Antagonist
1911	159	DRD3	C0002453	Amenorrhoea	3.17	3e-06	0.014	21.8	Antagonist
1911	2662	DRD3	C0027424	Nasal congestion	2.79	2.5e-10	2.1e-06	40.1	Binding
1911	122	DRD3	C0392156	Akathisia	4.09	4.1e-09	2e-05	34.6	Antagonist
1911	1930	DRD3	C0020514	Hyperprolactinaemia	4.32	5.8e-07	0.0027	25	Antagonist
1911	1930	DRD3	C0020514	Hyperprolactinaemia	4.12	2.2e-12	2e-08	49.3	Binding
1911	2974	DRD3	C0242422	Parkinsonism	3.52	5.4e-11	4.7e-07	43	Binding
1911	1238	DRD3	C0393593	Dystonia	3.53	1.5e-06	0.0071	23.1	Antagonist
1911	4219	DRD3	C0043094	Weight increased	2	5.4e-06	0.042	20.7	Binding
1911	1411	DRD3	C0015371	Extrapyramidal disorder	3.45	7.5e-10	3.7e-06	37.9	Antagonist
1911	2008	DRD3	C0413252	Hypothermia	3.02	7.8e-09	6.6e-05	33.3	Binding
1911	1719	DRD3	C0018418	Gynaecomastia	2.18	9.1e-07	0.0073	24.1	Binding
1911	2724	DRD3	C0027849	Neuroleptic malignant syndrome	4.28	2.1e-11	1.8e-07	44.9	Binding
1911	3827	DRD3	C0686347	Tardive dyskinesia	4.09	1.4e-08	6.6e-05	32.2	Antagonist
1911	2875	DRD3	C0020651	Orthostatic hypotension	2.59	7.3e-06	0.033	20.1	Antagonist
1911	1568	DRD3	C0235660	Galactorrhoea	3.05	1.7e-06	0.0078	22.9	Antagonist
1911	3827	DRD3	C0686347	Tardive dyskinesia	3.88	1.3e-15	1.2e-11	63.9	Binding
1911	2488	DRD3	C0025345	Menstrual disorder	2.84	6.1e-11	5.3e-07	42.8	Binding
1911	1411	DRD3	C0015371	Extrapyramidal disorder	3.17	2.9e-16	2.7e-12	66.9	Binding
1911	2875	DRD3	C0020651	Orthostatic hypotension	2.44	1.1e-10	9.7e-07	41.6	Binding
1911	1568	DRD3	C0235660	Galactorrhoea	2.77	6.9e-10	5.9e-06	38.1	Binding
1911	122	DRD3	C0392156	Akathisia	3.99	2.6e-18	2.4e-14	76.2	Binding
1911	1268	DRD3	C0235969	Ejaculation disorder	3.24	8.3e-07	0.0066	24.3	Binding
1911	1219	DRD3	C0013384	Dyskinesia	4.73	5.4e-19	5.1e-15	79.3	Binding
1911	159	DRD3	C0002453	Amenorrhoea	2.98	9.4e-11	8.2e-07	41.9	Binding
1911	1238	DRD3	C0393593	Dystonia	3.64	1.5e-14	1.3e-10	59.1	Binding
1911	1274	DRD3	C0855329	Electrocardiogram change	3.18	5.3e-12	4.7e-08	47.6	Binding
1911	2488	DRD3	C0025345	Menstrual disorder	3.15	7.6e-07	0.0036	24.5	Antagonist
1912	2339	DRD4	C0154251	Lipid metabolism disorder	3.89	4.8e-06	0.038	20.9	Binding
1912	1274	DRD4	C0855329	Electrocardiogram change	3.54	9.9e-15	9.1e-11	59.9	Binding
1912	2662	DRD4	C0027424	Nasal congestion	3.35	1.1e-15	9.9e-12	64.3	Binding
1912	1907	DRD4	C0020443	Hypercholesterolaemia	4.26	2.1e-07	0.0017	26.9	Binding
1912	3827	DRD4	C0686347	Tardive dyskinesia	4.13	3.5e-08	0.00017	30.4	Antagonist
1912	3827	DRD4	C0686347	Tardive dyskinesia	3.92	6.7e-15	6.2e-11	60.7	Binding
1912	2724	DRD4	C0027849	Neuroleptic malignant syndrome	3.9	1.7e-08	0.00014	31.8	Binding
1912	1930	DRD4	C0020514	Hyperprolactinaemia	3.24	1.9e-06	0.015	22.7	Binding
1912	159	DRD4	C0002453	Amenorrhoea	2.83	9.9e-09	8.4e-05	32.9	Binding
1912	2488	DRD4	C0025345	Menstrual disorder	2.66	1.8e-08	0.00015	31.7	Binding
1912	2488	DRD4	C0025345	Menstrual disorder	3.03	8.1e-06	0.037	19.9	Antagonist
1912	2875	DRD4	C0020651	Orthostatic hypotension	2.32	1.4e-08	0.00012	32.1	Binding
1912	1219	DRD4	C0013384	Dyskinesia	4.38	1.1e-14	1e-10	59.7	Binding
1912	1411	DRD4	C0015371	Extrapyramidal disorder	2.98	8.8e-13	7.9e-09	51.1	Binding
1912	2620	DRD4	C0026961	Mydriasis	3.1	2.5e-07	0.002	26.6	Binding
1912	1411	DRD4	C0015371	Extrapyramidal disorder	3.25	6.8e-08	0.00033	29.1	Antagonist
1912	122	DRD4	C0392156	Akathisia	4.43	3.5e-10	1.7e-06	39.4	Antagonist
1912	122	DRD4	C0392156	Akathisia	4.07	8.3e-18	7.7e-14	73.9	Binding
1912	2662	DRD4	C0027424	Nasal congestion	3.17	1.4e-06	0.0065	23.3	Antagonist
1912	1268	DRD4	C0235969	Ejaculation disorder	3.5	1.2e-07	0.00096	28.1	Binding
1912	1568	DRD4	C0235660	Galactorrhoea	2.56	1.8e-07	0.0015	27.2	Binding
1912	1238	DRD4	C0393593	Dystonia	3.56	7.7e-13	6.9e-09	51.3	Binding
1912	2974	DRD4	C0242422	Parkinsonism	3.81	2.2e-12	1.9e-08	49.3	Binding
1912	1238	DRD4	C0393593	Dystonia	3.55	3.5e-06	0.016	21.5	Antagonist
1912	2008	DRD4	C0413252	Hypothermia	3.26	4.8e-10	4.1e-06	38.8	Binding
1912	1274	DRD4	C0855329	Electrocardiogram change	3.34	2.2e-06	0.01	22.4	Antagonist
1913	2974	DRD5	C0242422	Parkinsonism	3.9	5.4e-09	4.5e-05	34.1	Binding
1913	1411	DRD5	C0015371	Extrapyramidal disorder	2.7	9.2e-07	0.0073	24.1	Binding
1913	2662	DRD5	C0027424	Nasal congestion	3.03	2.7e-08	0.00022	30.9	Binding
1913	3827	DRD5	C0686347	Tardive dyskinesia	4.49	5.7e-14	5.2e-10	56.5	Binding
1913	1238	DRD5	C0393593	Dystonia	3.52	1.5e-08	0.00013	32	Binding
1913	159	DRD5	C0002453	Amenorrhoea	2.95	9.9e-07	0.0078	24	Binding
1913	2724	DRD5	C0027849	Neuroleptic malignant syndrome	4.41	9.8e-08	8e-04	28.4	Binding
1913	122	DRD5	C0392156	Akathisia	5.12	2e-09	9.8e-06	36	Antagonist
1913	3827	DRD5	C0686347	Tardive dyskinesia	5.01	2e-08	9.4e-05	31.5	Antagonist
1913	122	DRD5	C0392156	Akathisia	4.65	1.4e-16	1.3e-12	68.4	Binding
1913	1568	DRD5	C0235660	Galactorrhoea	2.96	1.1e-07	0.00093	28.1	Binding
1913	1274	DRD5	C0855329	Electrocardiogram change	4.12	4.6e-07	0.0022	25.4	Antagonist
1913	2008	DRD5	C0413252	Hypothermia	3.4	1e-07	0.00084	28.3	Binding
1913	1219	DRD5	C0013384	Dyskinesia	4.13	1.1e-08	9.2e-05	32.7	Binding
1913	1274	DRD5	C0855329	Electrocardiogram change	3.92	5.8e-13	5.2e-09	51.9	Binding
2032	1065	EGFR	C0232462	Decreased appetite	4.79	2.6e-07	0.0021	26.5	Binding
2180	1096	ESR1	C0011570	Depression	3.96	1.8e-24	1.7e-20	104.2	Binding
2180	46	ESR1	C0702166	Acne	10.99	1.4e-19	1.3e-16	81.9	Agonist
2180	2488	ESR1	C0025345	Menstrual disorder	9.14	9.7e-21	8.7e-18	87.2	Agonist
2180	1096	ESR1	C0011570	Depression	3.86	2.1e-09	1.8e-06	35.9	Agonist
2180	4050	ESR1	C0042109	Urticaria	4.08	2.1e-18	2e-14	76.6	Binding
2180	1505	ESR1	C0016034	Fibrocystic breast disease	8.31	2.1e-35	2.1e-31	154.2	Binding
2180	818	ESR1	C0025218	Chloasma	55.17	0	0	1546.6	Binding
2180	2793	ESR1	C0013604	Oedema	2.74	1e-08	8.8e-05	32.8	Binding
2180	4065	ESR1	C0235883	Uterine inflammation	29.53	1.9e-68	1.7e-65	305.7	Agonist
2180	1814	ESR1	C0086565	Hepatic function abnormal	7.29	1.6e-26	1.5e-22	113.6	Binding
2180	1321	ESR1	C0014173	Endometrial hyperplasia	91.66	0	0	1798.7	Binding
2180	1719	ESR1	C0018418	Gynaecomastia	13.58	1.4e-37	1.2e-34	164.2	Agonist
2180	2518	ESR1	C0025874	Metrorrhagia	29.86	4.6e-87	4.5e-83	391.2	Binding
2180	4219	ESR1	C0043094	Weight increased	4.54	1.5e-10	7.6e-07	41	Antagonist
2180	4050	ESR1	C0042109	Urticaria	4.35	1.3e-07	0.00063	27.8	Antagonist
2180	2220	ESR1	C0022346	Jaundice	3.12	6.4e-12	5.6e-08	47.2	Binding
2180	1901	ESR1	C0020437	Hypercalcaemia	16.02	1.2e-78	1.2e-74	352.5	Binding
2180	1301	ESR1	C0549124	Embolism arterial	10.47	2e-18	1.9e-14	76.7	Binding
2180	1297	ESR1	C0342579	Electrolyte imbalance	4.36	7.6e-13	6.8e-09	51.4	Binding
2180	2220	ESR1	C0022346	Jaundice	4.15	2.9e-08	2.4e-05	30.8	Agonist
2180	2793	ESR1	C0013604	Oedema	3.41	7.2e-06	0.0054	20.1	Agonist
2180	1365	ESR1	C0151628	Epiphyses premature fusion	43.69	3.5e-211	3.5e-207	961.8	Binding
2180	561	ESR1	C0151539	Blood urea increased	21.05	1.1e-97	1.1e-93	440	Binding
2180	633	ESR1	C0024902	Breast pain	27.53	2.8e-102	2.8e-98	461.1	Binding
2180	1379	ESR1	C0014742	Erythema multiforme	7.9	5.6e-32	5.4e-28	138.5	Binding
2180	3170	ESR1	C0853026	Porphyria non-acute	57.05	3.8e-230	3.8e-226	1049.1	Binding
2180	4065	ESR1	C0235883	Uterine inflammation	42.96	4.2e-261	4.2e-257	1191.5	Binding
2180	46	ESR1	C0702166	Acne	10.77	1.2e-32	1.2e-28	141.5	Binding
2180	1319	ESR1	C0476089	Endometrial cancer	97.33	0	0	1625.7	Binding
2180	2488	ESR1	C0025345	Menstrual disorder	4.43	7.2e-18	6.7e-14	74.2	Binding
2180	4219	ESR1	C0043094	Weight increased	9.29	3.1e-34	2.8e-31	148.9	Agonist
2180	818	ESR1	C0025218	Chloasma	35.74	1.7e-83	1.6e-80	374.8	Agonist
2180	2693	ESR1	C0027651	Neoplasm	18.91	1.9e-68	1.9e-64	305.6	Binding
2180	4219	ESR1	C0043094	Weight increased	4.81	2.1e-35	2e-31	154.2	Binding
2180	1719	ESR1	C0018418	Gynaecomastia	4.23	1.3e-21	1.2e-17	91.3	Binding
2180	1505	ESR1	C0016034	Fibrocystic breast disease	23.94	4.2e-50	3.8e-47	221.5	Agonist
2180	1096	ESR1	C0011570	Depression	4.18	2e-09	9.9e-06	36	Antagonist
2180	582	ESR1	C0005940	Bone disorder	23.41	1.9e-95	1.8e-91	429.7	Binding
2180	4050	ESR1	C0042109	Urticaria	4.67	2.1e-08	1.7e-05	31.4	Agonist
2181	4219	ESR2	C0043094	Weight increased	7.88	2.2e-13	1.9e-10	53.8	Agonist
2181	1096	ESR2	C0011570	Depression	4.86	3.1e-12	1.5e-08	48.7	Antagonist
2181	1379	ESR2	C0014742	Erythema multiforme	7.97	1.3e-25	1.3e-21	109.4	Binding
2181	2793	ESR2	C0013604	Oedema	2.7	8.5e-07	0.0068	24.2	Binding
2181	1719	ESR2	C0018418	Gynaecomastia	3.83	6.3e-06	0.029	20.4	Antagonist
2181	1365	ESR2	C0151628	Epiphyses premature fusion	46.39	6.7e-186	6.7e-182	845.6	Binding
2181	1719	ESR2	C0018418	Gynaecomastia	4.12	5.1e-16	4.7e-12	65.8	Binding
2181	3170	ESR2	C0853026	Porphyria non-acute	50.89	1.4e-140	1.3e-136	637.2	Binding
2181	4219	ESR2	C0043094	Weight increased	4.24	1.3e-20	1.3e-16	86.6	Binding
2181	1814	ESR2	C0086565	Hepatic function abnormal	7.17	3.7e-20	3.5e-16	84.6	Binding
2181	818	ESR2	C0025218	Chloasma	53.89	7.1e-251	7.1e-247	1144.5	Binding
2181	1297	ESR2	C0342579	Electrolyte imbalance	4.76	1.5e-12	1.3e-08	50.1	Binding
2181	2693	ESR2	C0027651	Neoplasm	16.49	8.1e-40	7.9e-36	174.4	Binding
2181	2220	ESR2	C0022346	Jaundice	3.15	7.4e-10	6.4e-06	37.9	Binding
2181	633	ESR2	C0024902	Breast pain	20.31	8e-42	7.9e-38	183.6	Binding
2181	4219	ESR2	C0043094	Weight increased	4.65	3e-10	1.5e-06	39.6	Antagonist
2181	1096	ESR2	C0011570	Depression	4.2	9.5e-07	0.00074	24	Agonist
2181	2488	ESR2	C0025345	Menstrual disorder	4.48	1.5e-14	1.4e-10	59.1	Binding
2181	46	ESR2	C0702166	Acne	8.88	8e-17	7.4e-13	69.4	Binding
2181	582	ESR2	C0005940	Bone disorder	24.15	2.9e-79	2.9e-75	355.3	Binding
2181	2518	ESR2	C0025874	Metrorrhagia	27.9	2e-58	2e-54	259.7	Binding
2181	561	ESR2	C0151539	Blood urea increased	21.24	1.6e-77	1.6e-73	347.4	Binding
2181	4050	ESR2	C0042109	Urticaria	4.35	4.9e-07	0.0023	25.3	Antagonist
2181	1096	ESR2	C0011570	Depression	4.21	1.6e-22	1.5e-18	95.4	Binding
2181	2488	ESR2	C0025345	Menstrual disorder	5.06	8e-08	0.00038	28.8	Antagonist
2181	4050	ESR2	C0042109	Urticaria	3.82	1.8e-12	1.6e-08	49.7	Binding
2181	4065	ESR2	C0235883	Uterine inflammation	40.14	1.2e-176	1.2e-172	803	Binding
2181	1319	ESR2	C0476089	Endometrial cancer	89.57	3.2e-231	3.2e-227	1054	Binding
2181	1321	ESR2	C0014173	Endometrial hyperplasia	88.98	1.7e-286	1.7e-282	1308.3	Binding
2181	1901	ESR2	C0020437	Hypercalcaemia	16.49	2.9e-65	2.9e-61	291.1	Binding
2181	1505	ESR2	C0016034	Fibrocystic breast disease	8.05	6.8e-26	6.5e-22	110.7	Binding
2489	354	GABRA1	C0004134	Ataxia	2.97	4.9e-09	4.1e-06	34.2	Agonist
2489	1573	GABRA1	C0017086	Gangrene	5.51	3.6e-11	3.1e-07	43.8	Binding
2489	1108	GABRA1	C0011606	Dermatitis exfoliative	3.13	1.9e-06	0.015	22.7	Binding
2489	3444	GABRA1	C0035204	Respiratory disorder	2.3	4.6e-06	0.035	21	Binding
2489	830	GABRA1	C0008370	Cholestasis	3.48	2.1e-06	0.017	22.5	Binding
2489	268	GABRA1	C0003578	Apnoea	3.39	9.9e-11	8.6e-07	41.8	Binding
2489	115	GABRA1	C0085631	Agitation	2.63	1.2e-14	1.1e-10	59.5	Binding
2489	354	GABRA1	C0004134	Ataxia	3.73	1.6e-35	1.5e-31	154.8	Binding
2489	115	GABRA1	C0085631	Agitation	2.56	3.9e-05	0.027	16.9	Agonist
2489	2769	GABRA1	C0028738	Nystagmus	4.84	6.5e-17	6.1e-13	69.8	Binding
2489	2211	GABRA1	C0022107	Irritability	3.28	5.3e-08	0.00044	29.6	Binding
2489	3442	GABRA1	C0235063	Respiratory depression	3.34	5.8e-08	4.7e-05	29.4	Agonist
2489	162	GABRA1	C0002622	Amnesia	6.37	2e-20	1.9e-16	85.8	Binding
2489	2066	GABRA1	C0021167	Incontinence	6.41	1.7e-12	1.5e-08	49.8	Binding
2489	3693	GABRA1	C2830004	Somnolence	1.72	7.8e-08	0.00064	28.8	Binding
2489	1091	GABRA1	C0439857	Dependence	5.25	2.6e-30	2.5e-26	130.9	Binding
2489	2287	GABRA1	C0023066	Laryngospasm	8.05	7.7e-37	7.5e-33	160.8	Binding
2489	3869	GABRA1	C0040046	Thrombophlebitis	3.81	2.7e-07	0.0022	26.5	Binding
2489	2002	GABRA1	C3203356	Hypoprothrombinaemia	5.34	2.6e-12	2.3e-08	49	Binding
2489	4028	GABRA1	C0080274	Urinary retention	2.55	4.6e-12	4e-08	47.9	Binding
2489	927	GABRA1	C0009676	Confusional state	2.9	1.1e-24	1e-20	105.3	Binding
2489	1379	GABRA1	C0014742	Erythema multiforme	3.28	2.2e-08	0.00018	31.3	Binding
2489	2315	GABRA1	C0854382	Libido disorder	4.17	5.8e-26	5.6e-22	111	Binding
2489	3697	GABRA1	C0037822	Speech disorder	4.06	2e-06	0.016	22.5	Binding
2489	3522	GABRA1	C0036093	Salivary gland disorder	10.42	2.2e-18	2.1e-14	76.5	Binding
2489	3442	GABRA1	C0235063	Respiratory depression	5.24	5.2e-37	5e-33	161.6	Binding
2489	2315	GABRA1	C0854382	Libido disorder	4.02	7.9e-07	0.0037	24.4	Antagonist
2489	1536	GABRA1	C0016412	Folate deficiency	10.7	9.7e-25	9.3e-21	105.4	Binding
2489	2220	GABRA1	C0022346	Jaundice	2.09	2.6e-07	0.0021	26.5	Binding
2489	1859	GABRA1	C0019521	Hiccups	4.3	4.9e-12	4.3e-08	47.7	Binding
2489	2007	GABRA1	C0020649	Hypotension	1.8	8.5e-08	7e-04	28.7	Binding
2489	2287	GABRA1	C0023066	Laryngospasm	4.98	1.9e-08	1.5e-05	31.6	Agonist
2489	1213	GABRA1	C0013362	Dysarthria	2.75	2.9e-06	0.023	21.9	Binding
2489	2682	GABRA1	C0027540	Necrosis	8.98	3.1e-20	3e-16	84.9	Binding
2490	268	GABRA2	C0003578	Apnoea	3.91	1.7e-09	1.5e-05	36.3	Binding
2490	3693	GABRA2	C2830004	Somnolence	2.06	7.8e-10	6.8e-06	37.8	Binding
2490	3442	GABRA2	C0235063	Respiratory depression	5.62	1.3e-26	1.3e-22	113.9	Binding
2490	2220	GABRA2	C0022346	Jaundice	3.31	5.4e-06	0.004	20.7	Agonist
2490	3522	GABRA2	C0036093	Salivary gland disorder	17.34	5.4e-32	5.3e-28	138.6	Binding
2490	354	GABRA2	C0004134	Ataxia	4.82	2.4e-07	0.0011	26.7	Antagonist
2490	584	GABRA2	C0005956	Bone marrow disorder	2.21	2.3e-06	0.018	22.4	Binding
2490	1573	GABRA2	C0017086	Gangrene	7.75	2.2e-14	2e-10	58.4	Binding
2490	2211	GABRA2	C0022107	Irritability	4.36	6e-10	5.2e-06	38.3	Binding
2490	2315	GABRA2	C0854382	Libido disorder	3.81	8e-08	6.5e-05	28.8	Agonist
2490	4147	GABRA2	C0042571	Vertigo	1.9	7.5e-07	0.006	24.5	Binding
2490	2315	GABRA2	C0854382	Libido disorder	6.34	4.1e-43	4e-39	189.5	Binding
2490	2769	GABRA2	C0028738	Nystagmus	6.71	8.8e-22	8.4e-18	92	Binding
2490	4028	GABRA2	C0080274	Urinary retention	3.04	1.5e-05	0.011	18.8	Agonist
2490	2287	GABRA2	C0023066	Laryngospasm	7.93	1.8e-21	1.7e-17	90.5	Binding
2490	115	GABRA2	C0085631	Agitation	2.87	4.3e-05	0.03	16.7	Agonist
2490	162	GABRA2	C0002622	Amnesia	7.95	3.6e-20	3.4e-16	84.6	Binding
2490	2066	GABRA2	C0021167	Incontinence	10.66	1.1e-22	1.1e-18	96	Binding
2490	354	GABRA2	C0004134	Ataxia	5.33	1.2e-52	1.1e-48	233.3	Binding
2490	4028	GABRA2	C0080274	Urinary retention	3.42	5.3e-17	4.9e-13	70.2	Binding
2490	1108	GABRA2	C0011606	Dermatitis exfoliative	3.98	3.1e-07	0.0025	26.2	Binding
2490	927	GABRA2	C0009676	Confusional state	3.81	6.8e-06	0.031	20.3	Antagonist
2490	2007	GABRA2	C0020649	Hypotension	2.19	1e-09	8.6e-06	37.3	Binding
2490	2002	GABRA2	C3203356	Hypoprothrombinaemia	7.7	7.5e-17	7e-13	69.5	Binding
2490	2220	GABRA2	C0022346	Jaundice	2.9	3.8e-12	3.3e-08	48.2	Binding
2490	1379	GABRA2	C0014742	Erythema multiforme	3.9	5.1e-08	0.00042	29.7	Binding
2490	115	GABRA2	C0085631	Agitation	3.06	5.2e-14	4.7e-10	56.6	Binding
2490	1213	GABRA2	C0013362	Dysarthria	3.49	3.2e-07	0.0026	26.1	Binding
2490	584	GABRA2	C0005956	Bone marrow disorder	3.12	3.9e-05	0.027	16.9	Agonist
2490	1091	GABRA2	C0439857	Dependence	3.17	1.4e-05	0.01	18.9	Agonist
2490	3444	GABRA2	C0035204	Respiratory disorder	2.94	1.5e-07	0.0012	27.7	Binding
2490	1536	GABRA2	C0016412	Folate deficiency	16.43	1.5e-36	1.5e-32	159.4	Binding
2490	830	GABRA2	C0008370	Cholestasis	4.96	4.8e-09	4.1e-05	34.3	Binding
2490	927	GABRA2	C0009676	Confusional state	3.57	6e-27	5.8e-23	115.5	Binding
2490	1091	GABRA2	C0439857	Dependence	8.28	3.7e-52	3.6e-48	231	Binding
2490	354	GABRA2	C0004134	Ataxia	3.75	9e-12	7.8e-09	46.5	Agonist
2491	3522	GABRA3	C0036093	Salivary gland disorder	15.26	6.7e-28	6.5e-24	119.9	Binding
2491	3697	GABRA3	C0037822	Speech disorder	5.94	1.9e-10	1.6e-06	40.6	Binding
2491	927	GABRA3	C0009676	Confusional state	3.45	1.2e-27	1.2e-23	118.7	Binding
2491	1379	GABRA3	C0014742	Erythema multiforme	3.89	5.9e-09	5e-05	33.9	Binding
2491	3442	GABRA3	C0235063	Respiratory depression	3.33	1.2e-05	0.0087	19.2	Agonist
2491	2315	GABRA3	C0854382	Libido disorder	5.58	2.6e-36	2.6e-32	158.3	Binding
2491	927	GABRA3	C0009676	Confusional state	2.37	5.2e-05	0.036	16.4	Agonist
2491	2007	GABRA3	C0020649	Hypotension	2.09	2.4e-09	2e-05	35.7	Binding
2491	2220	GABRA3	C0022346	Jaundice	3.16	3e-05	0.021	17.4	Agonist
2491	354	GABRA3	C0004134	Ataxia	3.53	6.7e-10	5.6e-07	38.1	Agonist
2491	1091	GABRA3	C0439857	Dependence	7.29	1.8e-44	1.8e-40	195.7	Binding
2491	1573	GABRA3	C0017086	Gangrene	6.82	2.3e-12	2.1e-08	49.2	Binding
2491	2002	GABRA3	C3203356	Hypoprothrombinaemia	6.78	1.9e-14	1.7e-10	58.6	Binding
2491	3444	GABRA3	C0035204	Respiratory disorder	2.58	4.8e-06	0.037	20.9	Binding
2491	4028	GABRA3	C0080274	Urinary retention	3.23	2e-16	1.9e-12	67.6	Binding
2491	2315	GABRA3	C0854382	Libido disorder	3.92	3.9e-08	3.2e-05	30.2	Agonist
2491	115	GABRA3	C0085631	Agitation	2.95	2.6e-05	0.019	17.7	Agonist
2491	2066	GABRA3	C0021167	Incontinence	9.38	1.3e-19	1.2e-15	82	Binding
2491	1091	GABRA3	C0439857	Dependence	3.02	6.8e-05	0.046	15.9	Agonist
2491	2220	GABRA3	C0022346	Jaundice	2.61	3.1e-10	2.7e-06	39.6	Binding
2491	1108	GABRA3	C0011606	Dermatitis exfoliative	3.5	4.8e-06	0.038	20.9	Binding
2491	1536	GABRA3	C0016412	Folate deficiency	14.46	8.3e-32	8.1e-28	137.7	Binding
2491	162	GABRA3	C0002622	Amnesia	6.99	2.8e-17	2.6e-13	71.5	Binding
2491	830	GABRA3	C0008370	Cholestasis	4.37	1.2e-07	0.00099	28	Binding
2491	2211	GABRA3	C0022107	Irritability	4.08	1.4e-09	1.2e-05	36.7	Binding
2491	3693	GABRA3	C2830004	Somnolence	1.89	3.7e-08	0.00031	30.3	Binding
2491	3442	GABRA3	C0235063	Respiratory depression	5.43	9.6e-28	9.2e-24	119.2	Binding
2491	2769	GABRA3	C0028738	Nystagmus	5.9	1.7e-18	1.6e-14	77	Binding
2491	354	GABRA3	C0004134	Ataxia	4.55	1.3e-40	1.3e-36	178	Binding
2491	268	GABRA3	C0003578	Apnoea	3.44	7.6e-08	0.00063	28.9	Binding
2491	584	GABRA3	C0005956	Bone marrow disorder	3.2	2.4e-05	0.017	17.8	Agonist
2491	115	GABRA3	C0085631	Agitation	2.82	1.3e-12	1.2e-08	50.3	Binding
2491	1213	GABRA3	C0013362	Dysarthria	3.45	6.7e-08	0.00055	29.2	Binding
2491	4028	GABRA3	C0080274	Urinary retention	3.33	8.9e-07	7e-04	24.2	Agonist
2491	927	GABRA3	C0009676	Confusional state	3.17	6.3e-06	0.029	20.4	Antagonist
2491	2287	GABRA3	C0023066	Laryngospasm	6.98	2.2e-18	2.1e-14	76.5	Binding
2492	2220	GABRA4	C0022346	Jaundice	3.1	4.3e-05	0.029	16.8	Agonist
2492	115	GABRA4	C0085631	Agitation	2.91	4.6e-13	4.1e-09	52.4	Binding
2492	3697	GABRA4	C0037822	Speech disorder	5.7	4.6e-09	3.9e-05	34.3	Binding
2492	1108	GABRA4	C0011606	Dermatitis exfoliative	3.69	1.6e-06	0.013	23	Binding
2492	115	GABRA4	C0085631	Agitation	3.08	4.9e-06	0.0037	20.9	Agonist
2492	3442	GABRA4	C0235063	Respiratory depression	5.39	6.8e-26	6.5e-22	110.7	Binding
2492	2211	GABRA4	C0022107	Irritability	4.3	2.5e-10	2.2e-06	40	Binding
2492	1091	GABRA4	C0439857	Dependence	6.65	3.1e-34	3e-30	148.9	Binding
2492	2769	GABRA4	C0028738	Nystagmus	5.92	1.2e-17	1.1e-13	73.1	Binding
2492	4028	GABRA4	C0080274	Urinary retention	3.18	5.6e-15	5.1e-11	61	Binding
2492	354	GABRA4	C0004134	Ataxia	4.58	3.9e-39	3.8e-35	171.3	Binding
2492	162	GABRA4	C0002622	Amnesia	5.9	2.8e-11	2.5e-07	44.3	Binding
2492	2315	GABRA4	C0854382	Libido disorder	3.84	6.5e-08	5.3e-05	29.2	Agonist
2492	3693	GABRA4	C2830004	Somnolence	1.91	4.1e-08	0.00034	30.1	Binding
2492	1213	GABRA4	C0013362	Dysarthria	3.24	1.9e-06	0.015	22.7	Binding
2492	1536	GABRA4	C0016412	Folate deficiency	15.25	1e-33	1e-29	146.4	Binding
2492	584	GABRA4	C0005956	Bone marrow disorder	3.14	3.4e-05	0.024	17.2	Agonist
2492	2315	GABRA4	C0854382	Libido disorder	5.34	4.9e-31	4.7e-27	134.2	Binding
2492	2066	GABRA4	C0021167	Incontinence	9.07	2.8e-17	2.6e-13	71.5	Binding
2492	268	GABRA4	C0003578	Apnoea	3.63	1.7e-08	0.00014	31.9	Binding
2492	830	GABRA4	C0008370	Cholestasis	4.61	3.3e-08	0.00028	30.5	Binding
2492	927	GABRA4	C0009676	Confusional state	3.48	6.9e-27	6.6e-23	115.3	Binding
2492	1573	GABRA4	C0017086	Gangrene	7.2	3.5e-13	3.2e-09	52.9	Binding
2492	1379	GABRA4	C0014742	Erythema multiforme	4.1	1.1e-09	9.7e-06	37.1	Binding
2492	2002	GABRA4	C3203356	Hypoprothrombinaemia	7.15	2e-15	1.9e-11	63	Binding
2492	354	GABRA4	C0004134	Ataxia	3.62	9.9e-11	8.4e-08	41.8	Agonist
2492	927	GABRA4	C0009676	Confusional state	2.53	4.1e-06	0.0031	21.2	Agonist
2492	2287	GABRA4	C0023066	Laryngospasm	7.37	1.3e-19	1.2e-15	82.1	Binding
2492	4028	GABRA4	C0080274	Urinary retention	3.26	1.4e-06	0.0011	23.3	Agonist
2492	2007	GABRA4	C0020649	Hypotension	2.03	3.9e-08	0.00032	30.2	Binding
2492	2220	GABRA4	C0022346	Jaundice	2.49	1.8e-08	0.00015	31.7	Binding
2493	3697	GABRA5	C0037822	Speech disorder	5.88	2.5e-10	2.2e-06	40	Binding
2493	1108	GABRA5	C0011606	Dermatitis exfoliative	3.47	5.9e-06	0.046	20.5	Binding
2493	2211	GABRA5	C0022107	Irritability	4.04	1.9e-09	1.6e-05	36	Binding
2493	927	GABRA5	C0009676	Confusional state	3.17	6.3e-06	0.029	20.4	Antagonist
2493	1573	GABRA5	C0017086	Gangrene	6.75	3.2e-12	2.9e-08	48.5	Binding
2493	2066	GABRA5	C0021167	Incontinence	9.29	2.2e-19	2.1e-15	81	Binding
2493	354	GABRA5	C0004134	Ataxia	4.57	1.5e-41	1.4e-37	182.4	Binding
2493	1091	GABRA5	C0439857	Dependence	7.22	6.6e-44	6.5e-40	193.1	Binding
2493	354	GABRA5	C0004134	Ataxia	3.58	1.6e-10	1.4e-07	40.9	Agonist
2493	584	GABRA5	C0005956	Bone marrow disorder	3.1	4.2e-05	0.029	16.8	Agonist
2493	115	GABRA5	C0085631	Agitation	2.79	2.2e-12	2e-08	49.3	Binding
2493	2007	GABRA5	C0020649	Hypotension	2.03	1.2e-08	9.8e-05	32.6	Binding
2493	1536	GABRA5	C0016412	Folate deficiency	14.31	1.8e-31	1.8e-27	136.2	Binding
2493	830	GABRA5	C0008370	Cholestasis	4.32	1.5e-07	0.0012	27.6	Binding
2493	2315	GABRA5	C0854382	Libido disorder	5.53	8.2e-36	8e-32	156.1	Binding
2493	3444	GABRA5	C0035204	Respiratory disorder	2.56	6.1e-06	0.047	20.5	Binding
2493	2315	GABRA5	C0854382	Libido disorder	3.79	9e-08	7.3e-05	28.6	Agonist
2493	4028	GABRA5	C0080274	Urinary retention	3.22	1.9e-06	0.0014	22.7	Agonist
2493	927	GABRA5	C0009676	Confusional state	3.46	3.1e-28	3e-24	121.4	Binding
2493	2002	GABRA5	C3203356	Hypoprothrombinaemia	6.71	2.8e-14	2.6e-10	57.9	Binding
2493	268	GABRA5	C0003578	Apnoea	3.4	1e-07	0.00082	28.4	Binding
2493	3442	GABRA5	C0235063	Respiratory depression	5.22	1.6e-25	1.6e-21	109	Binding
2493	1379	GABRA5	C0014742	Erythema multiforme	3.85	7.9e-09	6.7e-05	33.3	Binding
2493	2220	GABRA5	C0022346	Jaundice	3.06	5.3e-05	0.036	16.3	Agonist
2493	115	GABRA5	C0085631	Agitation	2.86	4.7e-05	0.032	16.6	Agonist
2493	4028	GABRA5	C0080274	Urinary retention	3.2	3.9e-16	3.6e-12	66.3	Binding
2493	3522	GABRA5	C0036093	Salivary gland disorder	15.11	1.3e-27	1.3e-23	118.5	Binding
2493	3693	GABRA5	C2830004	Somnolence	1.9	2.5e-08	0.00021	31.1	Binding
2493	2220	GABRA5	C0022346	Jaundice	2.59	4.9e-10	4.2e-06	38.7	Binding
2493	162	GABRA5	C0002622	Amnesia	6.92	4.5e-17	4.1e-13	70.6	Binding
2493	2287	GABRA5	C0023066	Laryngospasm	6.91	3.7e-18	3.5e-14	75.5	Binding
2493	1213	GABRA5	C0013362	Dysarthria	3.42	8.8e-08	0.00072	28.6	Binding
2493	2769	GABRA5	C0028738	Nystagmus	5.84	2.9e-18	2.7e-14	75.9	Binding
2493	927	GABRA5	C0009676	Confusional state	2.4	2.5e-05	0.018	17.7	Agonist
2494	2220	GABRA6	C0022346	Jaundice	2.29	3.7e-07	0.003	25.8	Binding
2494	2211	GABRA6	C0022107	Irritability	3.78	2.2e-05	0.016	18	Agonist
2494	115	GABRA6	C0085631	Agitation	3.56	1.8e-10	1.5e-07	40.7	Agonist
2494	115	GABRA6	C0085631	Agitation	3.11	5.5e-17	5.2e-13	70.1	Binding
2494	354	GABRA6	C0004134	Ataxia	4.75	1.2e-46	1.2e-42	205.7	Binding
2494	3693	GABRA6	C2830004	Somnolence	1.91	1.1e-08	9.2e-05	32.7	Binding
2494	1823	GABRA6	C0019158	Hepatitis	3.46	1e-08	8.5e-05	32.8	Binding
2494	2315	GABRA6	C0854382	Libido disorder	5.04	2.5e-29	2.4e-25	126.4	Binding
2494	2287	GABRA6	C0023066	Laryngospasm	8.89	2.6e-32	2.5e-28	140	Binding
2494	2769	GABRA6	C0028738	Nystagmus	6.88	6.7e-27	6.5e-23	115.3	Binding
2494	2287	GABRA6	C0023066	Laryngospasm	5.72	4.7e-10	3.9e-07	38.8	Agonist
2494	3442	GABRA6	C0235063	Respiratory depression	4.24	1.8e-12	1.6e-09	49.7	Agonist
2494	1091	GABRA6	C0439857	Dependence	2.93	1.4e-05	0.011	18.8	Agonist
2494	2002	GABRA6	C3203356	Hypoprothrombinaemia	8.6	4e-25	3.8e-21	107.2	Binding
2494	354	GABRA6	C0004134	Ataxia	3.8	8.2e-15	7.2e-12	60.3	Agonist
2494	2066	GABRA6	C0021167	Incontinence	8.35	1.1e-15	9.9e-12	64.3	Binding
2494	1091	GABRA6	C0439857	Dependence	7.07	8.3e-43	8.1e-39	188.1	Binding
2494	1108	GABRA6	C0011606	Dermatitis exfoliative	4.44	8.2e-11	7.1e-07	42.2	Binding
2494	3442	GABRA6	C0235063	Respiratory depression	6.35	3.3e-41	3.2e-37	180.8	Binding
2494	927	GABRA6	C0009676	Confusional state	3.18	6e-06	0.027	20.5	Antagonist
2494	3444	GABRA6	C0035204	Respiratory disorder	2.94	9.3e-09	7.8e-05	33	Binding
2494	2315	GABRA6	C0854382	Libido disorder	3.09	1e-05	0.0076	19.5	Agonist
2494	268	GABRA6	C0003578	Apnoea	4.26	1.5e-13	1.3e-09	54.6	Binding
2494	162	GABRA6	C0002622	Amnesia	5.43	3.7e-10	3.2e-06	39.2	Binding
2494	2682	GABRA6	C0027540	Necrosis	10.8	4.8e-21	4.5e-17	88.6	Binding
2494	1573	GABRA6	C0017086	Gangrene	9.63	5.2e-27	5e-23	115.8	Binding
2494	830	GABRA6	C0008370	Cholestasis	5.65	4.4e-14	4e-10	57	Binding
2494	268	GABRA6	C0003578	Apnoea	4.33	4.7e-07	0.00038	25.4	Agonist
2494	3697	GABRA6	C0037822	Speech disorder	5.24	3.6e-08	3e-04	30.4	Binding
2494	2211	GABRA6	C0022107	Irritability	5.35	1.3e-18	1.2e-14	77.6	Binding
2494	887	GABRA6	C0005779	Coagulopathy	5.89	3e-11	2.7e-07	44.1	Binding
2494	2769	GABRA6	C0028738	Nystagmus	5.39	1.6e-08	1.3e-05	32	Agonist
2494	1379	GABRA6	C0014742	Erythema multiforme	4.67	4e-14	3.6e-10	57.2	Binding
2494	3601	GABRA6	C0036974	Shock	3.93	1.3e-08	0.00011	32.3	Binding
2494	927	GABRA6	C0009676	Confusional state	2.37	3.6e-06	0.0028	21.4	Agonist
2494	2007	GABRA6	C0020649	Hypotension	2.06	3.7e-09	3.2e-05	34.8	Binding
2494	927	GABRA6	C0009676	Confusional state	3.44	2.4e-28	2.3e-24	121.9	Binding
2494	4028	GABRA6	C0080274	Urinary retention	2.99	8.9e-14	8e-10	55.6	Binding
2494	1536	GABRA6	C0016412	Folate deficiency	18.71	1e-56	1e-52	251.9	Binding
2495	354	GABRB1	C0004134	Ataxia	3.93	1.2e-11	9.9e-09	46	Agonist
2495	3693	GABRB1	C2830004	Somnolence	2.06	8e-07	0.0064	24.4	Binding
2495	1213	GABRB1	C0013362	Dysarthria	3.98	9.9e-07	0.0079	23.9	Binding
2495	2220	GABRB1	C0022346	Jaundice	3.52	3.8e-06	0.0029	21.4	Agonist
2495	162	GABRB1	C0002622	Amnesia	8.05	1.2e-13	1e-09	55.1	Binding
2495	4028	GABRB1	C0080274	Urinary retention	4.09	6.3e-18	5.8e-14	74.4	Binding
2495	584	GABRB1	C0005956	Bone marrow disorder	3.57	2.9e-06	0.0022	21.9	Agonist
2495	2220	GABRB1	C0022346	Jaundice	3.41	9.8e-13	8.8e-09	50.9	Binding
2495	2315	GABRB1	C0854382	Libido disorder	7.62	3e-43	3e-39	190.1	Binding
2495	2315	GABRB1	C0854382	Libido disorder	4.36	1.9e-09	1.6e-06	36.1	Agonist
2495	927	GABRB1	C0009676	Confusional state	2.64	4.2e-06	0.0032	21.2	Agonist
2495	115	GABRB1	C0085631	Agitation	2.77	2.4e-07	0.002	26.7	Binding
2495	500	GABRB1	C0018939	Blood disorder	2.19	2.3e-06	0.018	22.3	Binding
2495	1091	GABRB1	C0439857	Dependence	6.8	3.7e-22	3.5e-18	93.7	Binding
2495	354	GABRB1	C0004134	Ataxia	5.2	7e-33	6.8e-29	142.6	Binding
2495	3442	GABRB1	C0235063	Respiratory depression	4.14	1e-08	8.8e-05	32.7	Binding
2495	2007	GABRB1	C0020649	Hypotension	2.31	5.6e-08	0.00046	29.5	Binding
2495	927	GABRB1	C0009676	Confusional state	3.97	1.4e-23	1.4e-19	100.1	Binding
2495	4028	GABRB1	C0080274	Urinary retention	3.48	7.8e-07	0.00062	24.4	Agonist
2495	115	GABRB1	C0085631	Agitation	3.07	2.5e-05	0.018	17.7	Agonist
2496	2315	GABRB2	C0854382	Libido disorder	3.66	7.7e-08	6.2e-05	28.9	Agonist
2496	2315	GABRB2	C0854382	Libido disorder	6.02	1.7e-36	1.7e-32	159.2	Binding
2496	2007	GABRB2	C0020649	Hypotension	1.94	2.7e-06	0.021	22	Binding
2496	354	GABRB2	C0004134	Ataxia	4.24	7.8e-29	7.6e-25	124.1	Binding
2496	2220	GABRB2	C0022346	Jaundice	2.99	4e-05	0.028	16.9	Agonist
2496	115	GABRB2	C0085631	Agitation	2.36	1.5e-06	0.012	23.2	Binding
2496	4028	GABRB2	C0080274	Urinary retention	2.92	1.6e-05	0.012	18.6	Agonist
2496	4028	GABRB2	C0080274	Urinary retention	3.49	3.4e-17	3.2e-13	71.1	Binding
2496	927	GABRB2	C0009676	Confusional state	2.36	1.5e-05	0.011	18.7	Agonist
2496	162	GABRB2	C0002622	Amnesia	7.76	2.7e-18	2.5e-14	76.1	Binding
2496	927	GABRB2	C0009676	Confusional state	3.26	3e-20	2.8e-16	85	Binding
2496	1091	GABRB2	C0439857	Dependence	5.85	9.9e-23	9.5e-19	96.3	Binding
2496	3693	GABRB2	C2830004	Somnolence	1.85	1.8e-06	0.014	22.8	Binding
2496	2220	GABRB2	C0022346	Jaundice	2.88	1.9e-11	1.6e-07	45.1	Binding
2496	2066	GABRB2	C0021167	Incontinence	9.29	4.1e-16	3.8e-12	66.2	Binding
2496	354	GABRB2	C0004134	Ataxia	3.52	4.3e-11	3.7e-08	43.5	Agonist
2496	584	GABRB2	C0005956	Bone marrow disorder	2.25	2e-06	0.016	22.6	Binding
2496	3442	GABRB2	C0235063	Respiratory depression	3.6	7.6e-09	6.4e-05	33.4	Binding
2497	115	GABRB3	C0085631	Agitation	2.59	9.6e-07	0.0077	24	Binding
2497	2220	GABRB3	C0022346	Jaundice	3.15	3.2e-05	0.023	17.3	Agonist
2497	4028	GABRB3	C0080274	Urinary retention	3.11	9e-06	0.0068	19.7	Agonist
2497	4028	GABRB3	C0080274	Urinary retention	4.01	6e-19	5.6e-15	79.1	Binding
2497	3442	GABRB3	C0235063	Respiratory depression	3.72	1.7e-07	0.0014	27.3	Binding
2497	1091	GABRB3	C0439857	Dependence	7.66	5.1e-32	4.9e-28	138.7	Binding
2497	354	GABRB3	C0004134	Ataxia	5.33	1e-38	9.8e-35	169.4	Binding
2497	584	GABRB3	C0005956	Bone marrow disorder	3.19	2.6e-05	0.018	17.7	Agonist
2497	927	GABRB3	C0009676	Confusional state	3.73	3.2e-22	3.1e-18	94	Binding
2497	500	GABRB3	C0018939	Blood disorder	2.08	6.1e-06	0.047	20.4	Binding
2497	162	GABRB3	C0002622	Amnesia	7.97	7.4e-15	6.8e-11	60.5	Binding
2497	354	GABRB3	C0004134	Ataxia	4	1.8e-13	1.6e-10	54.2	Agonist
2497	2315	GABRB3	C0854382	Libido disorder	7.47	7.8e-46	7.7e-42	202	Binding
2497	2315	GABRB3	C0854382	Libido disorder	3.9	4.3e-08	3.5e-05	30	Agonist
2497	2220	GABRB3	C0022346	Jaundice	3.27	1.4e-12	1.3e-08	50.1	Binding
2497	4147	GABRB3	C0042571	Vertigo	2.07	5.2e-07	0.0042	25.2	Binding
2497	2007	GABRB3	C0020649	Hypotension	2.28	2e-08	0.00017	31.5	Binding
2497	1091	GABRB3	C0439857	Dependence	3.01	7.3e-05	0.049	15.7	Agonist
2497	3693	GABRB3	C2830004	Somnolence	2.13	2.2e-08	0.00018	31.3	Binding
2498	3442	GABRD	C0235063	Respiratory depression	3.36	5.9e-05	0.04	16.1	Agonist
2498	1091	GABRD	C0439857	Dependence	3.32	2.9e-05	0.021	17.5	Agonist
2498	927	GABRD	C0009676	Confusional state	3.97	3.7e-22	3.6e-18	93.7	Binding
2498	584	GABRD	C0005956	Bone marrow disorder	3.82	6.9e-07	0.00054	24.7	Agonist
2498	3693	GABRD	C2830004	Somnolence	2.11	5.8e-07	0.0047	25	Binding
2498	927	GABRD	C0009676	Confusional state	2.56	2.3e-05	0.017	17.9	Agonist
2498	4028	GABRD	C0080274	Urinary retention	4.38	6.9e-20	6.5e-16	83.3	Binding
2498	115	GABRD	C0085631	Agitation	2.61	6.3e-06	0.048	20.4	Binding
2498	354	GABRD	C0004134	Ataxia	4.21	7.1e-13	6.2e-10	51.5	Agonist
2498	1091	GABRD	C0439857	Dependence	7.29	3.7e-24	3.5e-20	102.8	Binding
2498	354	GABRD	C0004134	Ataxia	5.44	3e-34	2.9e-30	148.9	Binding
2498	2315	GABRD	C0854382	Libido disorder	8.17	3.9e-47	3.8e-43	207.9	Binding
2498	2220	GABRD	C0022346	Jaundice	3.66	3.1e-14	2.8e-10	57.7	Binding
2498	1213	GABRD	C0013362	Dysarthria	4.26	2.1e-07	0.0017	26.9	Binding
2498	2315	GABRD	C0854382	Libido disorder	4.67	2.3e-10	2e-07	40.2	Agonist
2498	500	GABRD	C0018939	Blood disorder	2.95	2.6e-05	0.019	17.7	Agonist
2498	500	GABRD	C0018939	Blood disorder	2.28	8.9e-07	0.0071	24.2	Binding
2498	3442	GABRD	C0235063	Respiratory depression	4.43	1.4e-09	1.2e-05	36.7	Binding
2498	2220	GABRD	C0022346	Jaundice	3.77	9.2e-07	0.00072	24.1	Agonist
2498	162	GABRD	C0002622	Amnesia	8.63	8.5e-15	7.7e-11	60.2	Binding
2498	4028	GABRD	C0080274	Urinary retention	3.72	1.5e-07	0.00012	27.5	Agonist
2498	2007	GABRD	C0020649	Hypotension	2.41	1.4e-08	0.00012	32.1	Binding
2499	927	GABRE	C0009676	Confusional state	2.56	2.3e-05	0.017	17.9	Agonist
2499	2220	GABRE	C0022346	Jaundice	3.44	1.5e-12	1.4e-08	50	Binding
2499	4028	GABRE	C0080274	Urinary retention	3.72	1.5e-07	0.00012	27.5	Agonist
2499	1091	GABRE	C0439857	Dependence	6.74	7.8e-21	7.4e-17	87.7	Binding
2499	3442	GABRE	C0235063	Respiratory depression	3.36	5.9e-05	0.04	16.1	Agonist
2499	1091	GABRE	C0439857	Dependence	3.32	2.9e-05	0.021	17.5	Agonist
2499	3442	GABRE	C0235063	Respiratory depression	4.6	1e-10	8.9e-07	41.8	Binding
2499	584	GABRE	C0005956	Bone marrow disorder	3.82	6.9e-07	0.00054	24.7	Agonist
2499	4028	GABRE	C0080274	Urinary retention	4.26	4.2e-19	3.9e-15	79.8	Binding
2499	927	GABRE	C0009676	Confusional state	3.87	3.1e-21	2.9e-17	89.5	Binding
2499	2007	GABRE	C0020649	Hypotension	2.35	4.2e-08	0.00035	30.1	Binding
2499	2220	GABRE	C0022346	Jaundice	3.77	9.2e-07	0.00072	24.1	Agonist
2499	162	GABRE	C0002622	Amnesia	8.4	2.4e-14	2.2e-10	58.2	Binding
2499	2315	GABRE	C0854382	Libido disorder	4.67	2.3e-10	2e-07	40.2	Agonist
2499	354	GABRE	C0004134	Ataxia	4.21	7.1e-13	6.2e-10	51.5	Agonist
2499	3693	GABRE	C2830004	Somnolence	2.05	1.5e-06	0.012	23.1	Binding
2499	115	GABRE	C0085631	Agitation	2.65	2.4e-06	0.019	22.3	Binding
2499	2315	GABRE	C0854382	Libido disorder	7.72	1.2e-42	1.2e-38	187.3	Binding
2499	500	GABRE	C0018939	Blood disorder	2.95	2.6e-05	0.019	17.7	Agonist
2499	354	GABRE	C0004134	Ataxia	5.17	3.8e-31	3.7e-27	134.7	Binding
2499	1213	GABRE	C0013362	Dysarthria	4.49	1.5e-08	0.00013	32	Binding
2500	1213	GABRG1	C0013362	Dysarthria	4.19	3.2e-07	0.0026	26.1	Binding
2500	2220	GABRG1	C0022346	Jaundice	3.71	5.4e-15	4.9e-11	61.1	Binding
2500	2007	GABRG1	C0020649	Hypotension	2.43	6.9e-09	5.8e-05	33.6	Binding
2500	500	GABRG1	C0018939	Blood disorder	2.9	3.4e-05	0.024	17.2	Agonist
2500	1091	GABRG1	C0439857	Dependence	3.28	3.7e-05	0.026	17	Agonist
2500	584	GABRG1	C0005956	Bone marrow disorder	3.77	9.4e-07	0.00073	24.1	Agonist
2500	4147	GABRG1	C0042571	Vertigo	2.06	4.6e-06	0.036	21	Binding
2500	162	GABRG1	C0002622	Amnesia	8.48	1.7e-14	1.5e-10	58.9	Binding
2500	3442	GABRG1	C0235063	Respiratory depression	3.31	7.4e-05	0.049	15.7	Agonist
2500	4028	GABRG1	C0080274	Urinary retention	3.67	2.2e-07	0.00017	26.9	Agonist
2500	927	GABRG1	C0009676	Confusional state	2.65	6.1e-06	0.0046	20.4	Agonist
2500	2315	GABRG1	C0854382	Libido disorder	8.27	3.3e-49	3.3e-45	217.4	Binding
2500	354	GABRG1	C0004134	Ataxia	4.15	1.3e-12	1.1e-09	50.3	Agonist
2500	2315	GABRG1	C0854382	Libido disorder	4.6	3.6e-10	3.1e-07	39.3	Agonist
2500	3442	GABRG1	C0235063	Respiratory depression	4.36	2.4e-09	2e-05	35.7	Binding
2500	1091	GABRG1	C0439857	Dependence	7.52	2.4e-26	2.3e-22	112.8	Binding
2500	500	GABRG1	C0018939	Blood disorder	2.3	4.3e-07	0.0034	25.6	Binding
2500	927	GABRG1	C0009676	Confusional state	4.09	3.6e-24	3.5e-20	102.8	Binding
2500	584	GABRG1	C0005956	Bone marrow disorder	2.53	2.9e-06	0.023	21.9	Binding
2500	4028	GABRG1	C0080274	Urinary retention	4.43	7.7e-21	7.3e-17	87.7	Binding
2500	354	GABRG1	C0004134	Ataxia	5.47	2.5e-35	2.4e-31	153.9	Binding
2500	2220	GABRG1	C0022346	Jaundice	3.72	1.2e-06	0.00097	23.5	Agonist
2500	3693	GABRG1	C2830004	Somnolence	2.12	3.6e-07	0.0029	25.9	Binding
2501	2220	GABRG2	C0022346	Jaundice	2.96	9.8e-12	8.7e-08	46.4	Binding
2501	584	GABRG2	C0005956	Bone marrow disorder	3.24	2e-05	0.015	18.2	Agonist
2501	927	GABRG2	C0009676	Confusional state	2.39	4.2e-05	0.029	16.8	Agonist
2501	3442	GABRG2	C0235063	Respiratory depression	3.2	2.5e-06	0.019	22.2	Binding
2501	2220	GABRG2	C0022346	Jaundice	3.19	2.6e-05	0.018	17.7	Agonist
2501	4028	GABRG2	C0080274	Urinary retention	3.69	9.1e-19	8.6e-15	78.2	Binding
2501	4028	GABRG2	C0080274	Urinary retention	3.15	6.9e-06	0.0052	20.2	Agonist
2501	500	GABRG2	C0018939	Blood disorder	1.98	3.9e-06	0.031	21.3	Binding
2501	115	GABRG2	C0085631	Agitation	2.33	4.9e-06	0.038	20.9	Binding
2501	1091	GABRG2	C0439857	Dependence	6.17	2.2e-24	2.1e-20	103.8	Binding
2501	2315	GABRG2	C0854382	Libido disorder	3.95	3.1e-08	2.5e-05	30.7	Agonist
2501	2315	GABRG2	C0854382	Libido disorder	6.35	3.5e-39	3.5e-35	171.5	Binding
2501	354	GABRG2	C0004134	Ataxia	3.89	1.9e-12	1.7e-09	49.6	Agonist
2501	354	GABRG2	C0004134	Ataxia	4.47	2.9e-31	2.8e-27	135.3	Binding
2501	162	GABRG2	C0002622	Amnesia	7.6	1.4e-16	1.3e-12	68.3	Binding
2501	3693	GABRG2	C2830004	Somnolence	1.92	4.8e-07	0.0038	25.4	Binding
2501	584	GABRG2	C0005956	Bone marrow disorder	2.3	1.4e-06	0.011	23.3	Binding
2501	927	GABRG2	C0009676	Confusional state	3.32	4e-20	3.8e-16	84.4	Binding
2501	1091	GABRG2	C0439857	Dependence	3.05	5.8e-05	0.04	16.2	Agonist
2502	3693	GABRG3	C2830004	Somnolence	2.11	5.4e-07	0.0043	25.1	Binding
2502	584	GABRG3	C0005956	Bone marrow disorder	2.58	1.7e-06	0.014	22.9	Binding
2502	4028	GABRG3	C0080274	Urinary retention	4.39	6e-20	5.7e-16	83.6	Binding
2502	584	GABRG3	C0005956	Bone marrow disorder	3.82	6.9e-07	0.00054	24.7	Agonist
2502	3442	GABRG3	C0235063	Respiratory depression	3.36	5.9e-05	0.04	16.1	Agonist
2502	2007	GABRG3	C0020649	Hypotension	2.42	1.3e-08	0.00011	32.3	Binding
2502	500	GABRG3	C0018939	Blood disorder	2.95	2.6e-05	0.019	17.7	Agonist
2502	3442	GABRG3	C0235063	Respiratory depression	4.44	1.3e-09	1.1e-05	36.8	Binding
2502	500	GABRG3	C0018939	Blood disorder	2.28	8.3e-07	0.0066	24.3	Binding
2502	2220	GABRG3	C0022346	Jaundice	3.77	9.2e-07	0.00072	24.1	Agonist
2502	2220	GABRG3	C0022346	Jaundice	3.66	2.8e-14	2.5e-10	57.9	Binding
2502	2315	GABRG3	C0854382	Libido disorder	4.67	2.3e-10	2e-07	40.2	Agonist
2502	162	GABRG3	C0002622	Amnesia	8.65	7.8e-15	7.1e-11	60.4	Binding
2502	2315	GABRG3	C0854382	Libido disorder	8.19	3e-47	2.9e-43	208.5	Binding
2502	1091	GABRG3	C0439857	Dependence	3.32	2.9e-05	0.021	17.5	Agonist
2502	927	GABRG3	C0009676	Confusional state	2.56	2.3e-05	0.017	17.9	Agonist
2502	1091	GABRG3	C0439857	Dependence	7.67	5.4e-27	5.2e-23	115.8	Binding
2502	115	GABRG3	C0085631	Agitation	2.61	5.9e-06	0.046	20.5	Binding
2502	1213	GABRG3	C0013362	Dysarthria	4.27	2e-07	0.0017	27	Binding
2502	4028	GABRG3	C0080274	Urinary retention	3.72	1.5e-07	0.00012	27.5	Agonist
2502	927	GABRG3	C0009676	Confusional state	3.98	3.2e-22	3e-18	94	Binding
2502	354	GABRG3	C0004134	Ataxia	5.45	2.4e-34	2.3e-30	149.3	Binding
2502	354	GABRG3	C0004134	Ataxia	4.21	7.1e-13	6.2e-10	51.5	Agonist
2503	115	GABRP	C0085631	Agitation	2.64	4.5e-06	0.035	21	Binding
2503	162	GABRP	C0002622	Amnesia	8.74	5.1e-15	4.6e-11	61.2	Binding
2503	354	GABRP	C0004134	Ataxia	5.38	6.1e-33	5.9e-29	142.9	Binding
2503	3693	GABRP	C2830004	Somnolence	2.09	1.1e-06	0.0089	23.7	Binding
2503	1091	GABRP	C0439857	Dependence	7.39	1.5e-24	1.4e-20	104.6	Binding
2503	4028	GABRP	C0080274	Urinary retention	4.3	8.2e-19	7.7e-15	78.4	Binding
2503	2007	GABRP	C0020649	Hypotension	2.38	3.6e-08	3e-04	30.4	Binding
2503	584	GABRP	C0005956	Bone marrow disorder	3.82	6.9e-07	0.00054	24.7	Agonist
2503	500	GABRP	C0018939	Blood disorder	2.95	2.6e-05	0.019	17.7	Agonist
2503	927	GABRP	C0009676	Confusional state	3.93	2.6e-21	2.5e-17	89.8	Binding
2503	354	GABRP	C0004134	Ataxia	4.21	7.1e-13	6.2e-10	51.5	Agonist
2503	2220	GABRP	C0022346	Jaundice	3.59	2.2e-13	2e-09	53.8	Binding
2503	3442	GABRP	C0235063	Respiratory depression	4.49	9.4e-10	8e-06	37.5	Binding
2503	4028	GABRP	C0080274	Urinary retention	3.72	1.5e-07	0.00012	27.5	Agonist
2503	1091	GABRP	C0439857	Dependence	3.32	2.9e-05	0.021	17.5	Agonist
2503	500	GABRP	C0018939	Blood disorder	2.24	2.1e-06	0.017	22.5	Binding
2503	2220	GABRP	C0022346	Jaundice	3.77	9.2e-07	0.00072	24.1	Agonist
2503	2315	GABRP	C0854382	Libido disorder	8.04	8.2e-45	8e-41	197.3	Binding
2503	2315	GABRP	C0854382	Libido disorder	4.67	2.3e-10	2e-07	40.2	Agonist
2503	927	GABRP	C0009676	Confusional state	2.56	2.3e-05	0.017	17.9	Agonist
2503	584	GABRP	C0005956	Bone marrow disorder	2.51	6.2e-06	0.048	20.4	Binding
2503	3442	GABRP	C0235063	Respiratory depression	3.36	5.9e-05	0.04	16.1	Agonist
2503	1213	GABRP	C0013362	Dysarthria	4.32	1.6e-07	0.0013	27.5	Binding
8506	1091	GABRQ	C0439857	Dependence	3.32	2.9e-05	0.021	17.5	Agonist
8506	2007	GABRQ	C0020649	Hypotension	2.48	2e-08	0.00017	31.5	Binding
8506	500	GABRQ	C0018939	Blood disorder	2.95	2.6e-05	0.019	17.7	Agonist
8506	927	GABRQ	C0009676	Confusional state	4	2.3e-20	2.2e-16	85.5	Binding
8506	2220	GABRQ	C0022346	Jaundice	3.77	9.2e-07	0.00072	24.1	Agonist
8506	3693	GABRQ	C2830004	Somnolence	2.18	4.6e-07	0.0037	25.4	Binding
8506	1091	GABRQ	C0439857	Dependence	7.28	1e-21	9.6e-18	91.7	Binding
8506	500	GABRQ	C0018939	Blood disorder	2.38	4.6e-07	0.0037	25.4	Binding
8506	4028	GABRQ	C0080274	Urinary retention	4.56	6.9e-20	6.5e-16	83.3	Binding
8506	3442	GABRQ	C0235063	Respiratory depression	4.59	2e-09	1.7e-05	35.9	Binding
8506	4028	GABRQ	C0080274	Urinary retention	3.72	1.5e-07	0.00012	27.5	Agonist
8506	2220	GABRQ	C0022346	Jaundice	3.66	5.6e-13	5e-09	52	Binding
8506	584	GABRQ	C0005956	Bone marrow disorder	3.82	6.9e-07	0.00054	24.7	Agonist
8506	354	GABRQ	C0004134	Ataxia	5.6	3.7e-33	3.5e-29	143.9	Binding
8506	927	GABRQ	C0009676	Confusional state	2.56	2.3e-05	0.017	17.9	Agonist
8506	2315	GABRQ	C0854382	Libido disorder	4.67	2.3e-10	2e-07	40.2	Agonist
8506	354	GABRQ	C0004134	Ataxia	4.21	7.1e-13	6.2e-10	51.5	Agonist
8506	3442	GABRQ	C0235063	Respiratory depression	3.36	5.9e-05	0.04	16.1	Agonist
8506	2315	GABRQ	C0854382	Libido disorder	8.26	1.4e-43	1.4e-39	191.7	Binding
8506	584	GABRQ	C0005956	Bone marrow disorder	2.63	3e-06	0.023	21.8	Binding
2504	4028	GABRR1	C0080274	Urinary retention	4.44	2e-08	0.00016	31.5	Binding
2504	927	GABRR1	C0009676	Confusional state	4.05	1.7e-09	1.4e-05	36.3	Binding
2504	2315	GABRR1	C0854382	Libido disorder	9.29	3.1e-24	3e-20	103.2	Binding
2504	2220	GABRR1	C0022346	Jaundice	3.95	3.5e-07	0.0029	25.9	Binding
2504	354	GABRR1	C0004134	Ataxia	5	2.7e-11	2.3e-07	44.4	Binding
2505	354	GABRR2	C0004134	Ataxia	5.86	7.1e-14	6.4e-10	56	Binding
2505	2220	GABRR2	C0022346	Jaundice	4.63	6.7e-09	5.7e-05	33.6	Binding
2505	2315	GABRR2	C0854382	Libido disorder	10.87	4.5e-29	4.3e-25	125.3	Binding
2505	927	GABRR2	C0009676	Confusional state	4.74	7.6e-12	6.7e-08	46.9	Binding
2505	4028	GABRR2	C0080274	Urinary retention	5.21	2.2e-10	1.9e-06	40.3	Binding
10636	927	GABRR3	C0009676	Confusional state	4.74	7.6e-12	6.7e-08	46.9	Binding
10636	2220	GABRR3	C0022346	Jaundice	4.63	6.7e-09	5.7e-05	33.6	Binding
10636	2315	GABRR3	C0854382	Libido disorder	10.87	4.5e-29	4.3e-25	125.3	Binding
10636	4028	GABRR3	C0080274	Urinary retention	5.21	2.2e-10	1.9e-06	40.3	Binding
10636	354	GABRR3	C0004134	Ataxia	5.86	7.1e-14	6.4e-10	56	Binding
2665	3442	GLRA1	C0235063	Respiratory depression	9.94	6.5e-21	6.1e-17	88	Binding
2723	1524	GNRHR	C0016382	Flushing	3.34	5.2e-06	0.04	20.8	Binding
2844	3444	GRIA2	C0035204	Respiratory disorder	4.52	8.8e-07	0.0041	24.2	Antagonist
2844	2211	GRIA2	C0022107	Irritability	8.6	3.3e-16	3.1e-12	66.6	Binding
2844	3444	GRIA2	C0035204	Respiratory disorder	4.03	2.5e-06	0.019	22.2	Binding
2844	354	GRIA2	C0004134	Ataxia	6.01	5.8e-19	2.9e-15	79.1	Antagonist
2844	2769	GRIA2	C0028738	Nystagmus	12.02	1.7e-21	8.9e-18	90.6	Antagonist
2844	115	GRIA2	C0085631	Agitation	3.39	3.6e-06	0.017	21.4	Antagonist
2844	354	GRIA2	C0004134	Ataxia	5.24	4e-18	3.7e-14	75.3	Binding
2844	3442	GRIA2	C0235063	Respiratory depression	9.86	3e-24	1.6e-20	103.2	Antagonist
2844	1313	GRIA2	C0085584	Encephalopathy	3.38	1.7e-06	0.013	23	Binding
2844	2211	GRIA2	C0022107	Irritability	11.93	1.7e-23	8.6e-20	99.8	Antagonist
2844	2769	GRIA2	C0028738	Nystagmus	9.62	9.8e-17	9.1e-13	69	Binding
2844	3442	GRIA2	C0235063	Respiratory depression	7.28	6e-17	5.5e-13	70	Binding
2851	3635	GRIK2	C0037274	Skin disorder	3.8	2.5e-06	0.02	22.2	Binding
2851	2287	GRIK2	C0023066	Laryngospasm	24.41	7.4e-46	7.3e-42	202.1	Binding
2851	2211	GRIK2	C0022107	Irritability	18.31	7.3e-34	3.7e-30	147.1	Antagonist
2851	3442	GRIK2	C0235063	Respiratory depression	16.65	1.7e-43	9e-40	191.2	Antagonist
2851	3444	GRIK2	C0035204	Respiratory disorder	6.91	1.5e-12	1.3e-08	50.1	Binding
2851	115	GRIK2	C0085631	Agitation	4.3	1.7e-07	0.0014	27.4	Binding
2851	3442	GRIK2	C0235063	Respiratory depression	13.4	9.2e-37	9e-33	160.4	Binding
2851	354	GRIK2	C0004134	Ataxia	6.26	4.5e-16	4.1e-12	66	Binding
2851	115	GRIK2	C0085631	Agitation	4.91	6.2e-09	3e-05	33.8	Antagonist
2851	2211	GRIK2	C0022107	Irritability	13.42	3.3e-24	3.1e-20	103.1	Binding
2851	3444	GRIK2	C0035204	Respiratory disorder	7.64	7.3e-13	3.6e-09	51.5	Antagonist
2851	2769	GRIK2	C0028738	Nystagmus	16.51	2.6e-30	2.5e-26	130.9	Binding
2851	268	GRIK2	C0003578	Apnoea	10.69	7.6e-19	7.1e-15	78.6	Binding
2851	354	GRIK2	C0004134	Ataxia	7.11	1.8e-16	8.9e-13	67.9	Antagonist
2855	3442	GRIN1	C0235063	Respiratory depression	4.24	6.9e-08	0.00057	29.1	Binding
2856	3442	GRIN2A	C0235063	Respiratory depression	4.53	5.1e-08	0.00043	29.7	Binding
2859	1766	GRIN2D	C0018524	Hallucination	3.87	1.8e-06	0.014	22.8	Binding
9836	3442	GRIN3A	C0235063	Respiratory depression	4.2	3.8e-06	0.03	21.3	Binding
9836	1766	GRIN3A	C0018524	Hallucination	4.05	2e-07	0.0016	27.1	Binding
9837	1766	GRIN3B	C0018524	Hallucination	5.16	5.2e-08	0.00043	29.7	Binding
3141	2613	HMGCR	C0231528	Myalgia	10.84	5.2e-29	5e-25	125	Binding
3234	811	HRH1	C0235710	Chest discomfort	4.22	1.5e-26	1.4e-22	113.7	Binding
3234	2067	HRH1	C0232461	Increased appetite	4.63	4.7e-33	4.6e-29	143.4	Binding
3234	4219	HRH1	C0043094	Weight increased	1.7	3.1e-06	0.024	21.8	Binding
3234	1907	HRH1	C0020443	Hypercholesterolaemia	3.51	1.1e-05	0.048	19.4	Antagonist
3234	1029	HRH1	C0235238	Cycloplegia	2.76	1.9e-11	1.7e-07	45	Binding
3234	3693	HRH1	C2830004	Somnolence	1.49	1.5e-07	0.0012	27.6	Binding
3234	3569	HRH1	C0235195	Sedation	4.94	6.8e-35	6.6e-31	151.9	Binding
3234	3569	HRH1	C0235195	Sedation	5.83	4.5e-28	2.3e-24	120.7	Antagonist
3234	1568	HRH1	C0235660	Galactorrhoea	2.18	1.8e-09	1.5e-05	36.2	Binding
3234	811	HRH1	C0235710	Chest discomfort	4.7	6.6e-19	3.4e-15	78.9	Antagonist
3234	2067	HRH1	C0232461	Increased appetite	4.58	7.6e-19	3.9e-15	78.6	Antagonist
3234	766	HRH1	C0151560	Central nervous system stimulation	2.42	9.6e-10	8.3e-06	37.4	Binding
3234	354	HRH1	C0004134	Ataxia	1.73	3e-06	0.023	21.8	Binding
3234	2072	HRH1	C1096275	Increased viscosity of bronchial secretion	6.5	1.1e-10	9.3e-07	41.7	Binding
3234	3956	HRH1	C0040822	Tremor	1.7	1.2e-08	9.8e-05	32.6	Binding
3234	3892	HRH1	C0040264	Tinnitus	2.08	6.8e-09	5.8e-05	33.6	Binding
3234	3821	HRH1	C0039231	Tachycardia	1.96	1.5e-16	1.4e-12	68.2	Binding
3234	3821	HRH1	C0039231	Tachycardia	1.89	7e-08	0.00034	29.1	Antagonist
3234	1396	HRH1	C0235146	Euphoric mood	3.2	5.5e-19	5.2e-15	79.2	Binding
3234	3827	HRH1	C0686347	Tardive dyskinesia	2.38	2.6e-08	0.00022	31	Binding
3234	2605	HRH1	C0151786	Muscular weakness	3.26	2e-17	1.8e-13	72.2	Binding
3234	1199	HRH1	C0043352	Dry mouth	2.32	1.7e-17	8.6e-14	72.5	Antagonist
3234	1238	HRH1	C0393593	Dystonia	2.11	2.9e-06	0.023	21.9	Binding
3234	122	HRH1	C0392156	Akathisia	2.27	6.7e-08	0.00055	29.2	Binding
3234	2004	HRH1	C0151888	Hyporeflexia	4.27	1e-09	8.7e-06	37.3	Binding
3234	2713	HRH1	C0027769	Nervousness	1.93	7.4e-06	0.033	20.1	Antagonist
3234	1744	HRH1	C0002878	Haemolytic anaemia	2.67	2.9e-10	2.5e-06	39.7	Binding
3234	2605	HRH1	C0151786	Muscular weakness	3.82	6.7e-14	3.3e-10	56.2	Antagonist
3234	2641	HRH1	C0026848	Myopathy	2.24	2.2e-06	0.018	22.4	Binding
3234	2641	HRH1	C0026848	Myopathy	2.77	4.3e-06	0.02	21.1	Antagonist
3234	1411	HRH1	C0015371	Extrapyramidal disorder	2.62	4.6e-19	4.3e-15	79.6	Binding
3234	4031	HRH1	C0042075	Urinary tract disorder	3.77	3.2e-07	0.0015	26.1	Antagonist
3234	584	HRH1	C0005956	Bone marrow disorder	1.68	9e-07	0.0072	24.1	Binding
3234	3089	HRH1	C0162830	Photosensitivity reaction	2.26	7.8e-08	0.00037	28.9	Antagonist
3234	1240	HRH1	C0013428	Dysuria	2.54	1.3e-10	6.5e-07	41.3	Antagonist
3234	1396	HRH1	C0235146	Euphoric mood	3.63	1.1e-13	5.4e-10	55.2	Antagonist
3234	1907	HRH1	C0020443	Hypercholesterolaemia	3.12	2e-07	0.0016	27.1	Binding
3234	119	HRH1	C0001824	Agranulocytosis	2.24	4.8e-12	4.3e-08	47.8	Binding
3234	1240	HRH1	C0013428	Dysuria	2.54	1.7e-18	1.6e-14	77	Binding
3234	2713	HRH1	C0027769	Nervousness	1.92	8.6e-10	7.4e-06	37.6	Binding
3234	4031	HRH1	C0042075	Urinary tract disorder	2.95	6.1e-08	0.00051	29.3	Binding
3234	2161	HRH1	C0917801	Insomnia	1.52	6.4e-06	0.049	20.4	Binding
3234	354	HRH1	C0004134	Ataxia	2.04	1.1e-05	0.047	19.4	Antagonist
3234	4166	HRH1	C0344232	Vision blurred	2.05	6.5e-18	6e-14	74.4	Binding
3234	4166	HRH1	C0344232	Vision blurred	1.99	1.4e-09	6.8e-06	36.7	Antagonist
3234	966	HRH1	C0009806	Constipation	1.57	1.7e-08	0.00014	31.8	Binding
3234	972	HRH1	C0036572	Convulsion	1.71	9.6e-10	8.2e-06	37.4	Binding
3234	1199	HRH1	C0043352	Dry mouth	2.28	3.2e-30	3.1e-26	130.5	Binding
3234	2974	HRH1	C0242422	Parkinsonism	2.41	8.7e-08	0.00071	28.7	Binding
3234	3655	HRH1	C2939094	Skin sensitisation	9.61	1.5e-30	7.8e-27	132	Antagonist
3234	119	HRH1	C0001824	Agranulocytosis	2.18	6.6e-07	0.0031	24.7	Antagonist
3234	3655	HRH1	C2939094	Skin sensitisation	9.82	2.4e-52	2.4e-48	231.8	Binding
3234	235	HRH1	C0151500	Anticholinergic syndrome	2.84	5.3e-08	0.00026	29.6	Antagonist
3234	441	HRH1	C0005686	Bladder disorder	3.35	4.3e-09	3.7e-05	34.5	Binding
3234	3956	HRH1	C0040822	Tremor	1.79	6.7e-06	0.03	20.3	Antagonist
3234	925	HRH1	C0264886	Conduction disorder	2.56	5.6e-06	0.043	20.6	Binding
3234	3089	HRH1	C0162830	Photosensitivity reaction	2.19	1.1e-11	9.9e-08	46.1	Binding
3234	1411	HRH1	C0015371	Extrapyramidal disorder	2.39	1.3e-08	6.3e-05	32.3	Antagonist
3234	235	HRH1	C0151500	Anticholinergic syndrome	3.39	1.5e-20	1.4e-16	86.4	Binding
3234	4028	HRH1	C0080274	Urinary retention	1.77	1e-06	0.0081	23.9	Binding
3235	1029	HRH2	C0235238	Cycloplegia	5.39	3.2e-13	2.9e-09	53.1	Binding
3235	235	HRH2	C0151500	Anticholinergic syndrome	3.91	1.5e-06	0.012	23.2	Binding
10326	235	HRH4	C0151500	Anticholinergic syndrome	4.85	2.1e-07	0.0017	26.9	Binding
3291	2161	HTR1A	C0917801	Insomnia	1.64	4.5e-06	0.035	21	Binding
3291	349	HTR1A	C0004093	Asthenia	1.51	4.3e-06	0.033	21.1	Binding
3291	2875	HTR1A	C0020651	Orthostatic hypotension	2.21	3.4e-11	3e-07	43.9	Binding
3291	1199	HTR1A	C0043352	Dry mouth	1.77	1.2e-08	1e-04	32.4	Binding
3291	710	HTR1A	C0018802	Cardiac failure congestive	3.85	5.6e-06	0.043	20.6	Binding
3291	3039	HTR1A	C0277925	Peripheral coldness	6.45	9.7e-19	9.1e-15	78.1	Binding
3291	3375	HTR1A	C0034735	Raynaud's phenomenon	7.4	1.1e-13	1e-09	55.2	Binding
3291	2875	HTR1A	C0020651	Orthostatic hypotension	2.43	6e-07	0.0028	24.9	Antagonist
3291	3221	HTR1A	C0033117	Priapism	3.42	8.7e-08	0.00071	28.7	Binding
3291	1198	HTR1A	C0314719	Dry eye	4.79	5.2e-10	4.5e-06	38.6	Binding
3291	3293	HTR1A	C0033975	Psychotic disorder	2.01	3.7e-07	0.003	25.8	Binding
3292	3293	HTR1B	C0033975	Psychotic disorder	2.1	4.4e-06	0.034	21.1	Binding
3292	1655	HTR1B	C0340274	Gestational hypertension	8.22	4.9e-14	4.4e-10	56.8	Binding
3292	2875	HTR1B	C0020651	Orthostatic hypotension	2.03	3.2e-06	0.025	21.7	Binding
3293	3821	HTR1D	C0039231	Tachycardia	1.82	6.3e-07	0.005	24.8	Binding
3293	1655	HTR1D	C0340274	Gestational hypertension	8.67	2e-16	1.9e-12	67.6	Binding
3293	1219	HTR1D	C0013384	Dyskinesia	3.29	2.1e-08	0.00018	31.4	Binding
3293	2875	HTR1D	C0020651	Orthostatic hypotension	2.49	7.5e-06	0.034	20.1	Antagonist
3293	3693	HTR1D	C2830004	Somnolence	1.63	1.8e-06	0.014	22.8	Binding
3293	2875	HTR1D	C0020651	Orthostatic hypotension	2.13	1.8e-07	0.0015	27.2	Binding
3294	2875	HTR1E	C0020651	Orthostatic hypotension	2.31	6.1e-06	0.047	20.5	Binding
3294	1268	HTR1E	C0235969	Ejaculation disorder	3.73	3.7e-06	0.029	21.4	Binding
3296	1907	HTR2A	C0020443	Hypercholesterolaemia	4.29	4.5e-08	0.00022	29.9	Antagonist
3296	2339	HTR2A	C0154251	Lipid metabolism disorder	4.28	1.8e-07	0.00086	27.2	Antagonist
3296	1199	HTR2A	C0043352	Dry mouth	1.8	1.6e-06	0.0072	23.1	Antagonist
3296	2339	HTR2A	C0154251	Lipid metabolism disorder	3.45	4.3e-09	3.6e-05	34.5	Binding
3296	2875	HTR2A	C0020651	Orthostatic hypotension	2.18	4.9e-14	4.4e-10	56.8	Binding
3296	1238	HTR2A	C0393593	Dystonia	2.57	8.4e-11	7.3e-07	42.2	Binding
3296	3827	HTR2A	C0686347	Tardive dyskinesia	2.51	2.6e-09	2.3e-05	35.4	Binding
3296	995	HTR2A	C0423226	Corneal pigmentation	4.04	5.4e-09	4.6e-05	34	Binding
3296	2974	HTR2A	C0242422	Parkinsonism	2.48	4.9e-08	0.00041	29.8	Binding
3296	122	HTR2A	C0392156	Akathisia	2.46	1.6e-09	1.4e-05	36.4	Binding
3296	1370	HTR2A	C0242350	Erectile dysfunction	1.81	1.2e-06	0.0092	23.6	Binding
3296	2297	HTR2A	C1510497	Lenticular opacities	3.81	8.6e-08	0.00071	28.7	Binding
3296	2724	HTR2A	C0027849	Neuroleptic malignant syndrome	3.38	1.6e-06	0.0073	23.1	Antagonist
3296	1411	HTR2A	C0015371	Extrapyramidal disorder	2.56	1.8e-09	8.8e-06	36.2	Antagonist
3296	1199	HTR2A	C0043352	Dry mouth	1.85	2.1e-13	1.9e-09	53.9	Binding
3296	2662	HTR2A	C0027424	Nasal congestion	2.27	6.9e-06	0.031	20.2	Antagonist
3296	2724	HTR2A	C0027849	Neuroleptic malignant syndrome	3.28	2.8e-11	2.5e-07	44.3	Binding
3296	995	HTR2A	C0423226	Corneal pigmentation	4.59	6.2e-07	0.0029	24.8	Antagonist
3296	2536	HTR2A	C0026205	Miosis	3.49	4.8e-06	0.022	20.9	Antagonist
3296	235	HTR2A	C0151500	Anticholinergic syndrome	2.34	5.1e-07	0.0041	25.2	Binding
3296	2620	HTR2A	C0026961	Mydriasis	2.45	1.1e-07	0.00092	28.2	Binding
3296	2875	HTR2A	C0020651	Orthostatic hypotension	2.27	3.3e-08	0.00016	30.5	Antagonist
3296	1930	HTR2A	C0020514	Hyperprolactinaemia	2.73	3.5e-08	0.00029	30.4	Binding
3296	1907	HTR2A	C0020443	Hypercholesterolaemia	3.63	2.8e-10	2.4e-06	39.8	Binding
3296	1568	HTR2A	C0235660	Galactorrhoea	2.54	1.6e-14	1.4e-10	59	Binding
3296	1411	HTR2A	C0015371	Extrapyramidal disorder	2.8	3.9e-22	3.7e-18	93.6	Binding
3296	4219	HTR2A	C0043094	Weight increased	1.91	2.7e-09	2.3e-05	35.4	Binding
3296	1568	HTR2A	C0235660	Galactorrhoea	2.38	7.6e-07	0.0036	24.5	Antagonist
3296	1719	HTR2A	C0018418	Gynaecomastia	1.86	4.3e-07	0.0034	25.6	Binding
3296	1274	HTR2A	C0855329	Electrocardiogram change	2.18	1.3e-07	0.0011	27.9	Binding
3296	2161	HTR2A	C0917801	Insomnia	1.75	2.4e-10	2.1e-06	40.1	Binding
3296	2439	HTR2A	C0338831	Mania	2.54	1.3e-07	0.0011	27.8	Binding
3296	2662	HTR2A	C0027424	Nasal congestion	2.26	2.5e-10	2.1e-06	40.1	Binding
3296	1268	HTR2A	C0235969	Ejaculation disorder	3.82	1.1e-09	5.3e-06	37.2	Antagonist
3296	3821	HTR2A	C0039231	Tachycardia	1.69	1.3e-08	0.00011	32.3	Binding
3296	1268	HTR2A	C0235969	Ejaculation disorder	3.44	6.5e-15	5.9e-11	60.7	Binding
3296	1505	HTR2A	C0016034	Fibrocystic breast disease	2.68	1.1e-08	9.7e-05	32.6	Binding
3296	2536	HTR2A	C0026205	Miosis	2.8	9.6e-07	0.0076	24	Binding
3297	2875	HTR2B	C0020651	Orthostatic hypotension	2.54	6.1e-07	0.0029	24.9	Antagonist
3297	1411	HTR2B	C0015371	Extrapyramidal disorder	2.26	4e-07	0.0032	25.7	Binding
3297	1199	HTR2B	C0043352	Dry mouth	1.91	2.4e-09	2.1e-05	35.6	Binding
3297	1219	HTR2B	C0013384	Dyskinesia	3.06	1.7e-07	0.0014	27.3	Binding
3297	2662	HTR2B	C0027424	Nasal congestion	2.34	3.6e-07	0.0029	25.9	Binding
3297	2875	HTR2B	C0020651	Orthostatic hypotension	2.23	2.8e-09	2.4e-05	35.3	Binding
3297	2161	HTR2B	C0917801	Insomnia	1.75	1.9e-06	0.015	22.7	Binding
3298	1568	HTR2C	C0235660	Galactorrhoea	2.04	6.3e-06	0.049	20.4	Binding
3298	2974	HTR2C	C0242422	Parkinsonism	2.46	2.6e-06	0.02	22.1	Binding
3298	1268	HTR2C	C0235969	Ejaculation disorder	3.32	9.8e-11	8.5e-07	41.9	Binding
3298	1199	HTR2C	C0043352	Dry mouth	1.84	1.5e-10	1.3e-06	41	Binding
3298	2161	HTR2C	C0917801	Insomnia	1.71	1.7e-07	0.0014	27.3	Binding
3298	1268	HTR2C	C0235969	Ejaculation disorder	3.76	1.2e-07	0.00058	28	Antagonist
3298	122	HTR2C	C0392156	Akathisia	2.65	2.2e-09	1.9e-05	35.8	Binding
3298	2339	HTR2C	C0154251	Lipid metabolism disorder	3.38	6.9e-07	0.0055	24.7	Binding
3298	1907	HTR2C	C0020443	Hypercholesterolaemia	4.12	5.1e-06	0.023	20.8	Antagonist
3298	3293	HTR2C	C0033975	Psychotic disorder	3.33	2.7e-05	0.019	17.6	Agonist
3298	3821	HTR2C	C0039231	Tachycardia	1.64	2.8e-06	0.022	21.9	Binding
3298	1411	HTR2C	C0015371	Extrapyramidal disorder	2.46	6e-07	0.0028	24.9	Antagonist
3298	1411	HTR2C	C0015371	Extrapyramidal disorder	2.36	1.9e-10	1.6e-06	40.6	Binding
3298	2875	HTR2C	C0020651	Orthostatic hypotension	3.6	4.9e-05	0.034	16.5	Agonist
3298	3827	HTR2C	C0686347	Tardive dyskinesia	2.34	4.1e-06	0.032	21.2	Binding
3298	1568	HTR2C	C0235660	Galactorrhoea	2.41	6.7e-06	0.03	20.3	Antagonist
3298	1907	HTR2C	C0020443	Hypercholesterolaemia	3.39	6e-07	0.0048	24.9	Binding
3298	1238	HTR2C	C0393593	Dystonia	2.35	1.1e-06	0.0089	23.7	Binding
3298	2724	HTR2C	C0027849	Neuroleptic malignant syndrome	3.2	2.1e-08	0.00017	31.4	Binding
3298	2875	HTR2C	C0020651	Orthostatic hypotension	2.51	4.2e-09	2.1e-05	34.5	Antagonist
3298	2875	HTR2C	C0020651	Orthostatic hypotension	2.39	5.1e-15	4.7e-11	61.2	Binding
3298	2724	HTR2C	C0027849	Neuroleptic malignant syndrome	3.66	1.9e-06	0.0087	22.7	Antagonist
3300	1396	HTR3B	C0235146	Euphoric mood	3.41	3.4e-06	0.027	21.6	Binding
3303	122	HTR6	C0392156	Akathisia	4.05	2e-07	0.00095	27	Antagonist
3303	2724	HTR6	C0027849	Neuroleptic malignant syndrome	4.91	5.4e-11	4.7e-07	43	Binding
3303	1199	HTR6	C0043352	Dry mouth	1.97	1.1e-06	0.0084	23.8	Binding
3303	122	HTR6	C0392156	Akathisia	3.81	1.8e-11	1.6e-07	45.1	Binding
3303	3827	HTR6	C0686347	Tardive dyskinesia	4.32	4.1e-08	2e-04	30.1	Antagonist
3303	2974	HTR6	C0242422	Parkinsonism	4.03	2.4e-06	0.011	22.2	Antagonist
3303	1568	HTR6	C0235660	Galactorrhoea	2.64	2.8e-06	0.022	21.9	Binding
3303	2875	HTR6	C0020651	Orthostatic hypotension	2.87	1.9e-06	0.0088	22.7	Antagonist
3303	1411	HTR6	C0015371	Extrapyramidal disorder	2.6	8.6e-07	0.0068	24.2	Binding
3303	2875	HTR6	C0020651	Orthostatic hypotension	2.41	2.2e-07	0.0018	26.9	Binding
3303	2974	HTR6	C0242422	Parkinsonism	3.89	6.7e-10	5.8e-06	38.1	Binding
3303	3827	HTR6	C0686347	Tardive dyskinesia	4	8.1e-12	7.2e-08	46.7	Binding
3303	1238	HTR6	C0393593	Dystonia	3.14	4e-07	0.0032	25.7	Binding
3304	1238	HTR7	C0393593	Dystonia	2.74	5.7e-07	0.0046	25	Binding
3304	2875	HTR7	C0020651	Orthostatic hypotension	2.16	2.7e-07	0.0022	26.5	Binding
3304	122	HTR7	C0392156	Akathisia	3.32	1.8e-11	1.6e-07	45.1	Binding
3304	2974	HTR7	C0242422	Parkinsonism	3.11	5e-08	0.00042	29.7	Binding
3304	1268	HTR7	C0235969	Ejaculation disorder	3.25	7.6e-07	0.0061	24.5	Binding
3304	2724	HTR7	C0027849	Neuroleptic malignant syndrome	3.62	1.2e-07	0.001	28	Binding
3304	3827	HTR7	C0686347	Tardive dyskinesia	3.02	3.2e-08	0.00027	30.6	Binding
3622	3808	KCNH1	C0039070	Syncope	3.89	4.8e-06	0.022	20.9	Antagonist
3623	1282	KCNH2	C0151878	Electrocardiogram QT prolonged	5.7	5.7e-10	4.9e-06	38.4	Binding
3627	1934	KCNJ1	C0020517	Hypersensitivity	4.15	4.6e-12	4.1e-08	47.8	Binding
3627	1934	KCNJ1	C0020517	Hypersensitivity	7.34	7.8e-15	3.9e-11	60.4	Antagonist
3629	1978	KCNJ11	C0020615	Hypoglycaemia	16.91	6.4e-41	6.3e-37	179.4	Binding
3653	1952	KCNMA1	C0740394	Hyperuricaemia	12.71	7.9e-23	7.5e-19	96.7	Binding
3653	1986	KCNMA1	C0020621	Hypokalaemia	8.85	2.7e-18	2.6e-14	76.1	Binding
3653	3333	KCNMA1	C0268104	Purine metabolism disorder	28.58	7.3e-60	7.2e-56	266.3	Binding
3653	2938	KCNMA1	C0030305	Pancreatitis	9.72	1.2e-18	1.1e-14	77.7	Binding
3653	1696	KCNMA1	C0018099	Gout	14.4	7.2e-29	6.9e-25	124.3	Binding
3673	2888	KDR	C0029445	Osteonecrosis	47.13	2.2e-100	2.1e-96	452.4	Binding
3673	2793	KDR	C0013604	Oedema	4.66	1.1e-16	5.6e-13	68.8	Antagonist
3673	1938	KDR	C0020538	Hypertension	4.2	1.2e-11	1.1e-07	46	Binding
3673	1912	KDR	C0020456	Hyperglycaemia	4.33	2.6e-09	1.3e-05	35.4	Antagonist
3673	159	KDR	C0002453	Amenorrhoea	4.31	4.3e-08	0.00036	30	Binding
3673	2888	KDR	C0029445	Osteonecrosis	49.63	5.9e-106	3.1e-102	478	Antagonist
3673	3627	KDR	C0151514	Skin atrophy	46.19	4.4e-156	4.4e-152	708.4	Binding
3673	2793	KDR	C0013604	Oedema	4.4	1.6e-16	1.5e-12	68.1	Binding
3673	1946	KDR	C0020555	Hypertrichosis	41.32	1.2e-130	6.1e-127	591.5	Antagonist
3673	1986	KDR	C0020621	Hypokalaemia	8.34	4.4e-17	2.2e-13	70.6	Antagonist
3673	103	KDR	C0001621	Adrenal disorder	27.9	1.9e-75	1e-71	337.8	Antagonist
3673	106	KDR	C0001623	Adrenal insufficiency	27.37	6.3e-74	3.2e-70	330.8	Antagonist
3673	2488	KDR	C0025345	Menstrual disorder	3.67	1.9e-06	0.015	22.7	Binding
3673	582	KDR	C0005940	Bone disorder	30.04	3e-69	1.5e-65	309.4	Antagonist
3673	103	KDR	C0001621	Adrenal disorder	28.97	2.2e-78	2.2e-74	351.3	Binding
3673	2605	KDR	C0151786	Muscular weakness	8.03	2e-20	1.9e-16	85.8	Binding
3673	1396	KDR	C0235146	Euphoric mood	6.56	7.7e-13	3.8e-09	51.4	Antagonist
3673	582	KDR	C0005940	Bone disorder	24.68	2.6e-56	2.6e-52	250	Binding
3673	3830	KDR	C0039446	Telangiectasia	51.16	5.6e-152	5.6e-148	689.5	Binding
3673	1022	KDR	C0332601	Cushingoid	51.63	1.7e-218	8.7e-215	995.5	Antagonist
3673	2891	KDR	C0029456	Osteoporosis	42.19	1.2e-159	1.2e-155	724.9	Binding
3673	1946	KDR	C0020555	Hypertrichosis	35.18	1.8e-110	1.8e-106	498.7	Binding
3673	1022	KDR	C0332601	Cushingoid	44.85	9.8e-189	9.7e-185	858.6	Binding
3673	3790	KDR	C0038826	Superinfection	21.71	6.5e-45	3.3e-41	197.7	Antagonist
3673	2196	KDR	C0151740	Intracranial pressure increased	14.41	3.7e-26	3.5e-22	111.9	Binding
3673	2939	KDR	C0001339	Pancreatitis acute	22.59	2.7e-51	2.6e-47	227	Binding
3673	2605	KDR	C0151786	Muscular weakness	9.25	3.9e-24	2e-20	102.7	Antagonist
3673	2196	KDR	C0151740	Intracranial pressure increased	16.76	7.9e-31	4.1e-27	133.3	Antagonist
3673	3014	KDR	C0030920	Peptic ulcer	14.46	2.7e-26	1.4e-22	112.5	Antagonist
3673	1317	KDR	C0014130	Endocrine disorder	5.29	1.4e-17	7e-14	72.9	Antagonist
3673	3790	KDR	C0038826	Superinfection	23.8	2e-49	2e-45	218.4	Binding
3673	2488	KDR	C0025345	Menstrual disorder	4	2.6e-07	0.0013	26.5	Antagonist
3673	1938	KDR	C0020538	Hypertension	4.88	5.5e-13	2.7e-09	52	Antagonist
3673	1912	KDR	C0020456	Hyperglycaemia	3.93	4.2e-08	0.00035	30	Binding
3673	159	KDR	C0002453	Amenorrhoea	4.54	1.2e-08	5.6e-05	32.6	Antagonist
3673	3014	KDR	C0030920	Peptic ulcer	12.88	3.7e-23	3.5e-19	98.2	Binding
3673	3627	KDR	C0151514	Skin atrophy	52.88	1.4e-179	7.4e-176	816.5	Antagonist
3673	106	KDR	C0001623	Adrenal insufficiency	28.79	7e-78	6.9e-74	349	Binding
3673	3830	KDR	C0039446	Telangiectasia	55.49	2.4e-165	1.2e-161	751.1	Antagonist
3673	1986	KDR	C0020621	Hypokalaemia	7.19	1.7e-15	1.5e-11	63.4	Binding
3673	3656	KDR	C0152459	Skin striae	44.79	6.4e-114	6.4e-110	514.6	Binding
3673	2939	KDR	C0001339	Pancreatitis acute	25.93	2.3e-59	1.2e-55	264	Antagonist
3673	1396	KDR	C0235146	Euphoric mood	5.61	1.4e-10	1.3e-06	41.1	Binding
3673	3656	KDR	C0152459	Skin striae	50.84	7.3e-130	3.8e-126	587.9	Antagonist
3673	1317	KDR	C0014130	Endocrine disorder	5.1	1.1e-16	1e-12	68.8	Binding
3673	2891	KDR	C0029456	Osteoporosis	47.28	8.7e-180	4.5e-176	817.4	Antagonist
9679	1934	LACTB	C0020517	Hypersensitivity	4.23	1.7e-08	0.00014	31.8	Binding
4029	3293	MAOA	C0033975	Psychotic disorder	3.31	7.1e-09	6e-05	33.5	Binding
4029	2211	MAOA	C0022107	Irritability	4.57	7.5e-07	0.006	24.5	Binding
4029	2439	MAOA	C0338831	Mania	4.3	2.4e-06	0.019	22.2	Binding
4029	1199	MAOA	C0043352	Dry mouth	2.46	6.8e-08	0.00056	29.1	Binding
4029	1913	MAOA	C0020458	Hyperhidrosis	2.79	1.1e-06	0.0087	23.8	Binding
4029	3293	MAOA	C0033975	Psychotic disorder	3.16	3.3e-06	0.015	21.6	Antagonist
4030	3293	MAOB	C0033975	Psychotic disorder	3.12	9.2e-06	0.041	19.7	Antagonist
4030	2439	MAOB	C0338831	Mania	4.57	7.3e-07	0.0059	24.5	Binding
4030	3293	MAOB	C0033975	Psychotic disorder	3.36	1e-08	8.8e-05	32.8	Binding
4069	13	MAPK14	C0232492	Abdominal pain upper	3.96	3.2e-06	0.025	21.7	Binding
10662	595	NISCH	C0428977	Bradycardia	4.65	5e-07	0.0041	25.2	Binding
4668	1823	NR1I2	C0019158	Hepatitis	4.43	1.2e-06	0.00093	23.6	Agonist
4668	1823	NR1I2	C0019158	Hepatitis	4.73	1.7e-08	0.00014	31.8	Binding
4677	2891	NR3C1	C0029456	Osteoporosis	39.6	3.3e-289	3.3e-285	1320.9	Binding
4677	2793	NR3C1	C0013604	Oedema	4.18	2.7e-13	2.4e-10	53.4	Agonist
4677	3627	NR3C1	C0151514	Skin atrophy	25.1	1.7e-83	1.6e-80	374.7	Agonist
4677	1717	NR3C1	C0151686	Growth retardation	20.44	2.7e-58	2.6e-54	259.1	Binding
4677	2488	NR3C1	C0025345	Menstrual disorder	4.89	1.1e-24	1.1e-20	105.1	Binding
4677	46	NR3C1	C0702166	Acne	10.42	2.7e-33	2.6e-29	144.6	Binding
4677	2067	NR3C1	C0232461	Increased appetite	4.17	3.4e-07	0.0028	26	Binding
4677	2488	NR3C1	C0025345	Menstrual disorder	7.78	3.6e-21	3.2e-18	89.2	Agonist
4677	2891	NR3C1	C0029456	Osteoporosis	22.36	2.5e-78	2.3e-75	351	Agonist
4677	1946	NR3C1	C0020555	Hypertrichosis	34.86	2.6e-224	2.6e-220	1022.3	Binding
4677	2888	NR3C1	C0029445	Osteonecrosis	37.43	4.3e-80	4e-77	359.2	Agonist
4677	3627	NR3C1	C0151514	Skin atrophy	45.77	4.20000017840362e-317	4.19999999999652e-313	1449.3	Binding
4677	743	NR3C1	C0086543	Cataract	10.16	5.9e-36	5.8e-32	156.7	Binding
4677	1361	NR3C1	C1960509	Epidural lipomatosis	40.96	1.5e-95	1.5e-91	430.1	Binding
4677	1545	NR3C1	C0016514	Foot and mouth disease	7.51	1.3e-12	1.2e-08	50.3	Binding
4677	1022	NR3C1	C0332601	Cushingoid	46.55	0	0	1922.5	Binding
4677	106	NR3C1	C0001623	Adrenal insufficiency	30.57	7.4e-183	7.4e-179	831.6	Binding
4677	1228	NR3C1	C1527344	Dysphonia	28.55	4.5e-83	4.4e-79	372.9	Binding
4677	2841	NR3C1	C0006849	Oral candidiasis	32.81	3.2e-69	3.2e-65	309.2	Binding
4677	1986	NR3C1	C0020621	Hypokalaemia	5.51	9e-09	7.5e-06	33	Agonist
4677	3830	NR3C1	C0039446	Telangiectasia	30.44	1.8e-83	1.7e-80	374.6	Agonist
4677	3656	NR3C1	C0152459	Skin striae	51.21	2.70000000000129e-313	2.7e-309	1431.7	Binding
4677	103	NR3C1	C0001621	Adrenal disorder	21.53	2.8e-87	2.8e-83	392.2	Binding
4677	1912	NR3C1	C0020456	Hyperglycaemia	8.33	1e-28	9.4e-26	123.6	Agonist
4677	2888	NR3C1	C0029445	Osteonecrosis	38.21	2.6e-136	2.6e-132	617.5	Binding
4677	2605	NR3C1	C0151786	Muscular weakness	7.69	2.4e-37	2.4e-33	163.1	Binding
4677	1396	NR3C1	C0235146	Euphoric mood	3.51	7.2e-05	0.048	15.8	Agonist
4677	3585	NR3C1	C0243026	Sepsis	12.15	3.1e-26	3e-22	112.3	Binding
4677	3656	NR3C1	C0152459	Skin striae	30.89	3.7e-91	3.5e-88	410	Agonist
4677	1986	NR3C1	C0020621	Hypokalaemia	5.75	9.7e-19	9.1e-15	78.1	Binding
4677	2605	NR3C1	C0151786	Muscular weakness	7.83	1.2e-22	1.1e-19	95.9	Agonist
4677	3830	NR3C1	C0039446	Telangiectasia	50.68	5.40000000000001e-310	5.4e-306	1416.5	Binding
4677	1368	NR3C1	C0014591	Epistaxis	6.42	1.6e-14	1.4e-10	59	Binding
4677	2753	NR3C1	C0854100	Nitrogen balance negative	37.07	4e-109	4e-105	492.5	Binding
4677	2939	NR3C1	C0001339	Pancreatitis acute	20.02	1.3e-41	1.2e-38	182.7	Agonist
4677	3790	NR3C1	C0038826	Superinfection	25.44	6e-64	5.6e-61	285	Agonist
4677	103	NR3C1	C0001621	Adrenal disorder	25.38	1.2e-58	1.1e-55	260.7	Agonist
4677	2931	NR3C1	C0030286	Pancreatic disorder	8.14	1.3e-16	1.2e-12	68.5	Binding
4677	3014	NR3C1	C0030920	Peptic ulcer	12.76	1.1e-46	1e-42	206	Binding
4677	1938	NR3C1	C0020538	Hypertension	3.12	1.2e-10	1e-06	41.5	Binding
4677	1521	NR3C1	C0268000	Fluid retention	17.37	1.1e-55	1.1e-51	247.1	Binding
4677	1301	NR3C1	C0549124	Embolism arterial	16.27	8e-52	7.9e-48	229.4	Binding
4677	106	NR3C1	C0001623	Adrenal insufficiency	32.95	2.4e-104	2.3e-101	470.5	Agonist
4677	2939	NR3C1	C0001339	Pancreatitis acute	18.66	4.2e-71	4.1e-67	317.9	Binding
4677	2049	NR3C1	C0151692	Impaired healing	4.95	4e-11	3.5e-07	43.6	Binding
4677	1317	NR3C1	C0014130	Endocrine disorder	5.39	9.1e-38	8.9e-34	165	Binding
4677	159	NR3C1	C0002453	Amenorrhoea	10.15	2.7e-25	2.4e-22	108	Agonist
4677	582	NR3C1	C0005940	Bone disorder	15.28	1.5e-42	1.5e-38	186.9	Binding
4677	2793	NR3C1	C0013604	Oedema	3.71	3.4e-21	3.2e-17	89.3	Binding
4677	1317	NR3C1	C0014130	Endocrine disorder	12.08	4.1e-51	3.8e-48	226.1	Agonist
4677	1912	NR3C1	C0020456	Hyperglycaemia	4.67	9.6e-24	9.2e-20	100.9	Binding
4677	1672	NR3C1	C0017601	Glaucoma	24.45	6.7e-51	6.6e-47	225.2	Binding
4677	1561	NR3C1	C0026946	Fungal infection	12.5	2e-22	1.9e-18	94.9	Binding
4677	3790	NR3C1	C0038826	Superinfection	22.5	1.6e-91	1.5e-87	411.7	Binding
4677	2196	NR3C1	C0151740	Intracranial pressure increased	12.85	2.8e-42	2.8e-38	185.6	Binding
4677	1396	NR3C1	C0235146	Euphoric mood	5.09	1.1e-16	1.1e-12	68.7	Binding
4677	1096	NR3C1	C0011570	Depression	2.49	1.1e-07	0.00091	28.2	Binding
4677	1022	NR3C1	C0332601	Cushingoid	25.29	1e-104	9.6e-102	472.3	Agonist
4677	159	NR3C1	C0002453	Amenorrhoea	4.11	6.9e-14	6.2e-10	56.1	Binding
4677	1946	NR3C1	C0020555	Hypertrichosis	32.95	2.4e-104	2.3e-101	470.5	Agonist
4677	2196	NR3C1	C0151740	Intracranial pressure increased	8.61	2.1e-16	1.8e-13	67.5	Agonist
4677	743	NR3C1	C0086543	Cataract	18.42	1e-41	9.5e-39	183.1	Agonist
4677	1553	NR3C1	C0016658	Fracture	44.65	2.2e-104	2.1e-100	470.8	Binding
4677	683	NR3C1	C0006705	Calcium metabolism disorder	44.65	2.2e-104	2.1e-100	470.8	Binding
4678	3014	NR3C2	C0030920	Peptic ulcer	12.78	2.5e-25	2.4e-21	108.2	Binding
4678	1022	NR3C2	C0332601	Cushingoid	34.67	4.8e-123	4.8e-119	556.5	Binding
4678	1396	NR3C2	C0235146	Euphoric mood	4.64	1.2e-07	0.001	28	Binding
4678	46	NR3C2	C0702166	Acne	15.81	4.2e-44	4.1e-40	194	Binding
4678	1301	NR3C2	C0549124	Embolism arterial	20.91	3e-47	3e-43	208.4	Binding
4678	1096	NR3C2	C0011570	Depression	3.02	1.2e-07	0.001	28	Binding
4678	159	NR3C2	C0002453	Amenorrhoea	4.79	2.6e-11	2.3e-07	44.5	Binding
4678	2605	NR3C2	C0151786	Muscular weakness	6.76	1.8e-15	1.6e-11	63.3	Binding
4678	1317	NR3C2	C0014130	Endocrine disorder	4.39	5.9e-13	5.3e-09	51.9	Binding
4678	106	NR3C2	C0001623	Adrenal insufficiency	22.26	1.7e-50	1.7e-46	223.3	Binding
4678	1912	NR3C2	C0020456	Hyperglycaemia	4.02	2.3e-09	1.9e-05	35.7	Binding
4678	2793	NR3C2	C0013604	Oedema	3.67	9.8e-12	8.6e-08	46.4	Binding
4678	2891	NR3C2	C0029456	Osteoporosis	36.05	3.6e-128	3.6e-124	580.1	Binding
4678	1986	NR3C2	C0020621	Hypokalaemia	4.99	1.2e-07	0.00094	28.1	Binding
4678	2488	NR3C2	C0025345	Menstrual disorder	6.1	4.4e-23	4.2e-19	97.9	Binding
4792	3269	OPRD1	C0033774	Pruritus	2.82	9.2e-06	0.0069	19.7	Agonist
4792	1396	OPRD1	C0235146	Euphoric mood	4.28	1.6e-07	0.00013	27.4	Agonist
4792	1913	OPRD1	C0020458	Hyperhidrosis	3.06	1.2e-14	1.1e-10	59.5	Binding
4792	4010	OPRD1	C0948226	Ureteral spasm	33.62	4.2e-140	4.2e-136	634.9	Binding
4792	430	OPRD1	C0151824	Biliary colic	29.02	5.1e-120	5e-116	542.6	Binding
4792	4230	OPRD1	C0038587	Withdrawal syndrome	19.42	2e-36	1.8e-33	158.9	Agonist
4792	2146	OPRD1	C0151828	Injection site pain	3.56	6.6e-10	5.7e-06	38.1	Binding
4792	1063	OPRD1	C1306577	Death	3.72	1.3e-10	1.1e-06	41.3	Binding
4792	2141	OPRD1	C0521498	Injection site irritation	13.46	1.2e-49	1.2e-45	219.4	Binding
4792	1193	OPRD1	C0013220	Drug tolerance	14.27	5.6e-53	5.6e-49	234.7	Binding
4792	1913	OPRD1	C0020458	Hyperhidrosis	2.81	5.3e-06	0.004	20.7	Agonist
4792	3269	OPRD1	C0033774	Pruritus	2.42	1.4e-08	0.00012	32.2	Binding
4792	1091	OPRD1	C0439857	Dependence	8.42	5.4e-59	5.3e-55	262.3	Binding
4792	2008	OPRD1	C0413252	Hypothermia	4.51	3.9e-17	3.6e-13	70.8	Binding
4792	3601	OPRD1	C0036974	Shock	6.87	4.6e-29	4.5e-25	125.2	Binding
4792	1240	OPRD1	C0013428	Dysuria	2.51	1.5e-06	0.012	23.2	Binding
4792	2196	OPRD1	C0151740	Intracranial pressure increased	7.96	1.3e-13	1.1e-10	54.9	Agonist
4792	595	OPRD1	C0428977	Bradycardia	2.72	3.5e-05	0.025	17.1	Agonist
4792	1091	OPRD1	C0439857	Dependence	10.85	3.5e-19	1.8e-15	80.1	Antagonist
4792	1091	OPRD1	C0439857	Dependence	3.58	2e-08	1.6e-05	31.5	Agonist
4792	4010	OPRD1	C0948226	Ureteral spasm	17.31	3.2e-32	2.9e-29	139.6	Agonist
4792	3601	OPRD1	C0036974	Shock	4.78	1.1e-08	9.1e-06	32.7	Agonist
4792	2875	OPRD1	C0020651	Orthostatic hypotension	4.21	1.9e-08	1.6e-05	31.6	Agonist
4792	787	OPRD1	C0007820	Cerebrovascular disorder	8.24	1.1e-26	1e-22	114.4	Binding
4792	441	OPRD1	C0005686	Bladder disorder	8.33	1.3e-25	1.2e-21	109.5	Binding
4792	2196	OPRD1	C0151740	Intracranial pressure increased	13.01	4.5e-55	4.5e-51	244.3	Binding
4792	3442	OPRD1	C0235063	Respiratory depression	7.82	1.1e-61	1.1e-57	274.6	Binding
4792	2492	OPRD1	C0004936	Mental disorder	2.44	5.2e-07	0.0041	25.2	Binding
4792	430	OPRD1	C0151824	Biliary colic	15.93	1.8e-29	1.7e-26	127	Agonist
4792	595	OPRD1	C0428977	Bradycardia	2.9	1.3e-11	1.2e-07	45.7	Binding
4792	2146	OPRD1	C0151828	Injection site pain	3.7	3e-05	0.021	17.4	Agonist
4792	2536	OPRD1	C0026205	Miosis	16.16	1.7e-42	1.5e-39	186.7	Agonist
4792	1396	OPRD1	C0235146	Euphoric mood	4.59	2.7e-16	2.5e-12	67	Binding
4792	2825	OPRD1	C0028961	Oliguria	11.21	4.4e-20	3.9e-17	84.2	Agonist
4792	1106	OPRD1	C0011616	Dermatitis contact	7.15	9.2e-25	8.8e-21	105.6	Binding
4792	2008	OPRD1	C0413252	Hypothermia	10.07	1.3e-19	1.1e-16	82.1	Agonist
4792	4230	OPRD1	C0038587	Withdrawal syndrome	22.32	8.5e-91	8.4e-87	408.3	Binding
4792	787	OPRD1	C0007820	Cerebrovascular disorder	4.4	1.4e-06	0.0011	23.3	Agonist
4792	966	OPRD1	C0009806	Constipation	1.98	4.3e-08	0.00036	30	Binding
4792	3693	OPRD1	C2830004	Somnolence	1.84	4.4e-07	0.0035	25.5	Binding
4792	3442	OPRD1	C0235063	Respiratory depression	4.17	4.5e-11	3.9e-08	43.4	Agonist
4792	4050	OPRD1	C0042109	Urticaria	3.56	3.1e-06	0.0024	21.8	Agonist
4792	2825	OPRD1	C0028961	Oliguria	10.36	1.1e-38	1.1e-34	169.2	Binding
4792	1106	OPRD1	C0011616	Dermatitis contact	10.34	2.4e-18	2.1e-15	76.3	Agonist
4792	3442	OPRD1	C0235063	Respiratory depression	9.43	5e-23	2.6e-19	97.6	Antagonist
4792	2598	OPRD1	C0037763	Muscle spasms	3.71	4.1e-10	3.6e-06	39	Binding
4792	2536	OPRD1	C0026205	Miosis	12.43	1.3e-77	1.3e-73	347.8	Binding
4792	2875	OPRD1	C0020651	Orthostatic hypotension	2.25	4e-06	0.031	21.3	Binding
4793	3269	OPRK1	C0033774	Pruritus	2.29	2.5e-08	0.00021	31.1	Binding
4793	2536	OPRK1	C0026205	Miosis	11.65	1.9e-78	1.9e-74	351.6	Binding
4793	1091	OPRK1	C0439857	Dependence	11.92	1.7e-23	8.8e-20	99.8	Antagonist
4793	595	OPRK1	C0428977	Bradycardia	2.89	3.4e-13	3e-09	53	Binding
4793	4230	OPRK1	C0038587	Withdrawal syndrome	22.88	1.4e-111	1.4e-107	503.9	Binding
4793	1913	OPRK1	C0020458	Hyperhidrosis	2.93	5.2e-15	4.8e-11	61.2	Binding
4793	2492	OPRK1	C0004936	Mental disorder	2.31	9.1e-07	0.0073	24.1	Binding
4793	3442	OPRK1	C0235063	Respiratory depression	8.74	1.4e-19	7.2e-16	81.9	Antagonist
4793	2008	OPRK1	C0413252	Hypothermia	4.46	3e-19	2.8e-15	80.4	Binding
4793	3442	OPRK1	C0235063	Respiratory depression	3.18	1.1e-06	0.00086	23.7	Agonist
4793	966	OPRK1	C0009806	Constipation	1.87	1.7e-07	0.0014	27.3	Binding
4793	1063	OPRK1	C1306577	Death	4.22	1.2e-16	1.1e-12	68.6	Binding
4793	787	OPRK1	C0007820	Cerebrovascular disorder	8.22	8.6e-31	8.3e-27	133.1	Binding
4793	908	OPRK1	C0009421	Coma	2.96	8.8e-07	0.007	24.2	Binding
4793	2825	OPRK1	C0028961	Oliguria	10.62	1.8e-47	1.7e-43	209.5	Binding
4793	4230	OPRK1	C0038587	Withdrawal syndrome	16.56	8.7e-31	7.9e-28	133.1	Agonist
4793	2196	OPRK1	C0151740	Intracranial pressure increased	13.15	1.3e-65	1.3e-61	292.7	Binding
4793	3442	OPRK1	C0235063	Respiratory depression	6.88	1.8e-53	1.7e-49	237	Binding
4793	430	OPRK1	C0151824	Biliary colic	29.74	1.5e-147	1.5e-143	669.2	Binding
4793	1193	OPRK1	C0013220	Drug tolerance	13.51	5.9e-55	5.8e-51	243.8	Binding
4793	1091	OPRK1	C0439857	Dependence	2.89	1e-05	0.0076	19.5	Agonist
4793	1240	OPRK1	C0013428	Dysuria	2.56	6.9e-08	0.00057	29.1	Binding
4793	2598	OPRK1	C0037763	Muscle spasms	3.8	2.4e-12	2.2e-08	49.1	Binding
4793	2146	OPRK1	C0151828	Injection site pain	3.48	9e-11	7.9e-07	42	Binding
4793	3444	OPRK1	C0035204	Respiratory disorder	2.52	3.3e-06	0.026	21.6	Binding
4793	2141	OPRK1	C0521498	Injection site irritation	13.91	5e-62	5e-58	276.2	Binding
4793	441	OPRK1	C0005686	Bladder disorder	7.58	4.3e-24	4.1e-20	102.5	Binding
4793	1229	OPRK1	C0233477	Dysphoria	22.38	5.6e-42	5.5e-38	184.3	Binding
4793	1396	OPRK1	C0235146	Euphoric mood	4.58	9.1e-19	8.6e-15	78.2	Binding
4793	2536	OPRK1	C0026205	Miosis	11.81	1.1e-25	9.5e-23	109.9	Agonist
4793	3693	OPRK1	C2830004	Somnolence	1.79	2.5e-07	0.0021	26.6	Binding
4793	2875	OPRK1	C0020651	Orthostatic hypotension	3.33	1.1e-05	0.0084	19.3	Agonist
4793	1106	OPRK1	C0011616	Dermatitis contact	7.62	3.8e-33	3.7e-29	143.9	Binding
4793	4010	OPRK1	C0948226	Ureteral spasm	34.46	3e-172	3e-168	782.8	Binding
4793	3601	OPRK1	C0036974	Shock	6.82	3.3e-33	3.2e-29	144.2	Binding
4793	1091	OPRK1	C0439857	Dependence	8.14	2e-63	2e-59	282.6	Binding
4794	1913	OPRL1	C0020458	Hyperhidrosis	4.03	2.4e-06	0.019	22.3	Binding
4795	4010	OPRM1	C0948226	Ureteral spasm	32.92	2.1e-191	2.1e-187	870.9	Binding
4795	3269	OPRM1	C0033774	Pruritus	2.53	1.9e-05	0.014	18.3	Agonist
4795	1396	OPRM1	C0235146	Euphoric mood	3.57	2.7e-06	0.0021	22	Agonist
4795	1396	OPRM1	C0235146	Euphoric mood	4.43	8.7e-21	8.2e-17	87.4	Binding
4795	787	OPRM1	C0007820	Cerebrovascular disorder	8.31	2.7e-38	2.7e-34	167.4	Binding
4795	2196	OPRM1	C0151740	Intracranial pressure increased	12.84	7.5e-76	7.4e-72	339.7	Binding
4795	2008	OPRM1	C0413252	Hypothermia	9.16	6.6e-21	5.9e-18	88	Agonist
4795	595	OPRM1	C0428977	Bradycardia	3.31	2.1e-07	0.00098	27	Antagonist
4795	908	OPRM1	C0009421	Coma	4.38	3.7e-07	0.00029	25.8	Agonist
4795	2141	OPRM1	C0521498	Injection site irritation	7.96	1.2e-13	1e-10	55	Agonist
4795	3601	OPRM1	C0036974	Shock	6.56	9.4e-37	9.1e-33	160.4	Binding
4795	2536	OPRM1	C0026205	Miosis	11.93	2e-100	2e-96	452.6	Binding
4795	1913	OPRM1	C0020458	Hyperhidrosis	3.21	5.3e-23	5.1e-19	97.5	Binding
4795	4230	OPRM1	C0038587	Withdrawal syndrome	21.11	5.9e-115	5.8e-111	519.3	Binding
4795	2825	OPRM1	C0028961	Oliguria	9.49	2.1e-18	1.8e-15	76.6	Agonist
4795	966	OPRM1	C0009806	Constipation	1.83	3.6e-08	3e-04	30.4	Binding
4795	1193	OPRM1	C0013220	Drug tolerance	12.14	3.3e-53	3.2e-49	235.8	Binding
4795	3693	OPRM1	C2830004	Somnolence	1.86	6.1e-10	5.2e-06	38.3	Binding
4795	3601	OPRM1	C0036974	Shock	3.98	2.5e-07	2e-04	26.6	Agonist
4795	1091	OPRM1	C0439857	Dependence	8.01	2.2e-74	2.1e-70	333	Binding
4795	1913	OPRM1	C0020458	Hyperhidrosis	2.95	7.3e-06	0.033	20.1	Antagonist
4795	2536	OPRM1	C0026205	Miosis	11.58	5.2e-27	2.7e-23	115.8	Antagonist
4795	2875	OPRM1	C0020651	Orthostatic hypotension	3.47	7.8e-07	0.00061	24.4	Agonist
4795	2141	OPRM1	C0521498	Injection site irritation	13.37	2.2e-69	2.2e-65	310	Binding
4795	2536	OPRM1	C0026205	Miosis	15.1	2.3e-48	2.1e-45	213.5	Agonist
4795	3601	OPRM1	C0036974	Shock	7.31	2e-13	1e-09	54	Antagonist
4795	908	OPRM1	C0009421	Coma	2.8	5.5e-07	0.0044	25.1	Binding
4795	441	OPRM1	C0005686	Bladder disorder	7.22	2.7e-26	2.6e-22	112.5	Binding
4795	432	OPRM1	C0005424	Biliary tract disorder	2.76	4.8e-06	0.037	20.9	Binding
4795	2146	OPRM1	C0151828	Injection site pain	3.67	9.8e-15	8.9e-11	59.9	Binding
4795	430	OPRM1	C0151824	Biliary colic	13.48	3e-27	2.7e-24	116.9	Agonist
4795	430	OPRM1	C0151824	Biliary colic	28.42	7.5e-164	7.5e-160	744.1	Binding
4795	1091	OPRM1	C0439857	Dependence	3.22	3.2e-08	2.7e-05	30.6	Agonist
4795	2196	OPRM1	C0151740	Intracranial pressure increased	7.35	6.5e-15	5.7e-12	60.7	Agonist
4795	3444	OPRM1	C0035204	Respiratory disorder	2.62	7.3e-05	0.049	15.7	Agonist
4795	2596	OPRM1	C0026837	Muscle rigidity	9.23	1.3e-17	1.2e-13	73.1	Binding
4795	4230	OPRM1	C0038587	Withdrawal syndrome	14.94	1.3e-27	1.2e-24	118.5	Agonist
4795	1913	OPRM1	C0020458	Hyperhidrosis	2.61	2.9e-06	0.0023	21.8	Agonist
4795	4010	OPRM1	C0948226	Ureteral spasm	14.65	7.6e-30	6.9e-27	128.8	Agonist
4795	1106	OPRM1	C0011616	Dermatitis contact	8.75	9e-17	7.9e-14	69.2	Agonist
4795	1199	OPRM1	C0043352	Dry mouth	1.8	1.7e-06	0.013	23	Binding
4795	2146	OPRM1	C0151828	Injection site pain	4.24	3.1e-06	0.014	21.7	Antagonist
4795	2825	OPRM1	C0028961	Oliguria	10.15	2.8e-52	2.7e-48	231.5	Binding
4795	3269	OPRM1	C0033774	Pruritus	2.49	1.1e-12	9.7e-09	50.7	Binding
4795	2492	OPRM1	C0004936	Mental disorder	2.63	1.1e-11	9.5e-08	46.2	Binding
4795	595	OPRM1	C0428977	Bradycardia	3.51	5.6e-27	5.4e-23	115.7	Binding
4795	2598	OPRM1	C0037763	Muscle spasms	3.63	3.3e-13	3e-09	53	Binding
4795	1063	OPRM1	C1306577	Death	4.2	9.7e-20	9.1e-16	82.7	Binding
4795	3442	OPRM1	C0235063	Respiratory depression	7.52	3.8e-20	1.9e-16	84.5	Antagonist
4795	1106	OPRM1	C0011616	Dermatitis contact	7	3.2e-33	3.1e-29	144.2	Binding
4795	1091	OPRM1	C0439857	Dependence	11.37	1.4e-30	6.9e-27	132.2	Antagonist
4795	595	OPRM1	C0428977	Bradycardia	3.08	6.3e-09	5.2e-06	33.7	Agonist
4795	3442	OPRM1	C0235063	Respiratory depression	7.56	2.4e-80	2.4e-76	360.3	Binding
4795	1063	OPRM1	C1306577	Death	4.79	4.2e-10	3.5e-07	39	Agonist
4795	4050	OPRM1	C0042109	Urticaria	2.47	6.1e-09	5.2e-05	33.8	Binding
4795	1240	OPRM1	C0013428	Dysuria	2.77	1.2e-11	1e-07	46	Binding
4795	3444	OPRM1	C0035204	Respiratory disorder	3.41	1.7e-16	1.6e-12	67.9	Binding
4795	1229	OPRM1	C0233477	Dysphoria	18.43	3.3e-34	3.2e-30	148.7	Binding
4795	1159	OPRM1	C0233407	Disorientation	4.15	4.7e-06	0.036	21	Binding
4795	3442	OPRM1	C0235063	Respiratory depression	4.39	4.4e-16	3.8e-13	66.1	Agonist
4795	2008	OPRM1	C0413252	Hypothermia	4.51	9.3e-24	8.9e-20	101	Binding
4795	2008	OPRM1	C0413252	Hypothermia	4.05	2.2e-06	0.01	22.4	Antagonist
4795	4050	OPRM1	C0042109	Urticaria	3.16	6.2e-06	0.0047	20.4	Agonist
5053	1524	PDE10A	C0016382	Flushing	5.61	6.6e-09	5.6e-05	33.7	Binding
5054	1225	PDE11A	C0013395	Dyspepsia	8.49	5.2e-16	4.8e-12	65.7	Binding
5055	1524	PDE1A	C0016382	Flushing	5.75	6.3e-11	3.1e-07	42.7	Antagonist
5055	1524	PDE1A	C0016382	Flushing	5.46	2.7e-14	2.5e-10	57.9	Binding
5056	1524	PDE1B	C0016382	Flushing	6.47	1.3e-11	6.4e-08	45.8	Antagonist
5056	1524	PDE1B	C0016382	Flushing	5.86	9.2e-15	8.4e-11	60.1	Binding
5057	1524	PDE1C	C0016382	Flushing	4.84	3.9e-10	3.4e-06	39.1	Binding
5058	1524	PDE2A	C0016382	Flushing	4.42	3.4e-07	0.0028	26	Binding
5058	1782	PDE2A	C0018681	Headache	2.78	1.9e-06	0.015	22.7	Binding
5058	1225	PDE2A	C0013395	Dyspepsia	4.94	1.4e-07	0.0011	27.7	Binding
5059	2928	PDE3A	C0030252	Palpitations	3.78	2.7e-06	0.021	22	Binding
5059	1225	PDE3A	C0013395	Dyspepsia	4.23	9e-07	0.0072	24.1	Binding
5060	1225	PDE3B	C0013395	Dyspepsia	5	1.1e-07	0.00088	28.2	Binding
5061	1524	PDE4A	C0016382	Flushing	3.79	3.7e-08	0.00031	30.3	Binding
5061	2928	PDE4A	C0030252	Palpitations	3.33	5.3e-06	0.041	20.7	Binding
5061	1143	PDE4A	C0011991	Diarrhoea	2.65	4.2e-06	0.033	21.2	Binding
5061	1225	PDE4A	C0013395	Dyspepsia	4.35	4.8e-07	0.0023	25.3	Antagonist
5061	1225	PDE4A	C0013395	Dyspepsia	4.94	1.7e-12	1.5e-08	49.8	Binding
5062	1524	PDE4B	C0016382	Flushing	4.31	2.2e-06	0.01	22.4	Antagonist
5062	2928	PDE4B	C0030252	Palpitations	4.43	1.3e-06	0.0062	23.4	Antagonist
5062	1524	PDE4B	C0016382	Flushing	4.16	2.6e-09	2.2e-05	35.5	Binding
5062	2928	PDE4B	C0030252	Palpitations	3.92	4.4e-08	0.00036	30	Binding
5062	1225	PDE4B	C0013395	Dyspepsia	4.46	4.4e-09	3.7e-05	34.4	Binding
5062	1143	PDE4B	C0011991	Diarrhoea	2.77	2.3e-06	0.018	22.3	Binding
5063	1524	PDE4C	C0016382	Flushing	4.24	6.5e-08	0.00054	29.2	Binding
5063	1143	PDE4C	C0011991	Diarrhoea	2.98	2.6e-06	0.021	22.1	Binding
5063	1782	PDE4C	C0018681	Headache	2.58	2.6e-06	0.02	22.1	Binding
5063	1225	PDE4C	C0013395	Dyspepsia	5.6	3e-12	2.6e-08	48.7	Binding
5064	1524	PDE4D	C0016382	Flushing	3.81	3.1e-08	0.00026	30.7	Binding
5064	1524	PDE4D	C0016382	Flushing	3.79	7.4e-06	0.034	20.1	Antagonist
5064	1225	PDE4D	C0013395	Dyspepsia	4.39	1.9e-09	1.6e-05	36.1	Binding
5065	2928	PDE5A	C0030252	Palpitations	3.96	3.4e-06	0.027	21.6	Binding
5065	1143	PDE5A	C0011991	Diarrhoea	3.27	2.7e-07	0.0022	26.5	Binding
5065	1225	PDE5A	C0013395	Dyspepsia	6.58	4.8e-16	4.4e-12	65.9	Binding
5065	1524	PDE5A	C0016382	Flushing	5.36	2.2e-12	2e-08	49.3	Binding
5066	1225	PDE6A	C0013395	Dyspepsia	8.66	6.8e-15	6.2e-11	60.6	Binding
5080	1022	PDGFRA	C0332601	Cushingoid	48.59	3e-205	1.6e-201	934.6	Antagonist
5080	103	PDGFRA	C0001621	Adrenal disorder	26.26	9e-71	4.6e-67	316.4	Antagonist
5080	1946	PDGFRA	C0020555	Hypertrichosis	33.66	1.7e-105	1.7e-101	475.9	Binding
5080	3014	PDGFRA	C0030920	Peptic ulcer	13.6	1.3e-24	6.7e-21	104.9	Antagonist
5080	3830	PDGFRA	C0039446	Telangiectasia	48.95	3e-145	3e-141	658.6	Binding
5080	1396	PDGFRA	C0235146	Euphoric mood	5.37	5.4e-10	4.7e-06	38.5	Binding
5080	1938	PDGFRA	C0020538	Hypertension	4.59	6e-12	3e-08	47.3	Antagonist
5080	3790	PDGFRA	C0038826	Superinfection	22.77	3.6e-47	3.5e-43	208.1	Binding
5080	3014	PDGFRA	C0030920	Peptic ulcer	12.32	4.6e-22	4.4e-18	93.2	Binding
5080	1946	PDGFRA	C0020555	Hypertrichosis	38.88	1.1e-122	5.6e-119	554.9	Antagonist
5080	582	PDGFRA	C0005940	Bone disorder	28.27	5.3e-65	2.7e-61	289.9	Antagonist
5080	1317	PDGFRA	C0014130	Endocrine disorder	4.88	1.1e-15	9.7e-12	64.3	Binding
5080	3656	PDGFRA	C0152459	Skin striae	42.86	7.3e-109	7.2e-105	491.3	Binding
5080	2605	PDGFRA	C0151786	Muscular weakness	7.69	2.3e-19	2.1e-15	81	Binding
5080	1396	PDGFRA	C0235146	Euphoric mood	6.17	6.4e-12	3.2e-08	47.2	Antagonist
5080	3656	PDGFRA	C0152459	Skin striae	47.84	5.1e-122	2.6e-118	551.8	Antagonist
5080	2888	PDGFRA	C0029445	Osteonecrosis	45.1	5.9e-96	5.8e-92	432	Binding
5080	3790	PDGFRA	C0038826	Superinfection	20.43	4.1e-42	2.1e-38	184.9	Antagonist
5080	1938	PDGFRA	C0020538	Hypertension	3.82	1.2e-09	9.9e-06	37	Binding
5080	106	PDGFRA	C0001623	Adrenal insufficiency	27.55	2.3e-74	2.3e-70	332.8	Binding
5080	103	PDGFRA	C0001621	Adrenal disorder	27.72	7.6e-75	7.5e-71	335.1	Binding
5080	2196	PDGFRA	C0151740	Intracranial pressure increased	13.78	6.1e-25	5.9e-21	106.4	Binding
5080	2891	PDGFRA	C0029456	Osteoporosis	40.37	1.6e-152	1.6e-148	692.1	Binding
5080	1912	PDGFRA	C0020456	Hyperglycaemia	3.76	1.3e-07	0.0011	27.8	Binding
5080	2939	PDGFRA	C0001339	Pancreatitis acute	21.62	5.9e-49	5.8e-45	216.3	Binding
5080	3627	PDGFRA	C0151514	Skin atrophy	44.2	3.8e-149	3.8e-145	676.5	Binding
5080	2939	PDGFRA	C0001339	Pancreatitis acute	24.4	1.1e-55	5.5e-52	247.2	Antagonist
5080	1986	PDGFRA	C0020621	Hypokalaemia	7.41	2.7e-17	2.5e-13	71.5	Binding
5080	106	PDGFRA	C0001623	Adrenal insufficiency	25.76	2.4e-69	1.2e-65	309.8	Antagonist
5080	2605	PDGFRA	C0151786	Muscular weakness	8.7	1.8e-22	9.2e-19	95.1	Antagonist
5080	3627	PDGFRA	C0151514	Skin atrophy	49.76	1e-168	5.4e-165	766.5	Antagonist
5080	159	PDGFRA	C0002453	Amenorrhoea	4.6	1.9e-09	9.3e-06	36.1	Antagonist
5080	582	PDGFRA	C0005940	Bone disorder	23.62	9.4e-54	9.3e-50	238.3	Binding
5080	159	PDGFRA	C0002453	Amenorrhoea	4.76	1.4e-10	1.3e-06	41.1	Binding
5080	3830	PDGFRA	C0039446	Telangiectasia	52.21	2.3e-155	1.2e-151	705.2	Antagonist
5080	2793	PDGFRA	C0013604	Oedema	4.56	8.5e-17	4.3e-13	69.3	Antagonist
5080	2488	PDGFRA	C0025345	Menstrual disorder	4.05	5.8e-08	0.00028	29.4	Antagonist
5080	2196	PDGFRA	C0151740	Intracranial pressure increased	15.77	7e-29	3.6e-25	124.4	Antagonist
5080	2888	PDGFRA	C0029445	Osteonecrosis	46.7	1.4e-99	7.5e-96	448.6	Antagonist
5080	2891	PDGFRA	C0029456	Osteoporosis	44.49	7.4e-169	3.8e-165	767.2	Antagonist
5080	2793	PDGFRA	C0013604	Oedema	4.37	6.4e-17	5.9e-13	69.9	Binding
5080	2488	PDGFRA	C0025345	Menstrual disorder	4.05	1.9e-08	0.00016	31.6	Binding
5080	1986	PDGFRA	C0020621	Hypokalaemia	7.85	6.6e-16	3.3e-12	65.3	Antagonist
5080	1912	PDGFRA	C0020456	Hyperglycaemia	4.08	1.5e-08	7.3e-05	32.1	Antagonist
5080	1022	PDGFRA	C0332601	Cushingoid	42.91	2.6e-180	2.6e-176	819.9	Binding
5080	1317	PDGFRA	C0014130	Endocrine disorder	4.98	3.5e-16	1.7e-12	66.5	Antagonist
5081	2488	PDGFRB	C0025345	Menstrual disorder	3.5	4.9e-06	0.038	20.9	Binding
5081	2891	PDGFRB	C0029456	Osteoporosis	40.26	4.4e-152	4.3e-148	690.1	Binding
5081	3830	PDGFRB	C0039446	Telangiectasia	48.81	7.9e-145	7.8e-141	656.7	Binding
5081	159	PDGFRB	C0002453	Amenorrhoea	4.12	1.4e-07	0.0011	27.8	Binding
5081	1912	PDGFRB	C0020456	Hyperglycaemia	4.07	1.6e-08	7.7e-05	31.9	Antagonist
5081	103	PDGFRB	C0001621	Adrenal disorder	26.2	1.3e-70	6.7e-67	315.6	Antagonist
5081	1396	PDGFRB	C0235146	Euphoric mood	6.16	6.9e-12	3.4e-08	47.1	Antagonist
5081	582	PDGFRB	C0005940	Bone disorder	28.21	7.4e-65	3.8e-61	289.2	Antagonist
5081	1317	PDGFRB	C0014130	Endocrine disorder	4.86	1.2e-15	1.1e-11	64.1	Binding
5081	3014	PDGFRB	C0030920	Peptic ulcer	12.29	5.4e-22	5.1e-18	92.9	Binding
5081	2793	PDGFRB	C0013604	Oedema	4.55	9.5e-17	4.8e-13	69.1	Antagonist
5081	1946	PDGFRB	C0020555	Hypertrichosis	33.57	3.4e-105	3.4e-101	474.5	Binding
5081	3627	PDGFRB	C0151514	Skin atrophy	49.65	2.4e-168	1.3e-164	764.8	Antagonist
5081	2888	PDGFRB	C0029445	Osteonecrosis	46.61	2.4e-99	1.2e-95	447.6	Antagonist
5081	2488	PDGFRB	C0025345	Menstrual disorder	3.76	1.1e-06	0.0051	23.8	Antagonist
5081	1022	PDGFRB	C0332601	Cushingoid	48.48	8.4e-205	4.4e-201	932.5	Antagonist
5081	1022	PDGFRB	C0332601	Cushingoid	42.79	8.6e-180	8.5e-176	817.5	Binding
5081	2605	PDGFRB	C0151786	Muscular weakness	7.67	2.7e-19	2.5e-15	80.7	Binding
5081	3656	PDGFRB	C0152459	Skin striae	42.74	1.5e-108	1.5e-104	489.9	Binding
5081	3830	PDGFRB	C0039446	Telangiectasia	52.1	4.9e-155	2.5e-151	703.6	Antagonist
5081	2888	PDGFRB	C0029445	Osteonecrosis	44.97	1.1e-95	1.1e-91	430.8	Binding
5081	3790	PDGFRB	C0038826	Superinfection	22.7	4.9e-47	4.8e-43	207.5	Binding
5081	2196	PDGFRB	C0151740	Intracranial pressure increased	13.75	7.3e-25	7e-21	106	Binding
5081	3627	PDGFRB	C0151514	Skin atrophy	44.07	1e-148	1e-144	674.5	Binding
5081	1986	PDGFRB	C0020621	Hypokalaemia	6.86	1.2e-14	1.1e-10	59.5	Binding
5081	1986	PDGFRB	C0020621	Hypokalaemia	7.83	7.2e-16	3.6e-12	65.1	Antagonist
5081	1946	PDGFRB	C0020555	Hypertrichosis	38.8	2e-122	1e-118	553.7	Antagonist
5081	3014	PDGFRB	C0030920	Peptic ulcer	13.58	1.5e-24	7.6e-21	104.6	Antagonist
5081	103	PDGFRB	C0001621	Adrenal disorder	27.64	1.3e-74	1.2e-70	334.1	Binding
5081	1938	PDGFRB	C0020538	Hypertension	4.84	1.6e-13	8.2e-10	54.4	Antagonist
5081	2605	PDGFRB	C0151786	Muscular weakness	8.68	2e-22	1e-18	94.9	Antagonist
5081	159	PDGFRB	C0002453	Amenorrhoea	4.26	5.9e-08	0.00028	29.4	Antagonist
5081	106	PDGFRB	C0001623	Adrenal insufficiency	27.47	3.8e-74	3.8e-70	331.8	Binding
5081	2196	PDGFRB	C0151740	Intracranial pressure increased	15.74	8.1e-29	4.2e-25	124.1	Antagonist
5081	1938	PDGFRB	C0020538	Hypertension	4.21	3.2e-12	2.8e-08	48.6	Binding
5081	1317	PDGFRB	C0014130	Endocrine disorder	4.97	3.8e-16	1.9e-12	66.3	Antagonist
5081	2939	PDGFRB	C0001339	Pancreatitis acute	24.35	1.4e-55	7.3e-52	246.6	Antagonist
5081	106	PDGFRB	C0001623	Adrenal insufficiency	25.7	3.4e-69	1.7e-65	309.1	Antagonist
5081	2939	PDGFRB	C0001339	Pancreatitis acute	21.56	8.2e-49	8.1e-45	215.6	Binding
5081	1912	PDGFRB	C0020456	Hyperglycaemia	3.75	1.4e-07	0.0012	27.7	Binding
5081	3656	PDGFRB	C0152459	Skin striae	47.74	9.3e-122	4.8e-118	550.6	Antagonist
5081	582	PDGFRB	C0005940	Bone disorder	23.55	1.4e-53	1.3e-49	237.5	Binding
5081	3790	PDGFRB	C0038826	Superinfection	20.39	5.1e-42	2.6e-38	184.5	Antagonist
5081	2793	PDGFRB	C0013604	Oedema	4.35	7.5e-17	6.9e-13	69.5	Binding
5081	2891	PDGFRB	C0029456	Osteoporosis	44.4	1.7e-168	8.9e-165	765.5	Antagonist
5081	1396	PDGFRB	C0235146	Euphoric mood	5.35	5.9e-10	5.1e-06	38.4	Binding
5157	2488	PGR	C0025345	Menstrual disorder	9.26	5.8e-63	5.7e-59	280.5	Binding
5157	159	PGR	C0002453	Amenorrhoea	3.63	2.3e-06	0.018	22.3	Binding
5157	2315	PGR	C0854382	Libido disorder	4.93	1.8e-12	1.6e-08	49.7	Binding
5157	633	PGR	C0024902	Breast pain	40.5	1.1e-144	1.1e-140	656	Binding
5157	1719	PGR	C0018418	Gynaecomastia	3.63	8.2e-10	7.1e-06	37.7	Binding
5157	4219	PGR	C0043094	Weight increased	10.43	1.3e-31	1.1e-28	136.9	Agonist
5157	1865	PGR	C0019572	Hirsutism	15.13	1.8e-30	1.7e-26	131.7	Binding
5157	1096	PGR	C0011570	Depression	3.87	5.3e-07	0.00042	25.2	Agonist
5157	2793	PGR	C0013604	Oedema	4.39	2.3e-19	2.1e-15	81	Binding
5157	432	PGR	C0005424	Biliary tract disorder	4.17	4.3e-06	0.033	21.1	Binding
5157	4050	PGR	C0042109	Urticaria	3.17	1.4e-06	0.011	23.3	Binding
5157	46	PGR	C0702166	Acne	24.39	1.4e-75	1.3e-72	338.5	Agonist
5157	4219	PGR	C0043094	Weight increased	5.6	4e-33	3.9e-29	143.8	Binding
5157	1096	PGR	C0011570	Depression	4.23	7e-19	6.5e-15	78.8	Binding
5157	2221	PGR	C0022354	Jaundice cholestatic	8.26	4.5e-14	4.1e-10	56.9	Binding
5157	1505	PGR	C0016034	Fibrocystic breast disease	7.74	1.6e-19	1.5e-15	81.7	Binding
5157	2488	PGR	C0025345	Menstrual disorder	16.58	3.8e-53	3.5e-50	235.5	Agonist
5157	2518	PGR	C0025874	Metrorrhagia	43.27	5.9e-119	5.8e-115	537.7	Binding
5157	2531	PGR	C0149931	Migraine	13.82	5.1e-25	4.9e-21	106.7	Binding
5157	2793	PGR	C0013604	Oedema	5.1	6.6e-11	5.6e-08	42.6	Agonist
5157	46	PGR	C0702166	Acne	36.39	5.9e-272	5.9e-268	1241.5	Binding
5335	167	POLA1	C0002871	Anaemia	4.47	2.7e-07	0.0022	26.4	Binding
5335	2613	POLA1	C0231528	Myalgia	3.96	1.1e-06	0.0084	23.8	Binding
5335	328	POLA1	C0003862	Arthralgia	4.16	4.5e-06	0.035	21	Binding
5335	1005	POLA1	C0010200	Cough	4.64	5.3e-07	0.0043	25.1	Binding
5341	167	POLG	C0002871	Anaemia	4.72	8.1e-08	0.00067	28.8	Binding
5390	2613	PPARA	C0231528	Myalgia	7.77	1e-15	9.2e-12	64.4	Binding
5393	1225	PPARG	C0013395	Dyspepsia	3.7	3.2e-05	0.022	17.3	Agonist
5646	1524	PTGER2	C0016382	Flushing	4.05	2.1e-06	0.017	22.5	Binding
5647	1143	PTGER3	C0011991	Diarrhoea	4.38	6.9e-09	5.8e-05	33.6	Binding
5648	1143	PTGER4	C0011991	Diarrhoea	4.59	4.2e-10	3.6e-06	39	Binding
5654	13	PTGS1	C0232492	Abdominal pain upper	2.32	9.9e-09	8.3e-05	32.9	Binding
5654	1225	PTGS1	C0013395	Dyspepsia	3.1	1.8e-11	1.6e-07	45.1	Binding
5654	3427	PTGS1	C0151747	Renal tubular disorder	9.11	9.3e-16	8.6e-12	64.6	Binding
5654	1603	PTGS1	C0017181	Gastrointestinal haemorrhage	9.63	7.9e-56	7.8e-52	247.8	Binding
5654	1603	PTGS1	C0017181	Gastrointestinal haemorrhage	8.95	2.3e-26	1.2e-22	112.9	Antagonist
5654	3866	PTGS1	C0040034	Thrombocytopenia	3.1	2.5e-07	0.0012	26.6	Antagonist
5654	3413	PTGS1	C0035078	Renal failure	6.32	3e-15	2.7e-11	62.3	Binding
5654	2705	PTGS1	C0022658	Nephropathy	3.99	2.8e-07	0.0013	26.4	Antagonist
5654	3892	PTGS1	C0040264	Tinnitus	3.44	9.9e-12	8.7e-08	46.3	Binding
5654	3930	PTGS1	C0014518	Toxic epidermal necrolysis	5.88	2.1e-09	1.8e-05	35.9	Binding
5654	3866	PTGS1	C0040034	Thrombocytopenia	3.17	2.9e-12	2.6e-08	48.7	Binding
5654	3014	PTGS1	C0030920	Peptic ulcer	9.01	2.2e-23	2.1e-19	99.3	Binding
5654	3269	PTGS1	C0033774	Pruritus	2.44	1.4e-07	0.0011	27.7	Binding
5654	1732	PTGS1	C0018965	Haematuria	6.03	1.2e-10	5.9e-07	41.5	Antagonist
5654	1732	PTGS1	C0018965	Haematuria	6.69	1e-21	9.7e-18	91.7	Binding
5654	1379	PTGS1	C0014742	Erythema multiforme	3.97	1e-07	0.00085	28.3	Binding
5654	267	PTGS1	C0002874	Aplastic anaemia	6.2	5.9e-13	5.3e-09	51.9	Binding
5654	1823	PTGS1	C0019158	Hepatitis	3.53	2.3e-07	0.0019	26.7	Binding
5654	2705	PTGS1	C0022658	Nephropathy	4.08	1.1e-12	9.5e-09	50.7	Binding
5654	2793	PTGS1	C0013604	Oedema	2.92	6.1e-07	0.0029	24.9	Antagonist
5654	2793	PTGS1	C0013604	Oedema	3.19	4.3e-15	3.9e-11	61.6	Binding
5654	351	PTGS1	C0004096	Asthma	4.43	3.4e-07	0.0028	26	Binding
5654	3364	PTGS1	C0015230	Rash	1.79	4.2e-06	0.033	21.2	Binding
5655	1823	PTGS2	C0019158	Hepatitis	3.86	2.6e-09	2.2e-05	35.5	Binding
5655	2825	PTGS2	C0028961	Oliguria	5.68	5.1e-09	4.3e-05	34.2	Binding
5655	1732	PTGS2	C0018965	Haematuria	5.84	1.8e-16	1.7e-12	67.8	Binding
5655	3413	PTGS2	C0035078	Renal failure	7.36	5e-22	4.7e-18	93.1	Binding
5655	3866	PTGS2	C0040034	Thrombocytopenia	2.89	6.8e-10	5.9e-06	38.1	Binding
5655	1603	PTGS2	C0017181	Gastrointestinal haemorrhage	7.67	1.2e-20	6.3e-17	86.7	Antagonist
5655	3892	PTGS2	C0040264	Tinnitus	2.74	1e-06	0.0082	23.9	Binding
5655	2793	PTGS2	C0013604	Oedema	2.65	2.2e-09	1.9e-05	35.8	Binding
5655	2705	PTGS2	C0022658	Nephropathy	4.47	2.5e-10	1.3e-06	40	Antagonist
5655	3014	PTGS2	C0030920	Peptic ulcer	6.99	7.4e-14	6.7e-10	56	Binding
5655	1603	PTGS2	C0017181	Gastrointestinal haemorrhage	8.21	1.9e-40	1.9e-36	177.2	Binding
5655	3413	PTGS2	C0035078	Renal failure	7.12	5.1e-13	2.5e-09	52.2	Antagonist
5655	1514	PTGS2	C0016204	Flatulence	3.76	1.6e-08	0.00013	31.9	Binding
5655	1732	PTGS2	C0018965	Haematuria	5.49	1.8e-09	8.6e-06	36.2	Antagonist
5655	1379	PTGS2	C0014742	Erythema multiforme	4.12	1.2e-08	9.7e-05	32.6	Binding
5655	1823	PTGS2	C0019158	Hepatitis	3.74	9.9e-06	0.044	19.5	Antagonist
5655	1225	PTGS2	C0013395	Dyspepsia	3.09	9.2e-12	8.1e-08	46.5	Binding
5655	3269	PTGS2	C0033774	Pruritus	2.51	2.1e-08	0.00018	31.4	Binding
5655	13	PTGS2	C0232492	Abdominal pain upper	2.3	9.8e-09	8.2e-05	32.9	Binding
5655	267	PTGS2	C0002874	Aplastic anaemia	5.55	1.9e-10	1.7e-06	40.5	Binding
5655	2705	PTGS2	C0022658	Nephropathy	4.3	7.7e-15	7e-11	60.4	Binding
6121	328	RXRA	C0003862	Arthralgia	4.28	2.6e-06	0.021	22.1	Binding
6186	2713	SCN10A	C0027769	Nervousness	2.25	4.1e-07	0.002	25.6	Antagonist
6186	2369	SCN10A	C0041657	Loss of consciousness	6.96	1.4e-29	1.3e-25	127.6	Binding
6186	3892	SCN10A	C0040264	Tinnitus	2.96	1.6e-13	1.4e-09	54.5	Binding
6186	3447	SCN10A	C1145670	Respiratory failure	3.79	5e-10	2.5e-06	38.7	Antagonist
6186	2517	SCN10A	C0025637	Methaemoglobinaemia	4.63	2.2e-13	1.1e-09	53.8	Antagonist
6186	268	SCN10A	C0003578	Apnoea	3.31	9e-08	0.00043	28.6	Antagonist
6186	3444	SCN10A	C0035204	Respiratory disorder	2.5	1.6e-07	0.0013	27.5	Binding
6186	2049	SCN10A	C0151692	Impaired healing	5.4	3.3e-25	3.1e-21	107.6	Binding
6186	985	SCN10A	C0010034	Corneal disorder	6.87	1.1e-24	1.1e-20	105.2	Binding
6186	2369	SCN10A	C0041657	Loss of consciousness	4.7	4.7e-11	2.3e-07	43.3	Antagonist
6186	2629	SCN10A	C0340515	Myocardial depression	7.43	5.1e-37	5e-33	161.6	Binding
6186	972	SCN10A	C0036572	Convulsion	1.9	8.2e-08	0.00068	28.8	Binding
6186	2713	SCN10A	C0027769	Nervousness	2.53	1.1e-12	9.4e-09	50.7	Binding
6186	3580	SCN10A	C1325847	Sensitisation	7.14	1.3e-30	1.3e-26	132.2	Binding
6186	1063	SCN10A	C1306577	Death	3.26	3.9e-11	3.5e-07	43.6	Binding
6186	3220	SCN10A	C0700200	Presyncope	5.48	1.9e-18	9.4e-15	76.8	Antagonist
6186	703	SCN10A	C0018790	Cardiac arrest	3.6	4e-10	2e-06	39.1	Antagonist
6186	1964	SCN10A	C0521592	Hypoaesthesia oral	5.49	2e-14	9.9e-11	58.6	Antagonist
6186	4166	SCN10A	C0344232	Vision blurred	2.1	2.8e-10	2.5e-06	39.8	Binding
6186	2049	SCN10A	C0151692	Impaired healing	3.87	6.9e-10	3.4e-06	38	Antagonist
6186	3580	SCN10A	C1325847	Sensitisation	4.94	7.5e-12	3.7e-08	46.9	Antagonist
6186	703	SCN10A	C0018790	Cardiac arrest	4.71	2.3e-23	2.2e-19	99.2	Binding
6186	3220	SCN10A	C0700200	Presyncope	7.8	1.5e-44	1.5e-40	196.1	Binding
6186	1313	SCN10A	C0085584	Encephalopathy	2.18	9.5e-06	0.043	19.6	Antagonist
6186	2517	SCN10A	C0025637	Methaemoglobinaemia	6.77	3.7e-36	3.6e-32	157.6	Binding
6186	2243	SCN10A	C0022568	Keratitis	6.4	1.4e-26	1.3e-22	113.9	Binding
6186	1213	SCN10A	C0013362	Dysarthria	4.4	5.3e-20	5e-16	83.9	Binding
6186	115	SCN10A	C0085631	Agitation	2.05	1.1e-06	0.0084	23.8	Binding
6186	4119	SCN10A	C0595862	Vasodilatation	3.11	4.8e-07	0.0023	25.4	Antagonist
6186	3956	SCN10A	C0040822	Tremor	1.9	3.2e-07	0.0026	26.1	Binding
6186	908	SCN10A	C0009421	Coma	4.12	1e-19	9.7e-16	82.5	Binding
6186	985	SCN10A	C0010034	Corneal disorder	4.34	1.4e-07	0.00065	27.8	Antagonist
6186	1964	SCN10A	C0521592	Hypoaesthesia oral	7.94	1.4e-37	1.3e-33	164.2	Binding
6186	3892	SCN10A	C0040264	Tinnitus	2.34	4.3e-06	0.02	21.1	Antagonist
6186	1063	SCN10A	C1306577	Death	2.76	8.4e-06	0.038	19.8	Antagonist
6186	766	SCN10A	C0151560	Central nervous system stimulation	4.47	8e-26	7.7e-22	110.4	Binding
6186	1313	SCN10A	C0085584	Encephalopathy	2.21	5.6e-08	0.00046	29.5	Binding
6186	4119	SCN10A	C0595862	Vasodilatation	3.89	3.5e-15	3.2e-11	61.9	Binding
6186	1530	SCN10A	C0854268	Foetal damage	7.6	6e-23	5.8e-19	97.3	Binding
6186	1530	SCN10A	C0854268	Foetal damage	5.09	6.7e-08	0.00032	29.1	Antagonist
6186	4166	SCN10A	C0344232	Vision blurred	1.91	3.3e-06	0.015	21.6	Antagonist
6186	766	SCN10A	C0151560	Central nervous system stimulation	3.57	7e-13	3.5e-09	51.6	Antagonist
6186	2243	SCN10A	C0022568	Keratitis	4.44	1.2e-09	5.8e-06	37	Antagonist
6186	1213	SCN10A	C0013362	Dysarthria	3.83	3.3e-10	1.6e-06	39.5	Antagonist
6186	2604	SCN10A	C0231530	Muscle twitching	5.09	2e-25	1.9e-21	108.6	Binding
6186	908	SCN10A	C0009421	Coma	3.45	7.1e-10	3.5e-06	38	Antagonist
6186	2629	SCN10A	C0340515	Myocardial depression	5.15	9.3e-15	4.7e-11	60	Antagonist
6186	2604	SCN10A	C0231530	Muscle twitching	3.74	9.5e-11	4.7e-07	41.9	Antagonist
6186	268	SCN10A	C0003578	Apnoea	4.11	4.8e-17	4.4e-13	70.4	Binding
6186	3447	SCN10A	C1145670	Respiratory failure	4.94	2.9e-22	2.7e-18	94.2	Binding
6187	3447	SCN11A	C1145670	Respiratory failure	3.59	8.3e-09	7e-05	33.2	Binding
6187	2629	SCN11A	C0340515	Myocardial depression	5.87	2.2e-18	2e-14	76.5	Binding
6187	3892	SCN11A	C0040264	Tinnitus	2.53	1.6e-07	0.0013	27.5	Binding
6187	2629	SCN11A	C0340515	Myocardial depression	4.5	8.1e-10	4e-06	37.7	Antagonist
6187	3447	SCN11A	C1145670	Respiratory failure	3.15	7.6e-06	0.034	20	Antagonist
6187	4166	SCN11A	C0344232	Vision blurred	2.1	7.8e-09	6.6e-05	33.3	Binding
6187	703	SCN11A	C0018790	Cardiac arrest	3.08	2.7e-06	0.012	22	Antagonist
6187	908	SCN11A	C0009421	Coma	2.99	2.6e-06	0.012	22.1	Antagonist
6187	1530	SCN11A	C0854268	Foetal damage	5.51	1.6e-09	1.4e-05	36.4	Binding
6187	1213	SCN11A	C0013362	Dysarthria	3.18	5.9e-06	0.027	20.5	Antagonist
6187	908	SCN11A	C0009421	Coma	3.26	2.5e-09	2.1e-05	35.6	Binding
6187	3580	SCN11A	C1325847	Sensitisation	4.1	4.7e-07	0.0022	25.4	Antagonist
6187	1964	SCN11A	C0521592	Hypoaesthesia oral	4.29	1.7e-07	0.00083	27.3	Antagonist
6187	1964	SCN11A	C0521592	Hypoaesthesia oral	5.72	3.5e-15	3.2e-11	62	Binding
6187	2604	SCN11A	C0231530	Muscle twitching	3.91	1.9e-11	1.7e-07	45.1	Binding
6187	703	SCN11A	C0018790	Cardiac arrest	3.67	7.8e-11	6.8e-07	42.3	Binding
6187	2369	SCN11A	C0041657	Loss of consciousness	5.08	3e-12	2.6e-08	48.7	Binding
6187	2049	SCN11A	C0151692	Impaired healing	3.93	4.6e-10	4e-06	38.8	Binding
6187	1213	SCN11A	C0013362	Dysarthria	3.32	1.6e-08	0.00013	32	Binding
6187	972	SCN11A	C0036572	Convulsion	1.83	6.4e-06	0.049	20.4	Binding
6187	2713	SCN11A	C0027769	Nervousness	2.36	7.7e-09	6.5e-05	33.3	Binding
6187	1063	SCN11A	C1306577	Death	2.8	1.8e-06	0.014	22.8	Binding
6187	2369	SCN11A	C0041657	Loss of consciousness	3.9	1.4e-06	0.0067	23.2	Antagonist
6187	2517	SCN11A	C0025637	Methaemoglobinaemia	5.11	5e-16	4.6e-12	65.8	Binding
6187	2604	SCN11A	C0231530	Muscle twitching	3.2	1.1e-06	0.005	23.8	Antagonist
6187	2517	SCN11A	C0025637	Methaemoglobinaemia	3.84	7.2e-08	0.00034	29	Antagonist
6187	766	SCN11A	C0151560	Central nervous system stimulation	3.13	1.9e-08	9.4e-05	31.6	Antagonist
6187	268	SCN11A	C0003578	Apnoea	2.99	1.3e-06	0.011	23.4	Binding
6187	3220	SCN11A	C0700200	Presyncope	4.69	1.1e-11	5.7e-08	46.1	Antagonist
6187	3220	SCN11A	C0700200	Presyncope	5.99	1.1e-20	1e-16	87	Binding
6187	2713	SCN11A	C0027769	Nervousness	2.17	8.4e-06	0.038	19.8	Antagonist
6187	766	SCN11A	C0151560	Central nervous system stimulation	3.66	2.3e-13	2e-09	53.8	Binding
6187	985	SCN11A	C0010034	Corneal disorder	5.18	4.4e-11	3.9e-07	43.4	Binding
6187	2243	SCN11A	C0022568	Keratitis	4.67	5.9e-11	5.2e-07	42.8	Binding
6187	3580	SCN11A	C1325847	Sensitisation	5.22	1.1e-12	9.7e-09	50.7	Binding
6188	3220	SCN1A	C0700200	Presyncope	4.48	5.9e-11	2.9e-07	42.9	Antagonist
6188	766	SCN1A	C0151560	Central nervous system stimulation	2.99	8e-08	0.00038	28.8	Antagonist
6188	268	SCN1A	C0003578	Apnoea	2.76	2.4e-08	2e-04	31.1	Binding
6188	2369	SCN1A	C0041657	Loss of consciousness	4.61	7.9e-16	7.3e-12	64.9	Binding
6188	4119	SCN1A	C0595862	Vasodilatation	2.7	5.3e-08	0.00044	29.6	Binding
6188	115	SCN1A	C0085631	Agitation	1.82	5.9e-06	0.046	20.5	Binding
6188	3892	SCN1A	C0040264	Tinnitus	2.47	5.8e-11	5e-07	42.9	Binding
6188	3956	SCN1A	C0040822	Tremor	1.81	3.5e-08	0.00029	30.4	Binding
6188	2369	SCN1A	C0041657	Loss of consciousness	3.72	3.6e-06	0.017	21.4	Antagonist
6188	2049	SCN1A	C0151692	Impaired healing	3.75	2.1e-14	1.9e-10	58.4	Binding
6188	985	SCN1A	C0010034	Corneal disorder	4.48	8.7e-13	7.8e-09	51.1	Binding
6188	3580	SCN1A	C1325847	Sensitisation	4.93	4.4e-18	4.1e-14	75.2	Binding
6188	2243	SCN1A	C0022568	Keratitis	4.24	4.9e-14	4.5e-10	56.8	Binding
6188	703	SCN1A	C0018790	Cardiac arrest	2.94	7.5e-06	0.034	20.1	Antagonist
6188	3580	SCN1A	C1325847	Sensitisation	3.92	1.3e-06	0.0059	23.5	Antagonist
6188	1964	SCN1A	C0521592	Hypoaesthesia oral	5.3	1e-20	9.6e-17	87.1	Binding
6188	3220	SCN1A	C0700200	Presyncope	5.93	3.8e-33	3.6e-29	143.9	Binding
6188	2713	SCN1A	C0027769	Nervousness	2.36	4.5e-14	4.1e-10	56.9	Binding
6188	1213	SCN1A	C0013362	Dysarthria	3.06	6.2e-11	5.4e-07	42.8	Binding
6188	2604	SCN1A	C0231530	Muscle twitching	3.06	3.1e-06	0.014	21.7	Antagonist
6188	1063	SCN1A	C1306577	Death	2.75	1.6e-09	1.4e-05	36.4	Binding
6188	908	SCN1A	C0009421	Coma	2.85	7.5e-06	0.034	20.1	Antagonist
6188	1313	SCN1A	C0085584	Encephalopathy	1.86	4.8e-06	0.037	20.9	Binding
6188	972	SCN1A	C0036572	Convulsion	1.83	3.2e-09	2.7e-05	35.1	Binding
6188	2629	SCN1A	C0340515	Myocardial depression	5.51	6.1e-26	5.8e-22	110.9	Binding
6188	2713	SCN1A	C0027769	Nervousness	2.2	2.9e-06	0.013	21.9	Antagonist
6188	3447	SCN1A	C1145670	Respiratory failure	3.55	1.4e-13	1.3e-09	54.7	Binding
6188	1964	SCN1A	C0521592	Hypoaesthesia oral	4.1	4.9e-07	0.0023	25.3	Antagonist
6188	2517	SCN1A	C0025637	Methaemoglobinaemia	3.92	1.4e-08	6.8e-05	32.2	Antagonist
6188	1530	SCN1A	C0854268	Foetal damage	5.15	2.9e-13	2.6e-09	53.3	Binding
6188	2517	SCN1A	C0025637	Methaemoglobinaemia	4.86	3.7e-23	3.5e-19	98.2	Binding
6188	703	SCN1A	C0018790	Cardiac arrest	3.38	4.8e-14	4.4e-10	56.8	Binding
6188	2604	SCN1A	C0231530	Muscle twitching	3.87	6e-18	5.6e-14	74.5	Binding
6188	4166	SCN1A	C0344232	Vision blurred	2.05	1.2e-12	1e-08	50.6	Binding
6188	766	SCN1A	C0151560	Central nervous system stimulation	3.66	1.3e-21	1.2e-17	91.2	Binding
6188	2629	SCN1A	C0340515	Myocardial depression	4.3	3.2e-09	1.6e-05	35.1	Antagonist
6188	908	SCN1A	C0009421	Coma	3.12	3e-13	2.7e-09	53.2	Binding
6189	2049	SCN1B	C0151692	Impaired healing	4.04	1.6e-11	1.4e-07	45.4	Binding
6189	3447	SCN1B	C1145670	Respiratory failure	3.15	7.6e-06	0.034	20	Antagonist
6189	985	SCN1B	C0010034	Corneal disorder	5.52	1.2e-13	1e-09	55.1	Binding
6189	766	SCN1B	C0151560	Central nervous system stimulation	3.64	3.9e-14	3.5e-10	57.2	Binding
6189	3892	SCN1B	C0040264	Tinnitus	2.51	8e-08	0.00066	28.8	Binding
6189	3580	SCN1B	C1325847	Sensitisation	4.1	4.7e-07	0.0022	25.4	Antagonist
6189	2517	SCN1B	C0025637	Methaemoglobinaemia	3.84	7.2e-08	0.00034	29	Antagonist
6189	766	SCN1B	C0151560	Central nervous system stimulation	3.13	1.9e-08	9.4e-05	31.6	Antagonist
6189	4166	SCN1B	C0344232	Vision blurred	2.12	1e-09	8.5e-06	37.3	Binding
6189	1063	SCN1B	C1306577	Death	2.86	3.1e-07	0.0025	26.2	Binding
6189	2369	SCN1B	C0041657	Loss of consciousness	4.73	3.8e-11	3.3e-07	43.7	Binding
6189	2713	SCN1B	C0027769	Nervousness	2.34	2.9e-09	2.5e-05	35.3	Binding
6189	2604	SCN1B	C0231530	Muscle twitching	3.97	1e-12	9.2e-09	50.8	Binding
6189	908	SCN1B	C0009421	Coma	2.99	2.6e-06	0.012	22.1	Antagonist
6189	3220	SCN1B	C0700200	Presyncope	6.08	5.3e-23	5e-19	97.5	Binding
6189	1530	SCN1B	C0854268	Foetal damage	6.53	7.3e-15	6.7e-11	60.5	Binding
6189	268	SCN1B	C0003578	Apnoea	3.08	1.5e-07	0.0012	27.6	Binding
6189	1964	SCN1B	C0521592	Hypoaesthesia oral	5.96	8e-18	7.5e-14	73.9	Binding
6189	2243	SCN1B	C0022568	Keratitis	4.9	4.7e-13	4.2e-09	52.3	Binding
6189	2604	SCN1B	C0231530	Muscle twitching	3.2	1.1e-06	0.005	23.8	Antagonist
6189	1964	SCN1B	C0521592	Hypoaesthesia oral	4.29	1.7e-07	0.00083	27.3	Antagonist
6189	3220	SCN1B	C0700200	Presyncope	4.69	1.1e-11	5.7e-08	46.1	Antagonist
6189	1213	SCN1B	C0013362	Dysarthria	3.18	5.9e-06	0.027	20.5	Antagonist
6189	3580	SCN1B	C1325847	Sensitisation	5.16	2.9e-13	2.6e-09	53.3	Binding
6189	1213	SCN1B	C0013362	Dysarthria	3.68	9.2e-12	8.1e-08	46.5	Binding
6189	2369	SCN1B	C0041657	Loss of consciousness	3.9	1.4e-06	0.0067	23.2	Antagonist
6189	2629	SCN1B	C0340515	Myocardial depression	5.75	9.7e-19	9.1e-15	78.1	Binding
6189	2713	SCN1B	C0027769	Nervousness	2.17	8.4e-06	0.038	19.8	Antagonist
6189	3447	SCN1B	C1145670	Respiratory failure	3.52	5.9e-09	5e-05	33.9	Binding
6189	703	SCN1B	C0018790	Cardiac arrest	3.08	2.7e-06	0.012	22	Antagonist
6189	2629	SCN1B	C0340515	Myocardial depression	4.5	8.1e-10	4e-06	37.7	Antagonist
6189	908	SCN1B	C0009421	Coma	3.29	3.5e-10	3e-06	39.4	Binding
6189	703	SCN1B	C0018790	Cardiac arrest	3.71	6.3e-12	5.5e-08	47.2	Binding
6189	2517	SCN1B	C0025637	Methaemoglobinaemia	5.21	5.6e-18	5.2e-14	74.7	Binding
6190	2629	SCN2A	C0340515	Myocardial depression	5.66	6.6e-27	6.4e-23	115.3	Binding
6190	2713	SCN2A	C0027769	Nervousness	2.36	1.1e-13	9.8e-10	55.2	Binding
6190	1213	SCN2A	C0013362	Dysarthria	3.15	7.6e-06	0.034	20	Antagonist
6190	2517	SCN2A	C0025637	Methaemoglobinaemia	4.84	2.3e-22	2.2e-18	94.6	Binding
6190	4119	SCN2A	C0595862	Vasodilatation	2.77	2.1e-08	0.00018	31.4	Binding
6190	2517	SCN2A	C0025637	Methaemoglobinaemia	3.8	9.6e-08	0.00046	28.4	Antagonist
6190	4166	SCN2A	C0344232	Vision blurred	2.1	1.4e-13	1.3e-09	54.7	Binding
6190	3892	SCN2A	C0040264	Tinnitus	2.54	1.4e-11	1.2e-07	45.7	Binding
6190	2049	SCN2A	C0151692	Impaired healing	3.86	5.2e-15	4.7e-11	61.2	Binding
6190	1964	SCN2A	C0521592	Hypoaesthesia oral	4.24	2.3e-07	0.0011	26.8	Antagonist
6190	3447	SCN2A	C1145670	Respiratory failure	3.11	9.7e-06	0.043	19.6	Antagonist
6190	703	SCN2A	C0018790	Cardiac arrest	3.47	1.1e-14	1e-10	59.7	Binding
6190	3220	SCN2A	C0700200	Presyncope	6.09	2.3e-34	2.2e-30	149.4	Binding
6190	1964	SCN2A	C0521592	Hypoaesthesia oral	5.44	1.7e-21	1.6e-17	90.6	Binding
6190	766	SCN2A	C0151560	Central nervous system stimulation	3.09	2.8e-08	0.00013	30.8	Antagonist
6190	908	SCN2A	C0009421	Coma	3.21	7.1e-14	6.4e-10	56	Binding
6190	2629	SCN2A	C0340515	Myocardial depression	4.45	1.1e-09	5.6e-06	37.1	Antagonist
6190	115	SCN2A	C0085631	Agitation	1.84	5.1e-06	0.039	20.8	Binding
6190	2604	SCN2A	C0231530	Muscle twitching	3.98	1e-18	9.7e-15	78	Binding
6190	2369	SCN2A	C0041657	Loss of consciousness	4.74	1.9e-16	1.8e-12	67.7	Binding
6190	3580	SCN2A	C1325847	Sensitisation	4.06	6.1e-07	0.0029	24.9	Antagonist
6190	766	SCN2A	C0151560	Central nervous system stimulation	3.76	1.4e-22	1.3e-18	95.6	Binding
6190	908	SCN2A	C0009421	Coma	2.95	3.4e-06	0.016	21.6	Antagonist
6190	985	SCN2A	C0010034	Corneal disorder	4.6	2.8e-13	2.5e-09	53.3	Binding
6190	3220	SCN2A	C0700200	Presyncope	4.63	1.7e-11	8.7e-08	45.2	Antagonist
6190	2604	SCN2A	C0231530	Muscle twitching	3.16	1.4e-06	0.0066	23.3	Antagonist
6190	3447	SCN2A	C1145670	Respiratory failure	3.64	3.6e-14	3.3e-10	57.4	Binding
6190	972	SCN2A	C0036572	Convulsion	1.84	3.4e-09	2.9e-05	34.9	Binding
6190	1530	SCN2A	C0854268	Foetal damage	5.29	9.6e-14	8.7e-10	55.4	Binding
6190	2369	SCN2A	C0041657	Loss of consciousness	3.85	1.8e-06	0.0085	22.8	Antagonist
6190	2243	SCN2A	C0022568	Keratitis	4.36	1.4e-14	1.2e-10	59.3	Binding
6190	3956	SCN2A	C0040822	Tremor	1.8	1e-07	0.00084	28.3	Binding
6190	703	SCN2A	C0018790	Cardiac arrest	3.04	3.5e-06	0.016	21.5	Antagonist
6190	268	SCN2A	C0003578	Apnoea	2.84	9.3e-09	7.8e-05	33	Binding
6190	1063	SCN2A	C1306577	Death	2.82	5.2e-10	4.5e-06	38.6	Binding
6190	1213	SCN2A	C0013362	Dysarthria	3.24	2e-12	1.8e-08	49.4	Binding
6190	3580	SCN2A	C1325847	Sensitisation	5.07	9e-19	8.4e-15	78.3	Binding
6190	2713	SCN2A	C0027769	Nervousness	2.21	3.5e-06	0.016	21.5	Antagonist
6190	1313	SCN2A	C0085584	Encephalopathy	1.88	4.4e-06	0.034	21.1	Binding
6191	3892	SCN2B	C0040264	Tinnitus	2.51	2.1e-07	0.0017	27	Binding
6191	766	SCN2B	C0151560	Central nervous system stimulation	3.63	3.3e-13	3e-09	53	Binding
6191	703	SCN2B	C0018790	Cardiac arrest	3.08	2.7e-06	0.012	22	Antagonist
6191	2629	SCN2B	C0340515	Myocardial depression	5.83	3.4e-18	3.2e-14	75.7	Binding
6191	972	SCN2B	C0036572	Convulsion	1.84	3.6e-06	0.028	21.4	Binding
6191	3220	SCN2B	C0700200	Presyncope	5.94	1.8e-20	1.7e-16	86	Binding
6191	1964	SCN2B	C0521592	Hypoaesthesia oral	5.68	5e-15	4.6e-11	61.2	Binding
6191	1213	SCN2B	C0013362	Dysarthria	3.18	5.9e-06	0.027	20.5	Antagonist
6191	2517	SCN2B	C0025637	Methaemoglobinaemia	3.84	7.2e-08	0.00034	29	Antagonist
6191	2713	SCN2B	C0027769	Nervousness	2.34	1.1e-08	9.2e-05	32.7	Binding
6191	3447	SCN2B	C1145670	Respiratory failure	3.15	7.6e-06	0.034	20	Antagonist
6191	1063	SCN2B	C1306577	Death	2.78	2.3e-06	0.018	22.4	Binding
6191	4166	SCN2B	C0344232	Vision blurred	2.12	3.7e-09	3.2e-05	34.8	Binding
6191	703	SCN2B	C0018790	Cardiac arrest	3.64	1.1e-10	9.3e-07	41.7	Binding
6191	2243	SCN2B	C0022568	Keratitis	4.63	7.8e-11	6.8e-07	42.3	Binding
6191	908	SCN2B	C0009421	Coma	3.23	3.3e-09	2.8e-05	35	Binding
6191	2604	SCN2B	C0231530	Muscle twitching	3.2	1.1e-06	0.005	23.8	Antagonist
6191	985	SCN2B	C0010034	Corneal disorder	5.14	5.8e-11	5e-07	42.9	Binding
6191	2369	SCN2B	C0041657	Loss of consciousness	4.72	1.8e-10	1.6e-06	40.6	Binding
6191	3580	SCN2B	C1325847	Sensitisation	5.17	1.5e-12	1.3e-08	50.1	Binding
6191	3220	SCN2B	C0700200	Presyncope	4.69	1.1e-11	5.7e-08	46.1	Antagonist
6191	2049	SCN2B	C0151692	Impaired healing	3.9	6.1e-10	5.2e-06	38.3	Binding
6191	1530	SCN2B	C0854268	Foetal damage	5.96	2e-11	1.8e-07	45	Binding
6191	3580	SCN2B	C1325847	Sensitisation	4.1	4.7e-07	0.0022	25.4	Antagonist
6191	2629	SCN2B	C0340515	Myocardial depression	4.5	8.1e-10	4e-06	37.7	Antagonist
6191	2517	SCN2B	C0025637	Methaemoglobinaemia	5.07	7.5e-16	7e-12	65	Binding
6191	2713	SCN2B	C0027769	Nervousness	2.17	8.4e-06	0.038	19.8	Antagonist
6191	1213	SCN2B	C0013362	Dysarthria	3.45	1.9e-09	1.6e-05	36.1	Binding
6191	766	SCN2B	C0151560	Central nervous system stimulation	3.13	1.9e-08	9.4e-05	31.6	Antagonist
6191	3447	SCN2B	C1145670	Respiratory failure	3.56	1.1e-08	9e-05	32.7	Binding
6191	2604	SCN2B	C0231530	Muscle twitching	3.88	2.6e-11	2.3e-07	44.4	Binding
6191	908	SCN2B	C0009421	Coma	2.99	2.6e-06	0.012	22.1	Antagonist
6191	268	SCN2B	C0003578	Apnoea	2.96	1.6e-06	0.013	23	Binding
6191	1964	SCN2B	C0521592	Hypoaesthesia oral	4.29	1.7e-07	0.00083	27.3	Antagonist
6191	2369	SCN2B	C0041657	Loss of consciousness	3.9	1.4e-06	0.0067	23.2	Antagonist
6192	703	SCN3A	C0018790	Cardiac arrest	3.08	2.7e-06	0.012	22	Antagonist
6192	3956	SCN3A	C0040822	Tremor	1.79	1.7e-07	0.0014	27.4	Binding
6192	703	SCN3A	C0018790	Cardiac arrest	3.49	7.9e-15	7.2e-11	60.4	Binding
6192	1063	SCN3A	C1306577	Death	2.84	4e-10	3.5e-06	39.1	Binding
6192	2049	SCN3A	C0151692	Impaired healing	3.88	3.7e-15	3.4e-11	61.8	Binding
6192	2713	SCN3A	C0027769	Nervousness	2.17	8.4e-06	0.038	19.8	Antagonist
6192	2604	SCN3A	C0231530	Muscle twitching	3.2	1.1e-06	0.005	23.8	Antagonist
6192	3220	SCN3A	C0700200	Presyncope	4.69	1.1e-11	5.7e-08	46.1	Antagonist
6192	3220	SCN3A	C0700200	Presyncope	6.13	1.2e-34	1.2e-30	150.7	Binding
6192	766	SCN3A	C0151560	Central nervous system stimulation	3.13	1.9e-08	9.4e-05	31.6	Antagonist
6192	4166	SCN3A	C0344232	Vision blurred	2.09	2.7e-13	2.4e-09	53.4	Binding
6192	1964	SCN3A	C0521592	Hypoaesthesia oral	5.48	1.1e-21	1.1e-17	91.5	Binding
6192	3580	SCN3A	C1325847	Sensitisation	5.1	6.2e-19	5.8e-15	79	Binding
6192	3892	SCN3A	C0040264	Tinnitus	2.56	9.8e-12	8.6e-08	46.4	Binding
6192	2369	SCN3A	C0041657	Loss of consciousness	4.77	1.4e-16	1.3e-12	68.3	Binding
6192	4119	SCN3A	C0595862	Vasodilatation	2.79	1.7e-08	0.00014	31.8	Binding
6192	1964	SCN3A	C0521592	Hypoaesthesia oral	4.29	1.7e-07	0.00083	27.3	Antagonist
6192	2713	SCN3A	C0027769	Nervousness	2.34	2.8e-13	2.5e-09	53.3	Binding
6192	1213	SCN3A	C0013362	Dysarthria	3.16	1.4e-11	1.2e-07	45.7	Binding
6192	2517	SCN3A	C0025637	Methaemoglobinaemia	3.84	7.2e-08	0.00034	29	Antagonist
6192	908	SCN3A	C0009421	Coma	2.99	2.6e-06	0.012	22.1	Antagonist
6192	3447	SCN3A	C1145670	Respiratory failure	3.67	2.6e-14	2.4e-10	58	Binding
6192	2629	SCN3A	C0340515	Myocardial depression	4.5	8.1e-10	4e-06	37.7	Antagonist
6192	972	SCN3A	C0036572	Convulsion	1.84	5.6e-09	4.8e-05	34	Binding
6192	1213	SCN3A	C0013362	Dysarthria	3.18	5.9e-06	0.027	20.5	Antagonist
6192	2629	SCN3A	C0340515	Myocardial depression	5.7	3.9e-27	3.8e-23	116.4	Binding
6192	3580	SCN3A	C1325847	Sensitisation	4.1	4.7e-07	0.0022	25.4	Antagonist
6192	1530	SCN3A	C0854268	Foetal damage	5.33	7.4e-14	6.7e-10	56	Binding
6192	985	SCN3A	C0010034	Corneal disorder	4.63	2.2e-13	1.9e-09	53.9	Binding
6192	115	SCN3A	C0085631	Agitation	1.85	4e-06	0.031	21.3	Binding
6192	3447	SCN3A	C1145670	Respiratory failure	3.15	7.6e-06	0.034	20	Antagonist
6192	1313	SCN3A	C0085584	Encephalopathy	1.89	3.5e-06	0.027	21.5	Binding
6192	766	SCN3A	C0151560	Central nervous system stimulation	3.79	8.2e-23	7.8e-19	96.7	Binding
6192	2243	SCN3A	C0022568	Keratitis	4.38	1e-14	9.1e-11	59.9	Binding
6192	2604	SCN3A	C0231530	Muscle twitching	4	6.8e-19	6.4e-15	78.8	Binding
6192	908	SCN3A	C0009421	Coma	3.23	5e-14	4.5e-10	56.7	Binding
6192	2369	SCN3A	C0041657	Loss of consciousness	3.9	1.4e-06	0.0067	23.2	Antagonist
6192	2517	SCN3A	C0025637	Methaemoglobinaemia	4.87	1.5e-22	1.4e-18	95.5	Binding
6192	268	SCN3A	C0003578	Apnoea	2.85	7.4e-09	6.3e-05	33.4	Binding
12232	3447	SCN3B	C1145670	Respiratory failure	3.52	5.9e-09	5e-05	33.9	Binding
12232	2629	SCN3B	C0340515	Myocardial depression	5.75	9.7e-19	9.1e-15	78.1	Binding
12232	2713	SCN3B	C0027769	Nervousness	2.17	8.4e-06	0.038	19.8	Antagonist
12232	703	SCN3B	C0018790	Cardiac arrest	3.08	2.7e-06	0.012	22	Antagonist
12232	908	SCN3B	C0009421	Coma	3.29	3.5e-10	3e-06	39.4	Binding
12232	703	SCN3B	C0018790	Cardiac arrest	3.71	6.3e-12	5.5e-08	47.2	Binding
12232	766	SCN3B	C0151560	Central nervous system stimulation	3.64	3.9e-14	3.5e-10	57.2	Binding
12232	4166	SCN3B	C0344232	Vision blurred	2.12	1e-09	8.5e-06	37.3	Binding
12232	268	SCN3B	C0003578	Apnoea	3.08	1.5e-07	0.0012	27.6	Binding
12232	2049	SCN3B	C0151692	Impaired healing	4.04	1.6e-11	1.4e-07	45.4	Binding
12232	2243	SCN3B	C0022568	Keratitis	4.9	4.7e-13	4.2e-09	52.3	Binding
12232	1530	SCN3B	C0854268	Foetal damage	6.53	7.3e-15	6.7e-11	60.5	Binding
12232	2713	SCN3B	C0027769	Nervousness	2.34	2.9e-09	2.5e-05	35.3	Binding
12232	2604	SCN3B	C0231530	Muscle twitching	3.2	1.1e-06	0.005	23.8	Antagonist
12232	908	SCN3B	C0009421	Coma	2.99	2.6e-06	0.012	22.1	Antagonist
12232	3580	SCN3B	C1325847	Sensitisation	5.16	2.9e-13	2.6e-09	53.3	Binding
12232	1213	SCN3B	C0013362	Dysarthria	3.68	9.2e-12	8.1e-08	46.5	Binding
12232	2604	SCN3B	C0231530	Muscle twitching	3.97	1e-12	9.2e-09	50.8	Binding
12232	2369	SCN3B	C0041657	Loss of consciousness	4.73	3.8e-11	3.3e-07	43.7	Binding
12232	2517	SCN3B	C0025637	Methaemoglobinaemia	5.21	5.6e-18	5.2e-14	74.7	Binding
12232	3220	SCN3B	C0700200	Presyncope	4.69	1.1e-11	5.7e-08	46.1	Antagonist
12232	1063	SCN3B	C1306577	Death	2.86	3.1e-07	0.0025	26.2	Binding
12232	766	SCN3B	C0151560	Central nervous system stimulation	3.13	1.9e-08	9.4e-05	31.6	Antagonist
12232	1213	SCN3B	C0013362	Dysarthria	3.18	5.9e-06	0.027	20.5	Antagonist
12232	985	SCN3B	C0010034	Corneal disorder	5.52	1.2e-13	1e-09	55.1	Binding
12232	2369	SCN3B	C0041657	Loss of consciousness	3.9	1.4e-06	0.0067	23.2	Antagonist
12232	3892	SCN3B	C0040264	Tinnitus	2.51	8e-08	0.00066	28.8	Binding
12232	1964	SCN3B	C0521592	Hypoaesthesia oral	5.96	8e-18	7.5e-14	73.9	Binding
12232	3447	SCN3B	C1145670	Respiratory failure	3.15	7.6e-06	0.034	20	Antagonist
12232	1964	SCN3B	C0521592	Hypoaesthesia oral	4.29	1.7e-07	0.00083	27.3	Antagonist
12232	3580	SCN3B	C1325847	Sensitisation	4.1	4.7e-07	0.0022	25.4	Antagonist
12232	2629	SCN3B	C0340515	Myocardial depression	4.5	8.1e-10	4e-06	37.7	Antagonist
12232	3220	SCN3B	C0700200	Presyncope	6.08	5.3e-23	5e-19	97.5	Binding
12232	2517	SCN3B	C0025637	Methaemoglobinaemia	3.84	7.2e-08	0.00034	29	Antagonist
6193	3220	SCN4A	C0700200	Presyncope	5.92	3.4e-22	3.2e-18	93.9	Binding
6193	2713	SCN4A	C0027769	Nervousness	2.33	2.6e-09	2.2e-05	35.5	Binding
6193	3892	SCN4A	C0040264	Tinnitus	2.44	2.1e-07	0.0017	27	Binding
6193	3580	SCN4A	C1325847	Sensitisation	4.08	5.3e-07	0.0025	25.1	Antagonist
6193	2604	SCN4A	C0231530	Muscle twitching	3.18	1.2e-06	0.0057	23.5	Antagonist
6193	766	SCN4A	C0151560	Central nervous system stimulation	3.11	2.3e-08	0.00011	31.2	Antagonist
6193	972	SCN4A	C0036572	Convulsion	1.8	3.9e-06	0.031	21.3	Binding
6193	2713	SCN4A	C0027769	Nervousness	2.16	9.8e-06	0.044	19.5	Antagonist
6193	3580	SCN4A	C1325847	Sensitisation	5.02	8.6e-13	7.7e-09	51.1	Binding
6193	766	SCN4A	C0151560	Central nervous system stimulation	3.54	1.5e-13	1.4e-09	54.5	Binding
6193	1213	SCN4A	C0013362	Dysarthria	3.58	2.8e-11	2.5e-07	44.3	Binding
6193	3447	SCN4A	C1145670	Respiratory failure	3.43	1.4e-08	0.00012	32.2	Binding
6193	908	SCN4A	C0009421	Coma	2.97	3e-06	0.014	21.8	Antagonist
6193	2369	SCN4A	C0041657	Loss of consciousness	4.6	9.7e-11	8.5e-07	41.9	Binding
6193	703	SCN4A	C0018790	Cardiac arrest	3.61	2e-11	1.7e-07	45	Binding
6193	1213	SCN4A	C0013362	Dysarthria	3.17	6.7e-06	0.03	20.3	Antagonist
6193	1063	SCN4A	C1306577	Death	2.78	6.7e-07	0.0053	24.7	Binding
6193	985	SCN4A	C0010034	Corneal disorder	5.37	3.5e-13	3.1e-09	52.9	Binding
6193	4166	SCN4A	C0344232	Vision blurred	1.94	5.2e-06	0.024	20.8	Antagonist
6193	3220	SCN4A	C0700200	Presyncope	4.66	1.4e-11	6.9e-08	45.7	Antagonist
6193	268	SCN4A	C0003578	Apnoea	2.99	3.2e-07	0.0026	26.1	Binding
6193	2629	SCN4A	C0340515	Myocardial depression	4.48	9.5e-10	4.7e-06	37.4	Antagonist
6193	908	SCN4A	C0009421	Coma	3.2	9.7e-10	8.3e-06	37.4	Binding
6193	703	SCN4A	C0018790	Cardiac arrest	3.06	3.1e-06	0.014	21.8	Antagonist
6193	2629	SCN4A	C0340515	Myocardial depression	5.59	4.5e-18	4.2e-14	75.1	Binding
6193	4166	SCN4A	C0344232	Vision blurred	2.16	1.4e-10	1.2e-06	41.2	Binding
6193	3447	SCN4A	C1145670	Respiratory failure	3.13	8.5e-06	0.038	19.8	Antagonist
6193	1964	SCN4A	C0521592	Hypoaesthesia oral	5.8	3.3e-17	3.1e-13	71.1	Binding
6193	2517	SCN4A	C0025637	Methaemoglobinaemia	5.07	2.5e-17	2.4e-13	71.7	Binding
6193	1964	SCN4A	C0521592	Hypoaesthesia oral	4.27	2e-07	0.00094	27.1	Antagonist
6193	2604	SCN4A	C0231530	Muscle twitching	3.86	3.3e-12	3e-08	48.5	Binding
6193	2369	SCN4A	C0041657	Loss of consciousness	3.88	1.6e-06	0.0075	23	Antagonist
6193	2049	SCN4A	C0151692	Impaired healing	3.93	4.5e-11	4e-07	43.4	Binding
6193	1530	SCN4A	C0854268	Foetal damage	6.35	2.3e-14	2.1e-10	58.3	Binding
6193	2243	SCN4A	C0022568	Keratitis	4.76	1.4e-12	1.3e-08	50.2	Binding
6193	2517	SCN4A	C0025637	Methaemoglobinaemia	3.82	8.2e-08	0.00039	28.8	Antagonist
6194	3892	SCN4B	C0040264	Tinnitus	2.46	6.2e-07	0.005	24.8	Binding
6194	972	SCN4B	C0036572	Convulsion	1.83	5.4e-06	0.042	20.7	Binding
6194	908	SCN4B	C0009421	Coma	2.99	2.6e-06	0.012	22.1	Antagonist
6194	2369	SCN4B	C0041657	Loss of consciousness	4.79	1.2e-10	1.1e-06	41.4	Binding
6194	3220	SCN4B	C0700200	Presyncope	4.69	1.1e-11	5.7e-08	46.1	Antagonist
6194	4166	SCN4B	C0344232	Vision blurred	2.11	6.2e-09	5.3e-05	33.8	Binding
6194	1964	SCN4B	C0521592	Hypoaesthesia oral	4.29	1.7e-07	0.00083	27.3	Antagonist
6194	2604	SCN4B	C0231530	Muscle twitching	3.2	1.1e-06	0.005	23.8	Antagonist
6194	2049	SCN4B	C0151692	Impaired healing	3.74	6.7e-09	5.6e-05	33.6	Binding
6194	703	SCN4B	C0018790	Cardiac arrest	3.53	8.9e-10	7.6e-06	37.6	Binding
6194	2369	SCN4B	C0041657	Loss of consciousness	3.9	1.4e-06	0.0067	23.2	Antagonist
6194	3220	SCN4B	C0700200	Presyncope	5.74	1e-18	9.6e-15	78	Binding
6194	985	SCN4B	C0010034	Corneal disorder	4.84	2e-09	1.7e-05	36	Binding
6194	2604	SCN4B	C0231530	Muscle twitching	3.75	2.7e-10	2.3e-06	39.9	Binding
6194	3447	SCN4B	C1145670	Respiratory failure	3.15	7.6e-06	0.034	20	Antagonist
6194	1213	SCN4B	C0013362	Dysarthria	3.33	1.4e-08	0.00011	32.2	Binding
6194	2243	SCN4B	C0022568	Keratitis	4.4	1.7e-09	1.4e-05	36.3	Binding
6194	2629	SCN4B	C0340515	Myocardial depression	5.61	1.8e-16	1.7e-12	67.8	Binding
6194	1530	SCN4B	C0854268	Foetal damage	5.53	1.4e-09	1.2e-05	36.7	Binding
6194	3580	SCN4B	C1325847	Sensitisation	4.91	5e-11	4.4e-07	43.2	Binding
6194	1213	SCN4B	C0013362	Dysarthria	3.18	5.9e-06	0.027	20.5	Antagonist
6194	766	SCN4B	C0151560	Central nervous system stimulation	3.55	2.5e-12	2.2e-08	49.1	Binding
6194	2713	SCN4B	C0027769	Nervousness	2.17	8.4e-06	0.038	19.8	Antagonist
6194	3447	SCN4B	C1145670	Respiratory failure	3.42	8.9e-08	0.00073	28.6	Binding
6194	3580	SCN4B	C1325847	Sensitisation	4.1	4.7e-07	0.0022	25.4	Antagonist
6194	2713	SCN4B	C0027769	Nervousness	2.31	2.5e-08	0.00021	31.1	Binding
6194	1964	SCN4B	C0521592	Hypoaesthesia oral	5.41	2.6e-13	2.3e-09	53.5	Binding
6194	908	SCN4B	C0009421	Coma	3.14	1.9e-08	0.00016	31.6	Binding
6194	2517	SCN4B	C0025637	Methaemoglobinaemia	4.89	2.1e-14	1.9e-10	58.4	Binding
6194	703	SCN4B	C0018790	Cardiac arrest	3.08	2.7e-06	0.012	22	Antagonist
6194	766	SCN4B	C0151560	Central nervous system stimulation	3.13	1.9e-08	9.4e-05	31.6	Antagonist
6194	2517	SCN4B	C0025637	Methaemoglobinaemia	3.84	7.2e-08	0.00034	29	Antagonist
6194	2629	SCN4B	C0340515	Myocardial depression	4.5	8.1e-10	4e-06	37.7	Antagonist
6195	2769	SCN5A	C0028738	Nystagmus	3.13	4e-07	0.0032	25.7	Binding
6195	1964	SCN5A	C0521592	Hypoaesthesia oral	3.79	8.4e-07	0.004	24.3	Antagonist
6195	268	SCN5A	C0003578	Apnoea	2.77	1.2e-07	0.00098	28	Binding
6195	2369	SCN5A	C0041657	Loss of consciousness	3.88	2.1e-09	1.8e-05	35.9	Binding
6195	3892	SCN5A	C0040264	Tinnitus	2.22	3.7e-07	0.003	25.8	Binding
6195	1213	SCN5A	C0013362	Dysarthria	3.54	2.5e-14	2.3e-10	58.1	Binding
6195	3956	SCN5A	C0040822	Tremor	1.72	4.6e-06	0.036	21	Binding
6195	2629	SCN5A	C0340515	Myocardial depression	4.58	4.7e-15	4.3e-11	61.4	Binding
6195	3220	SCN5A	C0700200	Presyncope	4.05	4.9e-10	2.4e-06	38.7	Antagonist
6195	3220	SCN5A	C0700200	Presyncope	4.98	9.4e-20	8.9e-16	82.7	Binding
6195	2243	SCN5A	C0022568	Keratitis	4.16	5e-12	4.4e-08	47.7	Binding
6195	766	SCN5A	C0151560	Central nervous system stimulation	2.91	1.4e-10	1.3e-06	41.1	Binding
6195	2604	SCN5A	C0231530	Muscle twitching	3.37	2.1e-11	1.9e-07	44.8	Binding
6195	1153	SCN5A	C0012569	Diplopia	3.55	3.4e-13	3.1e-09	53	Binding
6195	2713	SCN5A	C0027769	Nervousness	2.14	2.9e-09	2.4e-05	35.3	Binding
6195	703	SCN5A	C0018790	Cardiac arrest	2.96	8.6e-07	0.004	24.2	Antagonist
6195	2517	SCN5A	C0025637	Methaemoglobinaemia	3.35	8.4e-07	0.0039	24.3	Antagonist
6195	3447	SCN5A	C1145670	Respiratory failure	2.95	1.2e-07	0.001	28	Binding
6195	1213	SCN5A	C0013362	Dysarthria	3.29	1e-07	0.00049	28.3	Antagonist
6195	1964	SCN5A	C0521592	Hypoaesthesia oral	5.02	2.1e-16	2e-12	67.5	Binding
6195	703	SCN5A	C0018790	Cardiac arrest	3.46	1.9e-13	1.7e-09	54.1	Binding
6195	2517	SCN5A	C0025637	Methaemoglobinaemia	4.29	2.1e-15	2e-11	62.9	Binding
6195	3580	SCN5A	C1325847	Sensitisation	4.2	4.1e-11	3.6e-07	43.6	Binding
6195	908	SCN5A	C0009421	Coma	2.85	1.2e-06	0.0056	23.6	Antagonist
6195	2604	SCN5A	C0231530	Muscle twitching	2.92	2.3e-06	0.011	22.3	Antagonist
6195	985	SCN5A	C0010034	Corneal disorder	4.77	2.8e-13	2.5e-09	53.4	Binding
6195	2049	SCN5A	C0151692	Impaired healing	3.51	6.5e-11	5.6e-07	42.7	Binding
6195	766	SCN5A	C0151560	Central nervous system stimulation	2.67	1.2e-06	0.0055	23.6	Antagonist
6195	908	SCN5A	C0009421	Coma	2.95	3.2e-10	2.7e-06	39.6	Binding
6195	4139	SCN5A	C0042510	Ventricular fibrillation	5.97	1.5e-10	1.3e-06	41	Binding
6195	4166	SCN5A	C0344232	Vision blurred	1.91	6.4e-09	5.4e-05	33.7	Binding
6195	1063	SCN5A	C1306577	Death	2.54	6.5e-07	0.0052	24.8	Binding
6195	1530	SCN5A	C0854268	Foetal damage	5.1	1.4e-11	1.2e-07	45.7	Binding
6195	2629	SCN5A	C0340515	Myocardial depression	3.67	2.2e-07	0.001	26.8	Antagonist
6196	2517	SCN7A	C0025637	Methaemoglobinaemia	5.2	6.5e-18	6e-14	74.4	Binding
6196	703	SCN7A	C0018790	Cardiac arrest	3.07	2.9e-06	0.013	21.9	Antagonist
6196	2629	SCN7A	C0340515	Myocardial depression	5.73	1.1e-18	1.1e-14	77.8	Binding
6196	985	SCN7A	C0010034	Corneal disorder	5.5	1.3e-13	1.2e-09	54.9	Binding
6196	3220	SCN7A	C0700200	Presyncope	4.67	1.3e-11	6.5e-08	45.8	Antagonist
6196	3892	SCN7A	C0040264	Tinnitus	2.51	8.8e-08	0.00072	28.6	Binding
6196	2517	SCN7A	C0025637	Methaemoglobinaemia	3.83	7.8e-08	0.00038	28.8	Antagonist
6196	3580	SCN7A	C1325847	Sensitisation	5.15	3.2e-13	2.9e-09	53.1	Binding
6196	2049	SCN7A	C0151692	Impaired healing	4.03	1.8e-11	1.5e-07	45.2	Binding
6196	3447	SCN7A	C1145670	Respiratory failure	3.51	6.4e-09	5.4e-05	33.7	Binding
6196	1964	SCN7A	C0521592	Hypoaesthesia oral	5.94	9.2e-18	8.5e-14	73.7	Binding
6196	2713	SCN7A	C0027769	Nervousness	2.16	9.3e-06	0.042	19.6	Antagonist
6196	2369	SCN7A	C0041657	Loss of consciousness	3.88	1.5e-06	0.0072	23.1	Antagonist
6196	3580	SCN7A	C1325847	Sensitisation	4.09	5.1e-07	0.0024	25.2	Antagonist
6196	2604	SCN7A	C0231530	Muscle twitching	3.96	1.1e-12	1e-08	50.6	Binding
6196	3447	SCN7A	C1145670	Respiratory failure	3.13	8.2e-06	0.037	19.9	Antagonist
6196	2713	SCN7A	C0027769	Nervousness	2.34	3.2e-09	2.7e-05	35	Binding
6196	2629	SCN7A	C0340515	Myocardial depression	4.49	9e-10	4.4e-06	37.5	Antagonist
6196	2369	SCN7A	C0041657	Loss of consciousness	4.72	4.2e-11	3.6e-07	43.5	Binding
6196	703	SCN7A	C0018790	Cardiac arrest	3.7	7e-12	6.2e-08	47	Binding
6196	908	SCN7A	C0009421	Coma	3.28	3.8e-10	3.3e-06	39.2	Binding
6196	766	SCN7A	C0151560	Central nervous system stimulation	3.63	4.4e-14	4e-10	57	Binding
6196	1213	SCN7A	C0013362	Dysarthria	3.17	6.4e-06	0.029	20.4	Antagonist
6196	3220	SCN7A	C0700200	Presyncope	6.07	6.3e-23	6e-19	97.2	Binding
6196	1213	SCN7A	C0013362	Dysarthria	3.67	1e-11	9e-08	46.3	Binding
6196	766	SCN7A	C0151560	Central nervous system stimulation	3.12	2.2e-08	1e-04	31.3	Antagonist
6196	2243	SCN7A	C0022568	Keratitis	4.88	5.3e-13	4.7e-09	52.1	Binding
6196	268	SCN7A	C0003578	Apnoea	3.07	1.6e-07	0.0013	27.5	Binding
6196	1530	SCN7A	C0854268	Foetal damage	6.51	8.1e-15	7.4e-11	60.3	Binding
6196	1063	SCN7A	C1306577	Death	2.85	3.3e-07	0.0027	26.1	Binding
6196	2604	SCN7A	C0231530	Muscle twitching	3.19	1.2e-06	0.0055	23.6	Antagonist
6196	908	SCN7A	C0009421	Coma	2.98	2.8e-06	0.013	21.9	Antagonist
6196	4166	SCN7A	C0344232	Vision blurred	2.12	1.1e-09	9.8e-06	37.1	Binding
6196	1964	SCN7A	C0521592	Hypoaesthesia oral	4.28	1.9e-07	9e-04	27.2	Antagonist
6197	1213	SCN8A	C0013362	Dysarthria	3.18	5.9e-06	0.027	20.5	Antagonist
6197	3447	SCN8A	C1145670	Respiratory failure	3.15	7.6e-06	0.034	20	Antagonist
6197	908	SCN8A	C0009421	Coma	3.26	2.8e-14	2.5e-10	57.9	Binding
6197	2243	SCN8A	C0022568	Keratitis	4.43	5.9e-15	5.4e-11	60.9	Binding
6197	2517	SCN8A	C0025637	Methaemoglobinaemia	4.92	6.7e-23	6.4e-19	97.1	Binding
6197	3580	SCN8A	C1325847	Sensitisation	4.1	4.7e-07	0.0022	25.4	Antagonist
6197	2713	SCN8A	C0027769	Nervousness	2.17	8.4e-06	0.038	19.8	Antagonist
6197	3892	SCN8A	C0040264	Tinnitus	2.58	5.4e-12	4.8e-08	47.5	Binding
6197	4119	SCN8A	C0595862	Vasodilatation	2.82	1.2e-08	9.8e-05	32.5	Binding
6197	3956	SCN8A	C0040822	Tremor	1.78	2.2e-07	0.0018	26.8	Binding
6197	703	SCN8A	C0018790	Cardiac arrest	3.08	2.7e-06	0.012	22	Antagonist
6197	2517	SCN8A	C0025637	Methaemoglobinaemia	3.84	7.2e-08	0.00034	29	Antagonist
6197	703	SCN8A	C0018790	Cardiac arrest	3.53	4.3e-15	4e-11	61.5	Binding
6197	2369	SCN8A	C0041657	Loss of consciousness	3.9	1.4e-06	0.0067	23.2	Antagonist
6197	1530	SCN8A	C0854268	Foetal damage	5.38	4.7e-14	4.3e-10	56.8	Binding
6197	766	SCN8A	C0151560	Central nervous system stimulation	3.83	3.3e-23	3.1e-19	98.5	Binding
6197	2369	SCN8A	C0041657	Loss of consciousness	4.82	7.8e-17	7.2e-13	69.5	Binding
6197	2629	SCN8A	C0340515	Myocardial depression	4.5	8.1e-10	4e-06	37.7	Antagonist
6197	2604	SCN8A	C0231530	Muscle twitching	4.04	3.3e-19	3.1e-15	80.2	Binding
6197	2049	SCN8A	C0151692	Impaired healing	3.92	2.1e-15	1.9e-11	63	Binding
6197	3220	SCN8A	C0700200	Presyncope	6.19	3.8e-35	3.7e-31	153	Binding
6197	2604	SCN8A	C0231530	Muscle twitching	3.2	1.1e-06	0.005	23.8	Antagonist
6197	2713	SCN8A	C0027769	Nervousness	2.37	1.3e-13	1.2e-09	54.8	Binding
6197	972	SCN8A	C0036572	Convulsion	1.86	2.9e-09	2.5e-05	35.2	Binding
6197	3447	SCN8A	C1145670	Respiratory failure	3.71	1.5e-14	1.4e-10	59.1	Binding
6197	2629	SCN8A	C0340515	Myocardial depression	5.76	1.6e-27	1.5e-23	118.2	Binding
6197	985	SCN8A	C0010034	Corneal disorder	4.68	1.4e-13	1.2e-09	54.8	Binding
6197	3220	SCN8A	C0700200	Presyncope	4.69	1.1e-11	5.7e-08	46.1	Antagonist
6197	908	SCN8A	C0009421	Coma	2.99	2.6e-06	0.012	22.1	Antagonist
6197	1964	SCN8A	C0521592	Hypoaesthesia oral	4.29	1.7e-07	0.00083	27.3	Antagonist
6197	1313	SCN8A	C0085584	Encephalopathy	1.87	5.9e-06	0.046	20.5	Binding
6197	1063	SCN8A	C1306577	Death	2.87	2.6e-10	2.2e-06	40	Binding
6197	115	SCN8A	C0085631	Agitation	1.87	2.7e-06	0.021	22	Binding
6197	766	SCN8A	C0151560	Central nervous system stimulation	3.13	1.9e-08	9.4e-05	31.6	Antagonist
6197	1964	SCN8A	C0521592	Hypoaesthesia oral	5.53	5.5e-22	5.2e-18	92.9	Binding
6197	3580	SCN8A	C1325847	Sensitisation	5.15	3.2e-19	3.1e-15	80.3	Binding
6197	268	SCN8A	C0003578	Apnoea	2.88	5e-09	4.3e-05	34.2	Binding
6197	4166	SCN8A	C0344232	Vision blurred	2.12	1.2e-13	1.1e-09	55	Binding
6197	1213	SCN8A	C0013362	Dysarthria	3.2	8.7e-12	7.7e-08	46.6	Binding
6198	3220	SCN9A	C0700200	Presyncope	4.69	1.1e-11	5.7e-08	46.1	Antagonist
6198	3892	SCN9A	C0040264	Tinnitus	2.4	1.4e-06	0.011	23.3	Binding
6198	2604	SCN9A	C0231530	Muscle twitching	3.2	1.1e-06	0.005	23.8	Antagonist
6198	766	SCN9A	C0151560	Central nervous system stimulation	3.46	7.8e-12	6.9e-08	46.8	Binding
6198	972	SCN9A	C0036572	Convulsion	1.82	6e-06	0.046	20.5	Binding
6198	703	SCN9A	C0018790	Cardiac arrest	3.08	2.7e-06	0.012	22	Antagonist
6198	3447	SCN9A	C1145670	Respiratory failure	3.33	1.8e-07	0.0015	27.2	Binding
6198	2517	SCN9A	C0025637	Methaemoglobinaemia	4.76	6.8e-14	6.1e-10	56.1	Binding
6198	908	SCN9A	C0009421	Coma	2.99	2.6e-06	0.012	22.1	Antagonist
6198	2713	SCN9A	C0027769	Nervousness	2.25	7.1e-08	0.00058	29.1	Binding
6198	3580	SCN9A	C1325847	Sensitisation	4.1	4.7e-07	0.0022	25.4	Antagonist
6198	2243	SCN9A	C0022568	Keratitis	4.29	3.6e-09	3.1e-05	34.8	Binding
6198	1213	SCN9A	C0013362	Dysarthria	3.25	3e-08	0.00025	30.7	Binding
6198	4166	SCN9A	C0344232	Vision blurred	2.12	2.3e-09	2e-05	35.7	Binding
6198	2369	SCN9A	C0041657	Loss of consciousness	4.66	2.8e-10	2.4e-06	39.8	Binding
6198	2713	SCN9A	C0027769	Nervousness	2.17	8.4e-06	0.038	19.8	Antagonist
6198	2629	SCN9A	C0340515	Myocardial depression	5.46	6.5e-16	6e-12	65.3	Binding
6198	1964	SCN9A	C0521592	Hypoaesthesia oral	4.29	1.7e-07	0.00083	27.3	Antagonist
6198	1964	SCN9A	C0521592	Hypoaesthesia oral	5.27	7.2e-13	6.4e-09	51.5	Binding
6198	3447	SCN9A	C1145670	Respiratory failure	3.15	7.6e-06	0.034	20	Antagonist
6198	2604	SCN9A	C0231530	Muscle twitching	3.65	6.7e-10	5.8e-06	38.1	Binding
6198	703	SCN9A	C0018790	Cardiac arrest	3.43	2.2e-09	1.8e-05	35.8	Binding
6198	985	SCN9A	C0010034	Corneal disorder	4.71	4.1e-09	3.5e-05	34.6	Binding
6198	2629	SCN9A	C0340515	Myocardial depression	4.5	8.1e-10	4e-06	37.7	Antagonist
6198	908	SCN9A	C0009421	Coma	3.06	4.3e-08	0.00036	30	Binding
6198	3220	SCN9A	C0700200	Presyncope	5.59	4.4e-18	4.1e-14	75.2	Binding
6198	3580	SCN9A	C1325847	Sensitisation	4.79	1.2e-10	1e-06	41.5	Binding
6198	2049	SCN9A	C0151692	Impaired healing	3.64	1.4e-08	0.00012	32.1	Binding
6198	1213	SCN9A	C0013362	Dysarthria	3.18	5.9e-06	0.027	20.5	Antagonist
6198	2517	SCN9A	C0025637	Methaemoglobinaemia	3.84	7.2e-08	0.00034	29	Antagonist
6198	2369	SCN9A	C0041657	Loss of consciousness	3.9	1.4e-06	0.0067	23.2	Antagonist
6198	1530	SCN9A	C0854268	Foetal damage	5.39	2.8e-09	2.4e-05	35.3	Binding
6198	766	SCN9A	C0151560	Central nervous system stimulation	3.13	1.9e-08	9.4e-05	31.6	Antagonist
6199	1213	SCNN1A	C0013362	Dysarthria	3.15	7.5e-06	0.034	20.1	Antagonist
6199	908	SCNN1A	C0009421	Coma	2.96	3.4e-06	0.016	21.6	Antagonist
6199	4166	SCNN1A	C0344232	Vision blurred	2.08	1.8e-08	0.00015	31.7	Binding
6199	3580	SCNN1A	C1325847	Sensitisation	4.06	6.1e-07	0.0029	24.9	Antagonist
6199	1213	SCNN1A	C0013362	Dysarthria	3.18	1.3e-07	0.001	27.9	Binding
6199	2604	SCNN1A	C0231530	Muscle twitching	3.16	1.4e-06	0.0066	23.3	Antagonist
6199	2369	SCNN1A	C0041657	Loss of consciousness	4.79	1.2e-10	1e-06	41.5	Binding
6199	2604	SCNN1A	C0231530	Muscle twitching	3.75	2.6e-10	2.2e-06	40	Binding
6199	2517	SCNN1A	C0025637	Methaemoglobinaemia	4.9	2e-14	1.8e-10	58.5	Binding
6199	1964	SCNN1A	C0521592	Hypoaesthesia oral	4.24	2.2e-07	0.0011	26.8	Antagonist
6199	703	SCNN1A	C0018790	Cardiac arrest	3.53	8.4e-10	7.2e-06	37.7	Binding
6199	2243	SCNN1A	C0022568	Keratitis	4.41	1.6e-09	1.4e-05	36.4	Binding
6199	703	SCNN1A	C0018790	Cardiac arrest	3.04	3.5e-06	0.016	21.5	Antagonist
6199	2049	SCNN1A	C0151692	Impaired healing	3.74	6.4e-09	5.4e-05	33.7	Binding
6199	1964	SCNN1A	C0521592	Hypoaesthesia oral	5.42	2.4e-13	2.2e-09	53.6	Binding
6199	766	SCNN1A	C0151560	Central nervous system stimulation	3.1	2.8e-08	0.00013	30.9	Antagonist
6199	985	SCNN1A	C0010034	Corneal disorder	4.84	1.9e-09	1.6e-05	36.1	Binding
6199	766	SCNN1A	C0151560	Central nervous system stimulation	3.55	2.3e-12	2.1e-08	49.2	Binding
6199	3220	SCNN1A	C0700200	Presyncope	5.75	9.4e-19	8.8e-15	78.2	Binding
6199	2369	SCNN1A	C0041657	Loss of consciousness	3.85	1.8e-06	0.0084	22.8	Antagonist
6199	3447	SCNN1A	C1145670	Respiratory failure	3.42	8.5e-08	7e-04	28.7	Binding
6199	2629	SCNN1A	C0340515	Myocardial depression	5.61	1.7e-16	1.6e-12	67.9	Binding
6199	3220	SCNN1A	C0700200	Presyncope	4.63	1.7e-11	8.5e-08	45.3	Antagonist
6199	2713	SCNN1A	C0027769	Nervousness	2.32	2.3e-08	2e-04	31.2	Binding
6199	3580	SCNN1A	C1325847	Sensitisation	4.92	4.8e-11	4.2e-07	43.3	Binding
6199	2629	SCNN1A	C0340515	Myocardial depression	4.45	1.1e-09	5.6e-06	37.1	Antagonist
6199	3892	SCNN1A	C0040264	Tinnitus	2.47	5.9e-07	0.0048	24.9	Binding
6199	1530	SCNN1A	C0854268	Foetal damage	5.54	1.3e-09	1.2e-05	36.7	Binding
6199	908	SCNN1A	C0009421	Coma	3.14	1.8e-08	0.00015	31.7	Binding
6199	2517	SCNN1A	C0025637	Methaemoglobinaemia	3.8	9.5e-08	0.00046	28.5	Antagonist
6199	3447	SCNN1A	C1145670	Respiratory failure	3.11	9.6e-06	0.043	19.6	Antagonist
6200	3447	SCNN1B	C1145670	Respiratory failure	3.42	8.5e-08	7e-04	28.7	Binding
6200	2604	SCNN1B	C0231530	Muscle twitching	3.16	1.4e-06	0.0066	23.3	Antagonist
6200	3580	SCNN1B	C1325847	Sensitisation	4.92	4.8e-11	4.2e-07	43.3	Binding
6200	1964	SCNN1B	C0521592	Hypoaesthesia oral	5.42	2.4e-13	2.2e-09	53.6	Binding
6200	2517	SCNN1B	C0025637	Methaemoglobinaemia	4.9	2e-14	1.8e-10	58.5	Binding
6200	703	SCNN1B	C0018790	Cardiac arrest	3.53	8.4e-10	7.2e-06	37.7	Binding
6200	703	SCNN1B	C0018790	Cardiac arrest	3.04	3.5e-06	0.016	21.5	Antagonist
6200	2049	SCNN1B	C0151692	Impaired healing	3.74	6.4e-09	5.4e-05	33.7	Binding
6200	1964	SCNN1B	C0521592	Hypoaesthesia oral	4.24	2.2e-07	0.0011	26.8	Antagonist
6200	2629	SCNN1B	C0340515	Myocardial depression	4.45	1.1e-09	5.6e-06	37.1	Antagonist
6200	1530	SCNN1B	C0854268	Foetal damage	5.54	1.3e-09	1.2e-05	36.7	Binding
6200	3447	SCNN1B	C1145670	Respiratory failure	3.11	9.6e-06	0.043	19.6	Antagonist
6200	3580	SCNN1B	C1325847	Sensitisation	4.06	6.1e-07	0.0029	24.9	Antagonist
6200	2517	SCNN1B	C0025637	Methaemoglobinaemia	3.8	9.5e-08	0.00046	28.5	Antagonist
6200	2369	SCNN1B	C0041657	Loss of consciousness	4.79	1.2e-10	1e-06	41.5	Binding
6200	4166	SCNN1B	C0344232	Vision blurred	2.08	1.8e-08	0.00015	31.7	Binding
6200	908	SCNN1B	C0009421	Coma	2.96	3.4e-06	0.016	21.6	Antagonist
6200	908	SCNN1B	C0009421	Coma	3.14	1.8e-08	0.00015	31.7	Binding
6200	2629	SCNN1B	C0340515	Myocardial depression	5.61	1.7e-16	1.6e-12	67.9	Binding
6200	3892	SCNN1B	C0040264	Tinnitus	2.47	5.9e-07	0.0048	24.9	Binding
6200	2604	SCNN1B	C0231530	Muscle twitching	3.75	2.6e-10	2.2e-06	40	Binding
6200	766	SCNN1B	C0151560	Central nervous system stimulation	3.55	2.3e-12	2.1e-08	49.2	Binding
6200	1213	SCNN1B	C0013362	Dysarthria	3.18	1.3e-07	0.001	27.9	Binding
6200	2713	SCNN1B	C0027769	Nervousness	2.32	2.3e-08	2e-04	31.2	Binding
6200	766	SCNN1B	C0151560	Central nervous system stimulation	3.1	2.8e-08	0.00013	30.9	Antagonist
6200	1213	SCNN1B	C0013362	Dysarthria	3.15	7.5e-06	0.034	20.1	Antagonist
6200	3220	SCNN1B	C0700200	Presyncope	5.75	9.4e-19	8.8e-15	78.2	Binding
6200	2243	SCNN1B	C0022568	Keratitis	4.41	1.6e-09	1.4e-05	36.4	Binding
6200	985	SCNN1B	C0010034	Corneal disorder	4.84	1.9e-09	1.6e-05	36.1	Binding
6200	2369	SCNN1B	C0041657	Loss of consciousness	3.85	1.8e-06	0.0084	22.8	Antagonist
6200	3220	SCNN1B	C0700200	Presyncope	4.63	1.7e-11	8.5e-08	45.3	Antagonist
6201	2604	SCNN1D	C0231530	Muscle twitching	3.8	5.8e-11	5.1e-07	42.9	Binding
6201	1530	SCNN1D	C0854268	Foetal damage	5.35	3.5e-09	2.9e-05	34.9	Binding
6201	703	SCNN1D	C0018790	Cardiac arrest	3.72	1.6e-11	1.4e-07	45.4	Binding
6201	3447	SCNN1D	C1145670	Respiratory failure	3.2	2.4e-06	0.011	22.3	Antagonist
6201	3892	SCNN1D	C0040264	Tinnitus	2.46	4e-07	0.0032	25.7	Binding
6201	2604	SCNN1D	C0231530	Muscle twitching	3.23	3.8e-07	0.0018	25.8	Antagonist
6201	2629	SCNN1D	C0340515	Myocardial depression	5.71	1e-17	9.6e-14	73.5	Binding
6201	908	SCNN1D	C0009421	Coma	3.16	6.6e-09	5.6e-05	33.6	Binding
6201	766	SCNN1D	C0151560	Central nervous system stimulation	3.55	8.9e-13	7.9e-09	51.1	Binding
6201	766	SCNN1D	C0151560	Central nervous system stimulation	3.12	1.1e-08	5.2e-05	32.7	Antagonist
6201	4166	SCNN1D	C0344232	Vision blurred	2.14	1.1e-09	9.2e-06	37.2	Binding
6201	2243	SCNN1D	C0022568	Keratitis	4.54	1.6e-10	1.4e-06	40.9	Binding
6201	1964	SCNN1D	C0521592	Hypoaesthesia oral	4.43	2e-08	9.7e-05	31.5	Antagonist
6201	3220	SCNN1D	C0700200	Presyncope	5.82	6.3e-20	6e-16	83.5	Binding
6201	3220	SCNN1D	C0700200	Presyncope	4.73	1.7e-12	8.7e-09	49.8	Antagonist
6201	985	SCNN1D	C0010034	Corneal disorder	4.68	5e-09	4.2e-05	34.2	Binding
6201	2629	SCNN1D	C0340515	Myocardial depression	4.58	1.1e-10	5.5e-07	41.6	Antagonist
6201	3580	SCNN1D	C1325847	Sensitisation	5.07	3.2e-12	2.9e-08	48.6	Binding
6201	908	SCNN1D	C0009421	Coma	3.01	1.1e-06	0.0051	23.7	Antagonist
6201	2049	SCNN1D	C0151692	Impaired healing	3.23	4.4e-06	0.02	21.1	Antagonist
6201	2713	SCNN1D	C0027769	Nervousness	2.13	1e-05	0.045	19.5	Antagonist
6201	2243	SCNN1D	C0022568	Keratitis	3.75	3.1e-06	0.014	21.7	Antagonist
6201	2517	SCNN1D	C0025637	Methaemoglobinaemia	3.91	1.5e-08	7.1e-05	32.1	Antagonist
6201	4166	SCNN1D	C0344232	Vision blurred	1.98	1.2e-06	0.0055	23.6	Antagonist
6201	2713	SCNN1D	C0027769	Nervousness	2.29	2.6e-08	0.00022	31	Binding
6201	2369	SCNN1D	C0041657	Loss of consciousness	4.03	2.2e-07	0.001	26.9	Antagonist
6201	2517	SCNN1D	C0025637	Methaemoglobinaemia	4.97	2.1e-15	1.9e-11	63	Binding
6201	1213	SCNN1D	C0013362	Dysarthria	3.24	1.8e-06	0.0084	22.8	Antagonist
6201	1964	SCNN1D	C0521592	Hypoaesthesia oral	5.56	1.3e-14	1.1e-10	59.5	Binding
6201	268	SCNN1D	C0003578	Apnoea	2.9	2.7e-06	0.021	22	Binding
6201	703	SCNN1D	C0018790	Cardiac arrest	3.11	1e-06	0.0047	23.9	Antagonist
6201	2049	SCNN1D	C0151692	Impaired healing	3.82	1.2e-09	1e-05	37	Binding
6201	3447	SCNN1D	C1145670	Respiratory failure	3.49	2e-08	0.00017	31.5	Binding
6201	3580	SCNN1D	C1325847	Sensitisation	4.24	6.2e-08	3e-04	29.3	Antagonist
6201	1213	SCNN1D	C0013362	Dysarthria	3.22	3.8e-08	0.00031	30.3	Binding
6201	2369	SCNN1D	C0041657	Loss of consciousness	4.94	8.5e-12	7.5e-08	46.6	Binding
6202	1530	SCNN1G	C0854268	Foetal damage	5.54	1.3e-09	1.2e-05	36.7	Binding
6202	2604	SCNN1G	C0231530	Muscle twitching	3.75	2.6e-10	2.2e-06	40	Binding
6202	908	SCNN1G	C0009421	Coma	2.96	3.4e-06	0.016	21.6	Antagonist
6202	2049	SCNN1G	C0151692	Impaired healing	3.74	6.4e-09	5.4e-05	33.7	Binding
6202	2629	SCNN1G	C0340515	Myocardial depression	4.45	1.1e-09	5.6e-06	37.1	Antagonist
6202	3892	SCNN1G	C0040264	Tinnitus	2.47	5.9e-07	0.0048	24.9	Binding
6202	3220	SCNN1G	C0700200	Presyncope	4.63	1.7e-11	8.5e-08	45.3	Antagonist
6202	4166	SCNN1G	C0344232	Vision blurred	2.08	1.8e-08	0.00015	31.7	Binding
6202	1213	SCNN1G	C0013362	Dysarthria	3.15	7.5e-06	0.034	20.1	Antagonist
6202	2517	SCNN1G	C0025637	Methaemoglobinaemia	4.9	2e-14	1.8e-10	58.5	Binding
6202	3220	SCNN1G	C0700200	Presyncope	5.75	9.4e-19	8.8e-15	78.2	Binding
6202	908	SCNN1G	C0009421	Coma	3.14	1.8e-08	0.00015	31.7	Binding
6202	3447	SCNN1G	C1145670	Respiratory failure	3.42	8.5e-08	7e-04	28.7	Binding
6202	3447	SCNN1G	C1145670	Respiratory failure	3.11	9.6e-06	0.043	19.6	Antagonist
6202	766	SCNN1G	C0151560	Central nervous system stimulation	3.1	2.8e-08	0.00013	30.9	Antagonist
6202	2243	SCNN1G	C0022568	Keratitis	4.41	1.6e-09	1.4e-05	36.4	Binding
6202	2604	SCNN1G	C0231530	Muscle twitching	3.16	1.4e-06	0.0066	23.3	Antagonist
6202	3580	SCNN1G	C1325847	Sensitisation	4.92	4.8e-11	4.2e-07	43.3	Binding
6202	2713	SCNN1G	C0027769	Nervousness	2.32	2.3e-08	2e-04	31.2	Binding
6202	1964	SCNN1G	C0521592	Hypoaesthesia oral	5.42	2.4e-13	2.2e-09	53.6	Binding
6202	2369	SCNN1G	C0041657	Loss of consciousness	4.79	1.2e-10	1e-06	41.5	Binding
6202	985	SCNN1G	C0010034	Corneal disorder	4.84	1.9e-09	1.6e-05	36.1	Binding
6202	703	SCNN1G	C0018790	Cardiac arrest	3.53	8.4e-10	7.2e-06	37.7	Binding
6202	766	SCNN1G	C0151560	Central nervous system stimulation	3.55	2.3e-12	2.1e-08	49.2	Binding
6202	1213	SCNN1G	C0013362	Dysarthria	3.18	1.3e-07	0.001	27.9	Binding
6202	2369	SCNN1G	C0041657	Loss of consciousness	3.85	1.8e-06	0.0084	22.8	Antagonist
6202	2517	SCNN1G	C0025637	Methaemoglobinaemia	3.8	9.5e-08	0.00046	28.5	Antagonist
6202	1964	SCNN1G	C0521592	Hypoaesthesia oral	4.24	2.2e-07	0.0011	26.8	Antagonist
6202	703	SCNN1G	C0018790	Cardiac arrest	3.04	3.5e-06	0.016	21.5	Antagonist
6202	3580	SCNN1G	C1325847	Sensitisation	4.06	6.1e-07	0.0029	24.9	Antagonist
6202	2629	SCNN1G	C0340515	Myocardial depression	5.61	1.7e-16	1.6e-12	67.9	Binding
981	1946	SERPINA6	C0020555	Hypertrichosis	35.13	1.3e-88	1.3e-84	398.2	Binding
981	2488	SERPINA6	C0025345	Menstrual disorder	5.89	9.4e-16	8.7e-12	64.5	Binding
981	159	SERPINA6	C0002453	Amenorrhoea	4.49	2.6e-07	0.0021	26.5	Binding
981	3656	SERPINA6	C0152459	Skin striae	55.05	1e-140	1e-136	637.8	Binding
981	2605	SERPINA6	C0151786	Muscular weakness	8.56	4.6e-19	4.3e-15	79.6	Binding
981	2793	SERPINA6	C0013604	Oedema	4.01	7.3e-11	6.3e-07	42.4	Binding
981	1912	SERPINA6	C0020456	Hyperglycaemia	5.79	2.7e-16	2.5e-12	67	Binding
981	3627	SERPINA6	C0151514	Skin atrophy	43.41	2.8e-110	2.8e-106	497.8	Binding
981	2891	SERPINA6	C0029456	Osteoporosis	38.21	1.5e-104	1.5e-100	471.5	Binding
981	3830	SERPINA6	C0039446	Telangiectasia	46.1	4e-98	4e-94	442	Binding
981	3790	SERPINA6	C0038826	Superinfection	26.58	3.9e-50	3.9e-46	221.7	Binding
981	1096	SERPINA6	C0011570	Depression	3.18	1.3e-06	0.01	23.5	Binding
981	46	SERPINA6	C0702166	Acne	17.23	2.1e-38	2e-34	168	Binding
981	1317	SERPINA6	C0014130	Endocrine disorder	5.41	1.1e-15	9.9e-12	64.3	Binding
981	1022	SERPINA6	C0332601	Cushingoid	36.74	2.1e-100	2.1e-96	452.4	Binding
981	3014	SERPINA6	C0030920	Peptic ulcer	15.83	5.9e-29	5.7e-25	124.7	Binding
981	1396	SERPINA6	C0235146	Euphoric mood	5.74	3.8e-09	3.3e-05	34.7	Binding
4796	3601	SIGMAR1	C0036974	Shock	3.22	4.9e-06	0.038	20.9	Binding
4796	1091	SIGMAR1	C0439857	Dependence	4.17	3.5e-14	3.2e-10	57.4	Binding
4796	2008	SIGMAR1	C0413252	Hypothermia	3.26	2.5e-09	2.1e-05	35.6	Binding
4796	3442	SIGMAR1	C0235063	Respiratory depression	5.1	7.3e-11	3.6e-07	42.4	Antagonist
4796	787	SIGMAR1	C0007820	Cerebrovascular disorder	4.93	2.2e-10	1.9e-06	40.2	Binding
4796	1193	SIGMAR1	C0013220	Drug tolerance	5.79	3e-09	2.6e-05	35.2	Binding
4796	430	SIGMAR1	C0151824	Biliary colic	14.58	6.8e-35	6.6e-31	151.9	Binding
4796	2825	SIGMAR1	C0028961	Oliguria	5.21	2.2e-10	1.9e-06	40.3	Binding
4796	2196	SIGMAR1	C0151740	Intracranial pressure increased	7.35	1.4e-19	1.3e-15	81.9	Binding
4796	1106	SIGMAR1	C0011616	Dermatitis contact	4.7	1.1e-11	9.8e-08	46.1	Binding
4796	441	SIGMAR1	C0005686	Bladder disorder	4.13	1.4e-06	0.011	23.2	Binding
4796	2536	SIGMAR1	C0026205	Miosis	7.12	3.9e-28	3.8e-24	120.9	Binding
4796	4010	SIGMAR1	C0948226	Ureteral spasm	16.89	5.8e-41	5.7e-37	179.6	Binding
4796	1199	SIGMAR1	C0043352	Dry mouth	1.87	1.1e-06	0.0084	23.8	Binding
4796	2536	SIGMAR1	C0026205	Miosis	7.6	4.6e-14	2.3e-10	56.9	Antagonist
4796	2141	SIGMAR1	C0521498	Injection site irritation	7.1	2.6e-15	2.4e-11	62.5	Binding
4796	4230	SIGMAR1	C0038587	Withdrawal syndrome	10.35	6.1e-22	5.8e-18	92.7	Binding
4796	3442	SIGMAR1	C0235063	Respiratory depression	4.05	3.6e-16	3.3e-12	66.4	Binding
4796	2146	SIGMAR1	C0151828	Injection site pain	2.76	2.9e-06	0.022	21.9	Binding
6421	1986	SLC10A2	C0020621	Hypokalaemia	4.46	1.2e-06	0.0054	23.7	Antagonist
6421	2938	SLC10A2	C0030305	Pancreatitis	4.77	2.9e-07	0.0014	26.3	Antagonist
6421	2938	SLC10A2	C0030305	Pancreatitis	4.75	3.3e-07	0.0027	26.1	Binding
6425	1370	SLC12A1	C0242350	Erectile dysfunction	4.34	5.2e-07	0.0042	25.2	Binding
6425	584	SLC12A1	C0005956	Bone marrow disorder	3.78	9.5e-07	0.0076	24	Binding
6425	1297	SLC12A1	C0342579	Electrolyte imbalance	9.79	2.7e-22	2.5e-18	94.3	Binding
6425	3333	SLC12A1	C0268104	Purine metabolism disorder	38.3	3.7e-73	3.6e-69	327.3	Binding
6425	2938	SLC12A1	C0030305	Pancreatitis	15.62	1.5e-34	1.5e-30	150.3	Binding
6425	1696	SLC12A1	C0018099	Gout	23.15	1.3e-52	1.3e-48	233	Binding
6425	1986	SLC12A1	C0020621	Hypokalaemia	17.39	2.7e-52	2.7e-48	231.6	Binding
6425	500	SLC12A1	C0018939	Blood disorder	3.67	1.4e-09	1.2e-05	36.6	Binding
6425	3089	SLC12A1	C0162830	Photosensitivity reaction	6.47	1.1e-14	1e-10	59.7	Binding
6436	1346	SLC15A2	C0014457	Eosinophilia	32.63	4.6e-82	4.5e-78	368.2	Binding
6436	2736	SLC15A2	C0027947	Neutropenia	11.79	5e-21	4.8e-17	88.5	Binding
6436	1811	SLC15A2	C0235996	Hepatic enzyme increased	9.99	2.8e-19	1.4e-15	80.6	Antagonist
6436	1346	SLC15A2	C0014457	Eosinophilia	31.93	2.9e-80	1.5e-76	359.9	Antagonist
6436	1811	SLC15A2	C0235996	Hepatic enzyme increased	10.75	6.4e-21	6.1e-17	88	Binding
6436	2309	SLC15A2	C0023530	Leukopenia	6.05	9.1e-10	4.5e-06	37.5	Antagonist
6436	2309	SLC15A2	C0023530	Leukopenia	6.56	9.4e-11	8.2e-07	41.9	Binding
6436	2736	SLC15A2	C0027947	Neutropenia	11.59	1.2e-20	6.3e-17	86.7	Antagonist
6551	3536	SLC6A2	C0036341	Schizophrenia	3.19	4.9e-08	4e-04	29.8	Binding
6551	3597	SLC6A2	C0549622	Sexual dysfunction	1.84	3.4e-07	0.0027	26	Binding
6551	4216	SLC6A2	C0043096	Weight decreased	2.19	1.2e-06	0.0098	23.5	Binding
6551	3293	SLC6A2	C0033975	Psychotic disorder	2.08	3.6e-08	3e-04	30.3	Binding
6551	1370	SLC6A2	C0242350	Erectile dysfunction	2.14	3.2e-09	2.7e-05	35.1	Binding
6551	508	SLC6A2	C0580546	Blood glucose abnormal	3.36	1e-08	8.7e-05	32.8	Binding
6551	2928	SLC6A2	C0030252	Palpitations	2.05	1.3e-09	1.1e-05	36.8	Binding
6551	1029	SLC6A2	C0235238	Cycloplegia	2.54	1e-06	0.008	23.9	Binding
6551	3666	SLC6A2	C0851578	Sleep disorder	2.29	1.1e-06	0.0051	23.8	Antagonist
6551	3956	SLC6A2	C0040822	Tremor	1.79	5.8e-08	0.00048	29.4	Binding
6551	1913	SLC6A2	C0020458	Hyperhidrosis	2.53	5.6e-09	2.7e-05	34	Antagonist
6551	2439	SLC6A2	C0338831	Mania	3.58	2.2e-08	0.00011	31.3	Antagonist
6551	2439	SLC6A2	C0338831	Mania	3.57	1.5e-14	1.4e-10	59.1	Binding
6551	235	SLC6A2	C0151500	Anticholinergic syndrome	3.09	9e-12	8e-08	46.5	Binding
6551	1913	SLC6A2	C0020458	Hyperhidrosis	2.36	3.1e-14	2.8e-10	57.7	Binding
6551	1268	SLC6A2	C0235969	Ejaculation disorder	3.15	3.3e-09	2.8e-05	35	Binding
6551	3666	SLC6A2	C0851578	Sleep disorder	2.12	1.1e-09	9.1e-06	37.2	Binding
6551	2928	SLC6A2	C0030252	Palpitations	2.11	9.8e-06	0.044	19.6	Antagonist
6551	2875	SLC6A2	C0020651	Orthostatic hypotension	1.97	8.5e-08	7e-04	28.7	Binding
6551	2161	SLC6A2	C0917801	Insomnia	1.73	8.9e-08	0.00073	28.6	Binding
6551	3293	SLC6A2	C0033975	Psychotic disorder	2.42	6.9e-07	0.0032	24.7	Antagonist
6551	1199	SLC6A2	C0043352	Dry mouth	1.91	9.3e-12	8.2e-08	46.5	Binding
6551	1990	SLC6A2	C0241934	Hypomania	3.98	2.7e-08	0.00023	30.9	Binding
6551	925	SLC6A2	C0264886	Conduction disorder	3.26	2.5e-08	0.00021	31	Binding
6552	3821	SLC6A3	C0039231	Tachycardia	1.74	5.9e-06	0.046	20.5	Binding
6552	2161	SLC6A3	C0917801	Insomnia	1.74	4e-06	0.031	21.2	Binding
6552	2620	SLC6A3	C0026961	Mydriasis	2.83	7.8e-07	0.0062	24.4	Binding
6552	1913	SLC6A3	C0020458	Hyperhidrosis	2.29	8.5e-10	7.3e-06	37.7	Binding
6552	2713	SLC6A3	C0027769	Nervousness	1.98	2.7e-06	0.021	22.1	Binding
6552	2928	SLC6A3	C0030252	Palpitations	2.09	7.4e-08	0.00061	29	Binding
6552	1913	SLC6A3	C0020458	Hyperhidrosis	2.49	7e-07	0.0033	24.6	Antagonist
6552	3956	SLC6A3	C0040822	Tremor	2.19	7.6e-07	0.0036	24.5	Antagonist
6552	1199	SLC6A3	C0043352	Dry mouth	1.93	1.8e-09	1.6e-05	36.2	Binding
6552	1268	SLC6A3	C0235969	Ejaculation disorder	3.07	1.4e-06	0.011	23.3	Binding
6552	3956	SLC6A3	C0040822	Tremor	2.02	1.4e-09	1.2e-05	36.7	Binding
6553	1370	SLC6A4	C0242350	Erectile dysfunction	2.2	1.5e-09	1.3e-05	36.5	Binding
6553	508	SLC6A4	C0580546	Blood glucose abnormal	4.09	2.7e-13	2.5e-09	53.4	Binding
6553	3536	SLC6A4	C0036341	Schizophrenia	3.89	2.5e-12	2.2e-08	49	Binding
6553	2439	SLC6A4	C0338831	Mania	4.07	1.3e-10	6.5e-07	41.3	Antagonist
6553	2928	SLC6A4	C0030252	Palpitations	2.06	3.5e-09	3e-05	34.9	Binding
6553	4216	SLC6A4	C0043096	Weight decreased	2.45	8.2e-09	6.9e-05	33.2	Binding
6553	3536	SLC6A4	C0036341	Schizophrenia	3.51	1.1e-05	0.05	19.3	Antagonist
6553	1199	SLC6A4	C0043352	Dry mouth	1.9	4e-06	0.018	21.3	Antagonist
6553	235	SLC6A4	C0151500	Anticholinergic syndrome	3.1	3.6e-11	3.1e-07	43.8	Binding
6553	2315	SLC6A4	C0854382	Libido disorder	2.45	3.1e-08	0.00026	30.6	Binding
6553	925	SLC6A4	C0264886	Conduction disorder	3.54	9.6e-06	0.043	19.6	Antagonist
6553	1029	SLC6A4	C0235238	Cycloplegia	2.6	8.1e-07	0.0064	24.3	Binding
6553	508	SLC6A4	C0580546	Blood glucose abnormal	3.64	5.6e-06	0.026	20.6	Antagonist
6553	4028	SLC6A4	C0080274	Urinary retention	1.9	3.3e-06	0.026	21.6	Binding
6553	3666	SLC6A4	C0851578	Sleep disorder	2.15	1.3e-09	1.1e-05	36.9	Binding
6553	2161	SLC6A4	C0917801	Insomnia	2.02	7.1e-07	0.0033	24.6	Antagonist
6553	2161	SLC6A4	C0917801	Insomnia	2.02	3.9e-13	3.5e-09	52.7	Binding
6553	1913	SLC6A4	C0020458	Hyperhidrosis	2.55	5.6e-17	5.2e-13	70.1	Binding
6553	3956	SLC6A4	C0040822	Tremor	2.01	4e-06	0.018	21.3	Antagonist
6553	2875	SLC6A4	C0020651	Orthostatic hypotension	2.03	3.7e-08	0.00031	30.3	Binding
6553	3821	SLC6A4	C0039231	Tachycardia	1.67	2.8e-06	0.022	21.9	Binding
6553	1913	SLC6A4	C0020458	Hyperhidrosis	2.64	1.4e-09	7e-06	36.6	Antagonist
6553	2315	SLC6A4	C0854382	Libido disorder	3.14	7.6e-07	0.0036	24.5	Antagonist
6553	1990	SLC6A4	C0241934	Hypomania	3.68	1.7e-06	0.013	22.9	Binding
6553	3597	SLC6A4	C0549622	Sexual dysfunction	1.9	1.1e-07	0.00089	28.2	Binding
6553	1568	SLC6A4	C0235660	Galactorrhoea	2.28	8.7e-08	0.00072	28.6	Binding
6553	3956	SLC6A4	C0040822	Tremor	1.97	8.9e-11	7.8e-07	42	Binding
6553	2713	SLC6A4	C0027769	Nervousness	1.99	7.5e-08	0.00062	28.9	Binding
6553	925	SLC6A4	C0264886	Conduction disorder	4.14	4.7e-14	4.2e-10	56.9	Binding
6553	1091	SLC6A4	C0439857	Dependence	3.75	3.2e-06	0.015	21.7	Antagonist
6553	2439	SLC6A4	C0338831	Mania	4.03	1.3e-18	1.3e-14	77.5	Binding
6553	1199	SLC6A4	C0043352	Dry mouth	2.01	1.7e-13	1.5e-09	54.3	Binding
6553	1411	SLC6A4	C0015371	Extrapyramidal disorder	2.04	3.5e-06	0.027	21.5	Binding
6553	3666	SLC6A4	C0851578	Sleep disorder	2.25	6.1e-06	0.028	20.4	Antagonist
6553	2928	SLC6A4	C0030252	Palpitations	2.2	3.8e-06	0.017	21.4	Antagonist
6553	3293	SLC6A4	C0033975	Psychotic disorder	1.98	1.6e-06	0.013	23	Binding
6738	1143	SRC	C0011991	Diarrhoea	4.21	2e-08	0.00017	31.5	Binding
6740	1719	SRD5A2	C0018418	Gynaecomastia	8.97	4.6e-17	4.3e-13	70.5	Binding
7030	3627	TEK	C0151514	Skin atrophy	55.76	2.1e-189	2.1e-185	861.6	Binding
7030	3790	TEK	C0038826	Superinfection	22.95	1.3e-47	6.8e-44	210.1	Antagonist
7030	1317	TEK	C0014130	Endocrine disorder	6.15	2e-21	1.9e-17	90.3	Binding
7030	103	TEK	C0001621	Adrenal disorder	29.49	6.3e-80	3.2e-76	358.4	Antagonist
7030	103	TEK	C0001621	Adrenal disorder	34.97	2.2e-95	2.2e-91	429.4	Binding
7030	1938	TEK	C0020538	Hypertension	5.16	5.4e-14	2.7e-10	56.6	Antagonist
7030	3656	TEK	C0152459	Skin striae	53.72	2.1e-137	1.1e-133	622.6	Antagonist
7030	159	TEK	C0002453	Amenorrhoea	5.21	2.2e-10	1.9e-06	40.3	Binding
7030	2196	TEK	C0151740	Intracranial pressure increased	17.71	1.1e-32	5.4e-29	141.8	Antagonist
7030	1396	TEK	C0235146	Euphoric mood	6.77	2.5e-13	2.2e-09	53.6	Binding
7030	3014	TEK	C0030920	Peptic ulcer	15.55	2.1e-28	2e-24	122.2	Binding
7030	2888	TEK	C0029445	Osteonecrosis	52.45	4.2e-112	2.2e-108	506.2	Antagonist
7030	2891	TEK	C0029456	Osteoporosis	49.97	2.6e-190	1.4e-186	865.8	Antagonist
7030	1022	TEK	C0332601	Cushingoid	54.13	3.8e-229	3.8e-225	1044.5	Binding
7030	2793	TEK	C0013604	Oedema	4.72	2.5e-16	2.3e-12	67.2	Binding
7030	3830	TEK	C0039446	Telangiectasia	61.75	2.9e-184	2.9e-180	838	Binding
7030	3627	TEK	C0151514	Skin atrophy	55.88	4.9e-190	2.6e-186	864.6	Antagonist
7030	3014	TEK	C0030920	Peptic ulcer	15.28	6.6e-28	3.4e-24	119.9	Antagonist
7030	2492	TEK	C0004936	Mental disorder	3.39	9.2e-06	0.041	19.7	Antagonist
7030	3790	TEK	C0038826	Superinfection	28.72	3.6e-60	3.5e-56	267.7	Binding
7030	2891	TEK	C0029456	Osteoporosis	50.93	6.9e-194	6.9e-190	882.3	Binding
7030	1986	TEK	C0020621	Hypokalaemia	8.08	4.3e-15	2.2e-11	61.5	Antagonist
7030	582	TEK	C0005940	Bone disorder	29.79	1.4e-68	1.4e-64	306.3	Binding
7030	2605	TEK	C0151786	Muscular weakness	9.7	1.8e-25	1.7e-21	108.8	Binding
7030	2888	TEK	C0029445	Osteonecrosis	56.89	1.1e-121	1.1e-117	550.2	Binding
7030	159	TEK	C0002453	Amenorrhoea	4.79	2.5e-09	1.2e-05	35.5	Antagonist
7030	2939	TEK	C0001339	Pancreatitis acute	27.41	6.6e-63	3.4e-59	280.3	Antagonist
7030	1912	TEK	C0020456	Hyperglycaemia	4.58	4.9e-10	2.4e-06	38.7	Antagonist
7030	2939	TEK	C0001339	Pancreatitis acute	27.27	1.6e-62	1.6e-58	278.5	Binding
7030	1946	TEK	C0020555	Hypertrichosis	43.66	2.6e-138	1.3e-134	626.7	Antagonist
7030	106	TEK	C0001623	Adrenal insufficiency	34.76	8.9e-95	8.9e-91	426.6	Binding
7030	2605	TEK	C0151786	Muscular weakness	9.77	9.9e-26	5.1e-22	110	Antagonist
7030	2488	TEK	C0025345	Menstrual disorder	4.23	7e-08	0.00034	29.1	Antagonist
7030	3830	TEK	C0039446	Telangiectasia	58.64	5.9e-175	3e-171	795.2	Antagonist
7030	1938	TEK	C0020538	Hypertension	4.57	7.4e-12	6.5e-08	46.9	Binding
7030	1396	TEK	C0235146	Euphoric mood	6.93	9.9e-14	5e-10	55.4	Antagonist
7030	1022	TEK	C0332601	Cushingoid	54.56	2.9e-231	1.5e-227	1054.2	Antagonist
7030	2793	TEK	C0013604	Oedema	4.73	2.3e-16	1.1e-12	67.4	Antagonist
7030	1946	TEK	C0020555	Hypertrichosis	42.47	3e-134	2.9e-130	608.1	Binding
7030	1317	TEK	C0014130	Endocrine disorder	5.59	6.3e-19	3.2e-15	79	Antagonist
7030	106	TEK	C0001623	Adrenal insufficiency	28.93	2.5e-78	1.3e-74	351.1	Antagonist
7030	2488	TEK	C0025345	Menstrual disorder	4.43	2.2e-08	0.00019	31.3	Binding
7030	2196	TEK	C0151740	Intracranial pressure increased	17.39	4.9e-32	4.8e-28	138.8	Binding
7030	582	TEK	C0005940	Bone disorder	31.75	2.4e-73	1.2e-69	328.2	Antagonist
7030	1986	TEK	C0020621	Hypokalaemia	7.34	1.8e-13	1.6e-09	54.2	Binding
7030	1912	TEK	C0020456	Hyperglycaemia	4.74	1.7e-10	1.4e-06	40.8	Binding
7030	3656	TEK	C0152459	Skin striae	54.07	3.6e-138	3.6e-134	626	Binding
7237	167	TOP1	C0002871	Anaemia	5.21	4.1e-08	0.00034	30.1	Binding
7237	149	TOP1	C0002170	Alopecia	6.01	1.6e-11	1.4e-07	45.4	Binding
7237	3753	TOP1	C0038362	Stomatitis	12.56	3.4e-27	3.3e-23	116.6	Binding
7238	203	TOP2A	C0002994	Angioedema	5.73	7.3e-11	6.4e-07	42.4	Binding
7238	1216	TOP2A	C0013378	Dysgeusia	4.02	6.6e-10	5.7e-06	38.1	Binding
7238	149	TOP2A	C0002170	Alopecia	3.38	2.9e-07	0.0024	26.3	Binding
7238	1748	TOP2A	C0019080	Haemorrhage	4.04	2.4e-06	0.019	22.3	Binding
7238	3753	TOP2A	C0038362	Stomatitis	6.23	5.9e-15	5.4e-11	60.9	Binding
7238	2571	TOP2A	C0333355	Mucosal inflammation	12.38	9.2e-27	8.9e-23	114.7	Binding
7239	167	TOP2B	C0002871	Anaemia	3.5	4.8e-06	0.037	20.9	Binding
7239	3753	TOP2B	C0038362	Stomatitis	8.11	1.2e-20	1.1e-16	86.8	Binding
7239	149	TOP2B	C0002170	Alopecia	4.14	2.9e-09	2.5e-05	35.2	Binding
7239	2571	TOP2B	C0333355	Mucosal inflammation	13.43	3e-24	2.9e-20	103.2	Binding
753	2315	TSPO	C0854382	Libido disorder	7.38	8.5e-20	7.6e-17	82.9	Agonist
753	3693	TSPO	C2830004	Somnolence	2.54	2.3e-10	2e-06	40.2	Binding
753	2220	TSPO	C0022346	Jaundice	4.12	4.7e-16	4.4e-12	65.9	Binding
753	500	TSPO	C0018939	Blood disorder	4.37	1.8e-09	1.5e-06	36.2	Agonist
753	1171	TSPO	C0012833	Dizziness	2.17	1.5e-06	0.012	23.2	Binding
753	354	TSPO	C0004134	Ataxia	4.82	3.4e-12	3e-09	48.4	Agonist
753	927	TSPO	C0009676	Confusional state	4.34	4.5e-23	4.3e-19	97.8	Binding
753	4028	TSPO	C0080274	Urinary retention	5.27	6.4e-26	6.2e-22	110.8	Binding
753	500	TSPO	C0018939	Blood disorder	2.59	2.7e-08	0.00022	30.9	Binding
753	1091	TSPO	C0439857	Dependence	6.59	4.9e-16	4.5e-12	65.8	Binding
753	4028	TSPO	C0080274	Urinary retention	5.51	6.8e-13	5.9e-10	51.6	Agonist
753	1213	TSPO	C0013362	Dysarthria	4.28	2.7e-06	0.021	22	Binding
753	3597	TSPO	C0549622	Sexual dysfunction	3.23	6.8e-10	5.8e-06	38.1	Binding
753	3597	TSPO	C0549622	Sexual dysfunction	5.45	4.6e-11	3.9e-08	43.4	Agonist
753	4147	TSPO	C0042571	Vertigo	2.76	7.5e-06	0.0057	20	Agonist
753	2315	TSPO	C0854382	Libido disorder	9.55	2.8e-55	2.7e-51	245.3	Binding
753	354	TSPO	C0004134	Ataxia	5.61	9.5e-31	9.2e-27	132.9	Binding
753	927	TSPO	C0009676	Confusional state	3.23	7.6e-07	6e-04	24.4	Agonist
753	2220	TSPO	C0022346	Jaundice	6.02	1.7e-13	1.5e-10	54.3	Agonist
753	2007	TSPO	C0020649	Hypotension	2.4	3.7e-07	0.003	25.8	Binding
753	4147	TSPO	C0042571	Vertigo	2.58	4.7e-10	4e-06	38.8	Binding
12290	167	TUBA1A	C0002871	Anaemia	4.96	1.3e-07	0.001	27.9	Binding
12290	149	TUBA1A	C0002170	Alopecia	7.15	9.4e-18	8.8e-14	73.6	Binding
12290	3866	TUBA1A	C0040034	Thrombocytopenia	5.46	1.8e-13	1.6e-09	54.2	Binding
11215	149	TUBA1B	C0002170	Alopecia	6.82	1.2e-15	1.1e-11	64.1	Binding
11215	167	TUBA1B	C0002871	Anaemia	5.07	7.8e-08	0.00065	28.8	Binding
11215	3866	TUBA1B	C0040034	Thrombocytopenia	5.58	7.4e-14	6.7e-10	55.9	Binding
12292	3866	TUBA1C	C0040034	Thrombocytopenia	5.58	7.4e-14	6.7e-10	55.9	Binding
12292	149	TUBA1C	C0002170	Alopecia	6.82	1.2e-15	1.1e-11	64.1	Binding
12292	167	TUBA1C	C0002871	Anaemia	5.07	7.8e-08	0.00065	28.8	Binding
7337	3866	TUBA3C	C0040034	Thrombocytopenia	5.58	7.4e-14	6.7e-10	55.9	Binding
7337	149	TUBA3C	C0002170	Alopecia	6.82	1.2e-15	1.1e-11	64.1	Binding
7337	167	TUBA3C	C0002871	Anaemia	5.07	7.8e-08	0.00065	28.8	Binding
13649	3866	TUBA3D	C0040034	Thrombocytopenia	5.58	7.4e-14	6.7e-10	55.9	Binding
13649	149	TUBA3D	C0002170	Alopecia	6.82	1.2e-15	1.1e-11	64.1	Binding
13649	167	TUBA3D	C0002871	Anaemia	5.07	7.8e-08	0.00065	28.8	Binding
12289	149	TUBA3E	C0002170	Alopecia	6.82	1.2e-15	1.1e-11	64.1	Binding
12289	3866	TUBA3E	C0040034	Thrombocytopenia	5.58	7.4e-14	6.7e-10	55.9	Binding
12289	167	TUBA3E	C0002871	Anaemia	5.07	7.8e-08	0.00065	28.8	Binding
7336	149	TUBA4A	C0002170	Alopecia	6.82	1.2e-15	1.1e-11	64.1	Binding
7336	167	TUBA4A	C0002871	Anaemia	5.07	7.8e-08	0.00065	28.8	Binding
7336	3866	TUBA4A	C0040034	Thrombocytopenia	5.58	7.4e-14	6.7e-10	55.9	Binding
7338	3866	TUBA8	C0040034	Thrombocytopenia	5.58	7.4e-14	6.7e-10	55.9	Binding
7338	167	TUBA8	C0002871	Anaemia	5.07	7.8e-08	0.00065	28.8	Binding
7338	149	TUBA8	C0002170	Alopecia	6.82	1.2e-15	1.1e-11	64.1	Binding
12299	3866	TUBB	C0040034	Thrombocytopenia	5.72	3.5e-15	3.2e-11	62	Binding
12299	149	TUBB	C0002170	Alopecia	7.06	1.8e-17	1.7e-13	72.3	Binding
12299	167	TUBB	C0002871	Anaemia	5.38	3.1e-09	2.6e-05	35.1	Binding
9564	3866	TUBB1	C0040034	Thrombocytopenia	5.65	4.5e-14	4.1e-10	56.9	Binding
9564	167	TUBB1	C0002871	Anaemia	5.13	6e-08	0.00049	29.4	Binding
9564	149	TUBB1	C0002170	Alopecia	6.9	6.8e-16	6.3e-12	65.2	Binding
7339	2732	TUBB2A	C0031117	Neuropathy peripheral	4.48	1.1e-06	0.0085	23.8	Binding
7339	3866	TUBB2A	C0040034	Thrombocytopenia	5.66	5.9e-15	5.4e-11	60.9	Binding
7339	149	TUBB2A	C0002170	Alopecia	6.97	3.2e-17	3e-13	71.2	Binding
7339	167	TUBB2A	C0002871	Anaemia	5.32	4.1e-09	3.5e-05	34.6	Binding
17909	3866	TUBB2B	C0040034	Thrombocytopenia	5.49	9.2e-13	8.2e-09	51	Binding
17909	149	TUBB2B	C0002170	Alopecia	6.65	4e-14	3.7e-10	57.2	Binding
12294	149	TUBB3	C0002170	Alopecia	6.8	1.4e-15	1.2e-11	63.8	Binding
12294	3866	TUBB3	C0040034	Thrombocytopenia	5.21	6.4e-12	5.7e-08	47.2	Binding
12294	167	TUBB3	C0002871	Anaemia	5.05	8.5e-08	7e-04	28.7	Binding
12298	3866	TUBB6	C0040034	Thrombocytopenia	5.49	9.2e-13	8.2e-09	51	Binding
12298	149	TUBB6	C0002170	Alopecia	6.65	4e-14	3.7e-10	57.2	Binding
9871	3866	TUBD1	C0040034	Thrombocytopenia	5.53	7e-13	6.3e-09	51.5	Binding
9871	149	TUBD1	C0002170	Alopecia	6.7	3e-14	2.7e-10	57.7	Binding
7340	3866	TUBG1	C0040034	Thrombocytopenia	5.46	1.1e-12	1e-08	50.6	Binding
7340	149	TUBG1	C0002170	Alopecia	6.62	5e-14	4.5e-10	56.7	Binding
7341	3866	TUBG2	C0040034	Thrombocytopenia	5.53	7e-13	6.3e-09	51.5	Binding
7341	149	TUBG2	C0002170	Alopecia	6.7	3e-14	2.7e-10	57.7	Binding
